Details of Disease

General Information of Disease (ID: DIS3IHTY)

• Disease Name: Adenocarcinoma
• Synonyms: ADNOS; adenocarcinoma, no subtype (morphologic abnormality); adenocarcinoma, malignant; adenocarcinoma; adenocarcinoma NOS (morphologic abnormality); adenocarcinomas
• Disease Class: 2D40: Adenocarcinoma
• Definition: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.
• Disease Hierarchy:
  DISTDLVN: Glandular cell neoplasm
  DISH9F1N: Carcinoma
  DIS3IHTY: Adenocarcinoma
• ICD Code:
  ICD-11: ICD-11: 2D40
  Expand ICD-11: '2D40
  Expand ICD-9: 1.40E+179
• Disease Identifiers:
  MONDO ID: MONDO_0004970
  MESH ID: D000230
  UMLS CUI: C0001418
  MedGen ID: 122
  SNOMED CT ID: 1187332001

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 12 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Bevacizumab	DMSD1UN	Approved	Monoclonal antibody	[1]
Capecitabine	DMTS85L	Approved	Small molecular drug	[2]
Carboplatin	DMG281S	Approved	Small molecular drug	[3]
Cisplatin	DMRHGI9	Approved	Small molecular drug	[4]
Dacarbazine	DMNPZL4	Approved	Small molecular drug	[5]
Fluorouracil	DMUM7HZ	Approved	Small molecular drug	[6]
Irinotecan	DMP6SC2	Approved	Small molecular drug	[7]
Oxaliplatin	DMQNWRD	Approved	Small molecular drug	[8]
Sorafenib	DMS8IFC	Approved	Small molecular drug	[9]
Temozolomide	DMKECZD	Approved	Small molecular drug	[10]
Vitamin C	DMXJ7O8	Approved	Small molecular drug	[11]
Zoledronate	DMIXC7G	Approved	Small molecular drug	[12]

This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
G-202	DMQR9I8	Phase 2	NA	[13]
CAR-CLD18 T cell	DM6ZHTV	Clinical trial	CAR T Cell Therapy	[14]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 555 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ABCC3	TTVLG21	Limited	Altered Expression	[15]
ADORA2B	TTNE7KG	Limited	Biomarker	[16]
ALOX12B	TTQ4QQH	Limited	Biomarker	[17]
ANXA8	TTSW16P	Limited	Altered Expression	[18]
AOC3	TT7HC21	Limited	Biomarker	[19]
ARRB2	TT8SO2I	Limited	Altered Expression	[20]
BCL2L2	TTQ79W8	Limited	Altered Expression	[21]
CBX7	TTBN3HC	Limited	Altered Expression	[22]
CCKAR	TTCG0AL	Limited	Biomarker	[23]
CD3E	TTZAT79	Limited	Biomarker	[24]
CD44	TTWFBT7	Limited	Altered Expression	[25]
CD83	TTT9MRQ	Limited	Biomarker	[26]
CEACAM3	TTPX7I5	Limited	Biomarker	[27]
CHRNA5	TTH2QRX	Limited	Genetic Variation	[28]
CHUK	TT1F8OQ	Limited	Posttranslational Modification	[29]
CRYZ	TTP6UO8	Limited	Biomarker	[30]
CTSK	TTDZN01	Limited	Biomarker	[31]
DIABLO	TTN74LE	Limited	Biomarker	[32]
EML4	TT92GY4	Limited	Genetic Variation	[33]
EPCAM	TTZ8WH4	Limited	Altered Expression	[34]
EPOR	TTAUX24	Limited	Altered Expression	[35]
FGF1	TTMY81X	Limited	Biomarker	[36]
FGF7	TTFY134	Limited	Altered Expression	[37]
FOLR1	TTVC37M	Limited	Altered Expression	[38]
FOXQ1	TTEJZOL	Limited	Altered Expression	[39]
FYN	TT2B9KF	Limited	Posttranslational Modification	[40]
GGH	TTZJRL0	Limited	Altered Expression	[41]
GIP	TT40HS5	Limited	Biomarker	[42]
GRIA2	TTWM461	Limited	Altered Expression	[43]
GSTA1	TT4P8DE	Limited	Altered Expression	[44]
HOXA7	TTMRE4Q	Limited	Altered Expression	[45]
ID1	TTBXVDE	Limited	Altered Expression	[46]
IGF2R	TTPNE41	Limited	Genetic Variation	[47]
IGFBP5	TTDWEA8	Limited	Altered Expression	[48]
IRF3	TTYR7OH	Limited	Altered Expression	[49]
ITGA4	TTJMF9P	Limited	Biomarker	[50]
JAG2	TTOJY1B	Limited	Altered Expression	[51]
KCNJ3	TTGM19J	Limited	Altered Expression	[52]
KLK14	TTDA81R	Limited	Biomarker	[53]
LIN28A	TTO50LN	Limited	Biomarker	[54]
LYZ	TTAOZBW	Limited	Biomarker	[55]
MAP2K2	TT8H9GB	Limited	Altered Expression	[56]
MCAM	TTHRE05	Limited	Altered Expression	[57]
MMP14	TTJ4QE7	Limited	Biomarker	[58]
MMP7	TTMTWOS	Limited	Altered Expression	[59]
MMP8	TTGA1IV	Limited	Altered Expression	[60]
MSH2	TTCAWRT	Limited	Altered Expression	[61]
MTAP	TTDBX7N	Limited	Genetic Variation	[62]
MUC1	TTBHFYQ	Limited	Biomarker	[63]
MUC5AC	TTEL90S	Limited	Altered Expression	[64]
NFKB2	TTKLNRV	Limited	Biomarker	[65]
NR4A2	TT9HKN3	Limited	Biomarker	[66]
NRP1	TTIPJCB	Limited	Altered Expression	[67]
NRP2	TTRXUVC	Limited	Altered Expression	[68]
NUF2	TTIXBFP	Limited	Altered Expression	[69]
OPA1	TTTU49Q	Limited	Biomarker	[70]
PAOX	TTNQ760	Limited	Biomarker	[71]
PDXP	TT9UYG4	Limited	Biomarker	[72]
PGRMC1	TTY3LAZ	Limited	Altered Expression	[73]
PIK3CB	TT9H4P3	Limited	Biomarker	[74]
PROM1	TTXMZ81	Limited	Altered Expression	[75]
PSIP1	TTH9LDP	Limited	Biomarker	[65]
PTGER2	TT1ZAVI	Limited	Biomarker	[76]
PTGER3	TTPNGDE	Limited	Altered Expression	[77]
PTGES2	TTWU04I	Limited	Altered Expression	[77]
PTP4A1	TTA8GFO	Limited	Biomarker	[78]
PTP4A2	TT1MHKD	Limited	Biomarker	[78]
PTP4A3	TT7YM8D	Limited	Biomarker	[78]
RARA	TTW38KT	Limited	Altered Expression	[79]
RASA1	TTPNZ1F	Limited	Altered Expression	[80]
RORA	TT1TYN7	Limited	Altered Expression	[81]
ROS1	TTSZ6Y3	Limited	Biomarker	[82]
RPH3A	TT9L4J8	Limited	Genetic Variation	[83]
S100A6	TT716MY	Limited	Altered Expression	[84]
SCGB2A2	TT1W3RE	Limited	Altered Expression	[85]
SELE	TT1PL7M	Limited	Biomarker	[86]
SERPINE1	TTTO43N	Limited	Biomarker	[87]
SFRP4	TTX8I1Y	Limited	Altered Expression	[88]
SFTPD	TTGLMU7	Limited	Biomarker	[89]
SLC19A1	TT09I7D	Limited	Biomarker	[90]
SLC5A1	TT2UE56	Limited	Altered Expression	[91]
SLC7A5	TTPH2JB	Limited	Altered Expression	[92]
SOX2	TTCNOT6	Limited	Biomarker	[93]
SSTR2	TTZ6T9E	Limited	Altered Expression	[94]
SSTR3	TTJX3UE	Limited	Biomarker	[95]
SSTR5	TT2BC4G	Limited	Altered Expression	[96]
STOML2	TTOI329	Limited	Altered Expression	[97]
TAGLN	TTDRZ9H	Limited	Biomarker	[98]
TFAP2A	TTDY4BS	Limited	Altered Expression	[99]
TFF1	TTNOJIZ	Limited	Altered Expression	[100]
TRPM7	TTFPVZO	Limited	Biomarker	[101]
TRPV6	TTBK14N	Limited	Altered Expression	[102]
TSG101	TTHU7JA	Limited	Altered Expression	[103]
TXNDC12	TTL0E3Y	Limited	Altered Expression	[104]
VIPR1	TTCL30I	Limited	Altered Expression	[105]
XPA	TTGT87E	Limited	Genetic Variation	[106]
ZFP36L1	TT8QVJO	Limited	Altered Expression	[66]
ABCC2	TTFLHJV	Disputed	Altered Expression	[107]
ANO7	TT2X79I	Disputed	Altered Expression	[108]
CAMP	TTULOB6	Disputed	Altered Expression	[109]
CDH3	TTARMD9	Disputed	Biomarker	[110]
FAP	TTGPQ0F	Disputed	Altered Expression	[111]
FUT4	TTNV1KZ	Disputed	Altered Expression	[112]
GSN	TTUH7OM	Disputed	Altered Expression	[113]
HOXA11	TTEX4ZA	Disputed	Posttranslational Modification	[114]
IGFBP2	TTU4QSN	Disputed	Posttranslational Modification	[115]
LOXL2	TTFSUHX	Disputed	Altered Expression	[116]
MMP12	TTXZ0KQ	Disputed	Altered Expression	[117]
PADI4	TTQHAXM	Disputed	Altered Expression	[118]
PLA2G2A	TTO8QRU	Disputed	Biomarker	[119]
PLA2G4A	TTT1JVS	Disputed	Biomarker	[120]
PSEN2	TTWN3F4	Disputed	Altered Expression	[121]
PTGES	TTYLQ8V	Disputed	Altered Expression	[122]
RRM2	TT1S4LJ	Disputed	Altered Expression	[123]
SHH	TTIENCJ	Disputed	Biomarker	[124]
TNFRSF10B	TTW20TU	Disputed	Altered Expression	[125]
AKR1C3	TT5ZWB6	moderate	Altered Expression	[126]
ARL2	TTIDSFT	moderate	Biomarker	[127]
BSG	TT5UJWD	moderate	Altered Expression	[128]
CA9	TT2LVK8	moderate	Altered Expression	[129]
CCNA2	TTAMQ62	moderate	Biomarker	[130]
CCND3	TT1JXNR	moderate	Altered Expression	[131]
CNTN1	TTPR8FK	moderate	Biomarker	[132]
COPS5	TTSTNJR	moderate	Altered Expression	[133]
CYP11B2	TT9MNE2	moderate	Altered Expression	[134]
DUSP10	TTF3RJ0	moderate	Altered Expression	[135]
DYRK1B	TTYGQ8A	moderate	Biomarker	[136]
E2F3	TTWIJYH	moderate	Altered Expression	[137]
EPAS1	TTWPA54	moderate	Altered Expression	[138]
EPHA4	TTG84D3	moderate	Altered Expression	[139]
ESRRA	TTPNQAC	moderate	Altered Expression	[140]
ESRRG	TT9ZRHB	moderate	Altered Expression	[140]
FABP3	TT3TGLR	moderate	Biomarker	[141]
FOXM1	TTD3KOX	moderate	Biomarker	[142]
GSS	TTVEWR4	moderate	Altered Expression	[143]
HSPA5	TTW26OG	moderate	Altered Expression	[144]
IL11RA	TTZPLJS	moderate	Biomarker	[145]
ITGA2	TTSJ542	moderate	Altered Expression	[146]
ITGAV	TTT1R2L	moderate	Biomarker	[147]
KLK5	TTULSEW	moderate	Altered Expression	[148]
LNPEP	TTY2KP7	moderate	Biomarker	[149]
MMP17	TTVSZKN	moderate	Altered Expression	[150]
MTA1	TTO4HUS	moderate	Altered Expression	[151]
MUC16	TTC1PS3	moderate	Biomarker	[152]
PDCD1	TTNBFWK	moderate	Biomarker	[153]
PDCD2	TTYOVWN	moderate	Altered Expression	[154]
PIM3	TTCGOIN	moderate	Biomarker	[155]
PTGER4	TT79WV3	moderate	Biomarker	[156]
PTGFR	TTT2ZAR	moderate	Altered Expression	[157]
PTGIS	TTLXKZR	moderate	Biomarker	[158]
RTN4	TT7GXMU	moderate	Altered Expression	[159]
S100A9	TT0TMQG	moderate	Posttranslational Modification	[160]
SERPINB5	TT1KW50	moderate	Biomarker	[161]
SLC2A4	TTP6MT5	moderate	Biomarker	[149]
SLC33A1	TTL69WB	moderate	Altered Expression	[162]
SLC38A1	TT1YE9Z	moderate	Altered Expression	[163]
SQSTM1	TTOT2RY	moderate	Biomarker	[164]
THRB	TTGER3L	moderate	Genetic Variation	[165]
TK1	TTP3QRF	moderate	Biomarker	[166]
TMBIM6	TT7QSMG	moderate	Altered Expression	[167]
TMPRSS2	TT1GM2Z	moderate	Genetic Variation	[168]
TNFRSF12A	TTKPS7V	moderate	Altered Expression	[169]
TNNC1	TT8RDXP	moderate	Altered Expression	[170]
TYMP	TTO0IB8	moderate	Altered Expression	[171]
TYRO3	TTIEMFN	moderate	Biomarker	[172]
ABCC1	TTOI92F	Strong	Genetic Variation	[173]
ABL1	TT6B75U	Strong	Biomarker	[58]
ACAT1	TTK3C21	Strong	Genetic Variation	[174]
ACR	TTAHE2N	Strong	Genetic Variation	[175]
ACVR1B	TTPKHTZ	Strong	Genetic Variation	[176]
ADAM9	TTTYQNS	Strong	Altered Expression	[177]
ADCYAP1	TTW4LYC	Strong	Biomarker	[178]
ADCYAP1R1	TT5OREU	Strong	Biomarker	[178]
ADH7	TT3LE7P	Strong	Altered Expression	[179]
ADK	TTL732K	Strong	Genetic Variation	[180]
AGR2	TT9K86S	Strong	Posttranslational Modification	[181]
ALOX12	TT12ABZ	Strong	Altered Expression	[182]
ALOX15	TTN9T81	Strong	Altered Expression	[183]
ALOX5	TTSJ6Q4	Strong	Biomarker	[17]
ANGPT2	TTKLQTJ	Strong	Altered Expression	[184]
ANO1	TTOJI4S	Strong	Genetic Variation	[185]
ANPEP	TTPHMWB	Strong	Altered Expression	[186]
ANXA1	TTUCK4B	Strong	Altered Expression	[187]
ANXA10	TT0NL6U	Strong	Altered Expression	[188]
ANXA2	TT4YANI	Strong	Altered Expression	[189]
APEX1	TTHGL48	Strong	Altered Expression	[190]
APOA1	TT5S8DR	Strong	Biomarker	[191]
AQP1	TTSF1KH	Strong	Biomarker	[192]
AQP3	TTLDNMQ	Strong	Biomarker	[193]
ARAF	TT5TURO	Strong	Biomarker	[194]
AREG	TT76B3W	Strong	Biomarker	[195]
ATF4	TTQCKWT	Strong	Biomarker	[196]
AURKA	TTPS3C0	Strong	Altered Expression	[197]
AURKB	TT9RTBL	Strong	Altered Expression	[198]
AXL	TTZPY6J	Strong	Genetic Variation	[199]
AZGP1	TTUPYLV	Strong	Altered Expression	[200]
BAGE	TTS5GLJ	Strong	Altered Expression	[201]
BAK1	TTFM7V0	Strong	Genetic Variation	[202]
BIRC3	TTAIWZN	Strong	Altered Expression	[203]
BIRC5	TTTPU1G	Strong	Biomarker	[204]
BTLA	TTER58P	Strong	Genetic Variation	[205]
BUB1	TT78309	Strong	Altered Expression	[206]
C1QBP	TTWTD7F	Strong	Altered Expression	[207]
CA1	TTHQPL7	Strong	Biomarker	[191]
CA2	TTANPDJ	Strong	Altered Expression	[208]
CALCA	TTVSFJW	Strong	Altered Expression	[105]
CALCR	TTLWS2O	Strong	Altered Expression	[209]
CASP8	TT6SZNG	Strong	Altered Expression	[210]
CCK	TT90CMU	Strong	Genetic Variation	[211]
CCKBR	TTVFO0U	Strong	Altered Expression	[212]
CCL17	TTMPHAE	Strong	Biomarker	[213]
CCN2	TTIL516	Strong	Biomarker	[214]
CCND1	TTFCJ7S	Strong	Biomarker	[215]
CCNE1	TTCEJ4F	Strong	Biomarker	[216]
CCR7	TT2GIDQ	Strong	Biomarker	[217]
CD200	TT0BE68	Strong	Biomarker	[218]
CD24	TTCTYNP	Strong	Biomarker	[219]
CD276	TT6CQUM	Strong	Altered Expression	[220]
CD55	TT5Z9WY	Strong	Genetic Variation	[221]
CDA	TTQ12RK	Strong	Biomarker	[222]
CDH2	TT1WS0T	Strong	Biomarker	[223]
CDK12	TTJ21A9	Strong	Altered Expression	[224]
CDK13	TTRIM0E	Strong	Altered Expression	[224]
CDK2	TT7HF4W	Strong	Biomarker	[225]
CDKN1C	TTBSUAR	Strong	Altered Expression	[226]
CEACAM1	TTA9CK4	Strong	Altered Expression	[227]
CEACAM6	TTIGH2W	Strong	Altered Expression	[228]
CEL	TTTRNQW	Strong	Biomarker	[229]
CES1	TTMF541	Strong	Biomarker	[230]
CHST5	TTP4ICS	Strong	Altered Expression	[231]
CLDN18	TT6PKBX	Strong	Genetic Variation	[232]
CLDN4	TTMTS9H	Strong	Biomarker	[233]
CLIC1	TT8KZG6	Strong	Altered Expression	[234]
CMA1	TT8VUE0	Strong	Altered Expression	[235]
COL1A2	TTUABC1	Strong	Altered Expression	[236]
CPB2	TTP18AY	Strong	Altered Expression	[237]
CRHR1	TT7EFHR	Strong	Altered Expression	[238]
CSE1L	TTTRULD	Strong	Altered Expression	[239]
CSF1	TT0IQER	Strong	Altered Expression	[240]
CSNK2A2	TT7GR5W	Strong	Biomarker	[241]
CXCL8	TTCTE1G	Strong	Biomarker	[242]
CYP1A2	TTS1DTU	Strong	Biomarker	[243]
CYP1B1	TTI84H7	Strong	Genetic Variation	[244]
CYP26A1	TTD7Q0R	Strong	Altered Expression	[245]
CYP2E1	TTWVHQ5	Strong	Biomarker	[246]
CYSLTR1	TTGKOY9	Strong	Altered Expression	[247]
DAG1	TT4X7PG	Strong	Biomarker	[248]
DCLK1	TTOHTCY	Strong	Biomarker	[249]
DDR1	TTI1FPZ	Strong	Biomarker	[214]
DDR2	TTU98HG	Strong	Biomarker	[250]
DEK	TT1NMGV	Strong	Biomarker	[251]
DHCR24	TTTK0NH	Strong	Altered Expression	[252]
DICER1	TTTEOPU	Strong	Altered Expression	[253]
DKK3	TTY2ZV6	Strong	Altered Expression	[254]
DLL4	TTV23LH	Strong	Altered Expression	[255]
DNMT1	TT6S2FE	Strong	Altered Expression	[256]
DNMT3B	TT6VZ78	Strong	Genetic Variation	[257]
DSG3	TTEO4P8	Strong	Biomarker	[258]
E2F1	TTASI04	Strong	Altered Expression	[259]
E2F2	TT5FYX0	Strong	Altered Expression	[260]
EGFL7	TT7WD0H	Strong	Biomarker	[261]
EIF2AK3	TT79U1M	Strong	Biomarker	[262]
EIF4E	TTZGCP6	Strong	Altered Expression	[263]
EIF5A	TTIVCNR	Strong	Altered Expression	[264]
ELANE	TTPLTSQ	Strong	Biomarker	[265]
ELAVL1	TTPC9D0	Strong	Biomarker	[266]
EPHB2	TTKPV6O	Strong	Biomarker	[267]
EPHX2	TT7WVHI	Strong	Biomarker	[230]
EPX	TTCIO0M	Strong	Biomarker	[268]
ERBB3	TTSINU2	Strong	Biomarker	[269]
ESR2	TTOM3J0	Strong	Altered Expression	[270]
ETS1	TTTGPSD	Strong	Biomarker	[271]
ETS2	TT9AH0M	Strong	Altered Expression	[272]
F11R	TT3C8EG	Strong	Genetic Variation	[273]
F2R	TTL935N	Strong	Altered Expression	[274]
F2RL1	TTQR74A	Strong	Genetic Variation	[275]
F3	TT38MDJ	Strong	Altered Expression	[276]
FAM83B	TT1Q347	Strong	Altered Expression	[277]
FASN	TT7AOUD	Strong	Biomarker	[278]
FBXW7	TT29KY7	Strong	Altered Expression	[279]
FDFT1	TTFQEO5	Strong	Altered Expression	[280]
FFAR2	TT0FYAN	Strong	Biomarker	[281]
FGF18	TT6ICRA	Strong	Biomarker	[282]
FGF8	TTIUF3J	Strong	Biomarker	[282]
FKBP4	TTHY0FT	Strong	Biomarker	[283]
FLT4	TTDCBX5	Strong	Biomarker	[284]
FMNL1	TTW20PQ	Strong	Biomarker	[285]
FOLH1	TT9G4N0	Strong	Altered Expression	[286]
FOLR2	TTT54CI	Strong	Altered Expression	[38]
FOSL1	TTY8LZG	Strong	Altered Expression	[287]
FOXC2	TTLBAP1	Strong	Altered Expression	[288]
FPR1	TT5Y4EM	Strong	Altered Expression	[187]
FSCN1	TTTRS9B	Strong	Altered Expression	[289]
GAPDH	TTUGSWA	Strong	Altered Expression	[290]
GAST	TT4LRVO	Strong	Biomarker	[291]
GATA4	TT1VDN2	Strong	Biomarker	[292]
GHRHR	TTG4R8V	Strong	Biomarker	[293]
GHRL	TT1OCL0	Strong	Biomarker	[58]
GJB1	TTSJIRP	Strong	Altered Expression	[294]
GPBAR1	TTSDVTR	Strong	Altered Expression	[295]
GPR39	TTTPCNU	Strong	Biomarker	[296]
GRK5	TTTCXO0	Strong	Altered Expression	[297]
GRM1	TTVBPDM	Strong	Altered Expression	[298]
GRM3	TT8A9EF	Strong	Altered Expression	[299]
GSR	TTEP6RV	Strong	Altered Expression	[300]
GUCY2C	TTLDPRG	Strong	Altered Expression	[301]
HBEGF	TT15SL0	Strong	Altered Expression	[302]
HGFAC	TTD96RW	Strong	Biomarker	[303]
HLA-G	TTLKFB3	Strong	Altered Expression	[304]
HMGA1	TTBA219	Strong	Altered Expression	[305]
HPGDS	TTCYE56	Strong	Biomarker	[306]
HPSE	TTR7GJO	Strong	Altered Expression	[307]
HRH4	TTXJ178	Strong	Biomarker	[308]
HSD17B1	TTIWB6L	Strong	Altered Expression	[309]
HSP90B1	TTFPKXQ	Strong	Altered Expression	[310]
HSPA8	TTMQL3K	Strong	Biomarker	[191]
HSPD1	TT9HL5R	Strong	Biomarker	[311]
IDO1	TTZJYKH	Strong	Altered Expression	[312]
IGFBP1	TTCJTWF	Strong	Biomarker	[313]
IGFBP3	TTZHNQA	Strong	Genetic Variation	[314]
IGFBP6	TTLAYV8	Strong	Altered Expression	[315]
IGFBP7	TTUQ01B	Strong	Altered Expression	[316]
IL11	TTGUYTR	Strong	Altered Expression	[317]
IL31RA	TT9HPX0	Strong	Biomarker	[318]
IMP3	TTEJA2R	Strong	Genetic Variation	[319]
INHBA	TTVB30D	Strong	Biomarker	[320]
IRF1	TT4TU3L	Strong	Biomarker	[196]
ISG15	TTVOH3T	Strong	Biomarker	[321]
ITGA6	TT165T3	Strong	Altered Expression	[322]
ITGAE	TTH0Z37	Strong	Biomarker	[323]
ITGAL	TT48WR6	Strong	Biomarker	[324]
ITGB1	TTBVIQC	Strong	Biomarker	[325]
ITGB3	TTJA1ZO	Strong	Altered Expression	[326]
KCNQ1	TT846HF	Strong	Biomarker	[327]
KDM4A	TTZHPB8	Strong	Genetic Variation	[328]
KDR	TTUTJGQ	Strong	Biomarker	[329]
KEAP1	TT3Z6Y9	Strong	Altered Expression	[330]
KHDRBS1	TTAT6C7	Strong	Biomarker	[164]
KISS1	TTU2O6T	Strong	Altered Expression	[331]
KLK2	TTJLNAW	Strong	Biomarker	[332]
KLK6	TTLPF4X	Strong	Altered Expression	[333]
KLK7	TTE6GTB	Strong	Biomarker	[334]
KLK8	TTH5MRS	Strong	Altered Expression	[335]
KMT2A	TT1GNDM	Strong	Biomarker	[336]
KRT17	TTKV0EC	Strong	Biomarker	[337]
KRT19	TT3JF9E	Strong	Altered Expression	[338]
KRT6A	TT2FX8W	Strong	Biomarker	[339]
LAMP1	TTC214J	Strong	Altered Expression	[340]
LAPTM4B	TTEJQT0	Strong	Altered Expression	[341]
LDHA	TTW76JE	Strong	Biomarker	[342]
LGALS3	TTFPQV7	Strong	Altered Expression	[343]
LTB4R	TTN53ZF	Strong	Biomarker	[344]
LYN	TT1RWNJ	Strong	Biomarker	[345]
MAGEA1	TT63M7Q	Strong	Biomarker	[346]
MAGEA2	TTOZT28	Strong	Genetic Variation	[347]
MAGEC2	TTKGUEB	Strong	Altered Expression	[348]
MAOA	TT3WG5C	Strong	Biomarker	[349]
MAP2K5	TTV3O87	Strong	Altered Expression	[350]
MAP3K8	TTGECUM	Strong	Altered Expression	[351]
MAPK7	TTU6FSC	Strong	Altered Expression	[350]
MARK2	TTAJ45Y	Strong	Altered Expression	[274]
MAS1	TTOISYB	Strong	Biomarker	[352]
MDK	TTV8UE7	Strong	Biomarker	[353]
MDM4	TT9OUDQ	Strong	Genetic Variation	[173]
MELK	TTBZOTY	Strong	Altered Expression	[354]
MGAM	TTXWASR	Strong	Altered Expression	[355]
MGLL	TTZ963I	Strong	Biomarker	[356]
MIA	TT5HNVS	Strong	Biomarker	[357]
MKI67	TTB4UNG	Strong	Biomarker	[358]
MME	TT5TKPM	Strong	Biomarker	[359]
MMP13	TTHY57M	Strong	Biomarker	[360]
MSI1	TTSM4BA	Strong	Altered Expression	[361]
MSI2	TTTXQF6	Strong	Biomarker	[362]
MSLN	TT4RXME	Strong	Altered Expression	[363]
MSR1	TT2TDH9	Strong	Biomarker	[364]
MST1R	TTBQ3OC	Strong	Altered Expression	[365]
MTOR	TTCJG29	Strong	Biomarker	[366]
MUC17	TTVO0JU	Strong	Altered Expression	[367]
MUTYH	TTNB0ZK	Strong	Genetic Variation	[368]
MYC	TTNQ5ZP	Strong	Biomarker	[156]
MYCN	TT9JBY5	Strong	Biomarker	[369]
NAGLU	TTDM6HZ	Strong	Genetic Variation	[370]
NCAM1	TTVXPHT	Strong	Altered Expression	[371]
NCF1	TTZ4JC3	Strong	Genetic Variation	[372]
NCOA3	TT124R0	Strong	Biomarker	[373]
NFKB1	TTUIZKC	Strong	Altered Expression	[374]
NOP2	TTBLG3H	Strong	Biomarker	[375]
NOS3	TTCM4B3	Strong	Biomarker	[58]
NPEPPS	TT371QC	Strong	Biomarker	[376]
NR1I2	TT7LCTF	Strong	Altered Expression	[274]
NR5A2	TTAU3SY	Strong	Altered Expression	[377]
NTRK3	TTXABCW	Strong	Altered Expression	[378]
NTSR1	TTTUMEP	Strong	Altered Expression	[379]
OGFR	TT6IEYX	Strong	Altered Expression	[380]
OGG1	TTRU01G	Strong	Biomarker	[381]
OPRD1	TT27RFC	Strong	Biomarker	[382]
P2RX4	TT1NLOA	Strong	Altered Expression	[383]
PAK1	TTFN95D	Strong	Genetic Variation	[384]
PAK4	TT7Y3BZ	Strong	Biomarker	[385]
PAM	TTF4ZPC	Strong	Altered Expression	[386]
PAWR	TT3I4WV	Strong	Biomarker	[387]
PCCA	TT1JDE3	Strong	Altered Expression	[388]
PCCB	TT5LURU	Strong	Altered Expression	[388]
PDE3A	TT06AWU	Strong	Altered Expression	[389]
PDGFA	TTSM78N	Strong	Altered Expression	[390]
PDK2	TTJGCKM	Strong	Genetic Variation	[391]
PEBP1	TT1BGU8	Strong	Altered Expression	[392]
PFKFB3	TTTHMQJ	Strong	Altered Expression	[393]
PGD	TTZ3IFB	Strong	Biomarker	[394]
PGF	TT48I1Y	Strong	Altered Expression	[395]
PHB	TT6U071	Strong	Biomarker	[396]
PHF8	TT81PFE	Strong	Biomarker	[397]
PHGDH	TT8DRCK	Strong	Altered Expression	[398]
PKM	TT4LOT8	Strong	Biomarker	[399]
PLAC1	TTM18HX	Strong	Genetic Variation	[400]
PLAU	TTGY7WI	Strong	Altered Expression	[401]
PLCB1	TTLPGU7	Strong	Altered Expression	[402]
PLK2	TT976FS	Strong	Biomarker	[403]
POR	TTOQ9GZ	Strong	Biomarker	[404]
PPARD	TT2JWF6	Strong	Altered Expression	[405]
PPM1A	TTLA7IX	Strong	Biomarker	[406]
PRAME	TTPH7T0	Strong	Altered Expression	[407]
PRDX4	TTPBL9I	Strong	Altered Expression	[408]
PRKCI	TTWJTHX	Strong	Biomarker	[384]
PRKCZ	TTBSN0L	Strong	Biomarker	[409]
PRKD1	TTSLUMT	Strong	Genetic Variation	[410]
PRL	TTJ2TSA	Strong	Biomarker	[411]
PSCA	TT9T4AV	Strong	Genetic Variation	[412]
PTGER1	TTG1QMU	Strong	Altered Expression	[77]
PTGS1	TT8NGED	Strong	Altered Expression	[413]
PTK2	TTON5IT	Strong	Altered Expression	[414]
PTK7	TTXH2ZN	Strong	Altered Expression	[415]
PTPN11	TT7WUAV	Strong	Genetic Variation	[416]
PTPRB	TT64I9Q	Strong	Altered Expression	[417]
PTPRJ	TTWMKXP	Strong	Biomarker	[418]
PTPRZ1	TT4SEA8	Strong	Altered Expression	[419]
RAD51	TTC0G1L	Strong	Altered Expression	[420]
RARB	TTISP28	Strong	Posttranslational Modification	[421]
RARG	TT1Q3IE	Strong	Altered Expression	[79]
RICTOR	TT143WL	Strong	Biomarker	[422]
ROBO1	TTND1YP	Strong	Biomarker	[423]
ROCK2	TTGWKQJ	Strong	Biomarker	[424]
ROR1	TTDEJAU	Strong	Altered Expression	[425]
ROR2	TTUDPCI	Strong	Altered Expression	[426]
S100B	TTQ0V86	Strong	Biomarker	[427]
SAA1	TTY0DN9	Strong	Altered Expression	[428]
SATB1	TTLFRIC	Strong	Altered Expression	[429]
SCD	TT6RIOV	Strong	Altered Expression	[430]
SCGB1A1	TTONPVW	Strong	Biomarker	[431]
SERPINA1	TTA7UJC	Strong	Biomarker	[432]
SERPINB3	TT6QLPX	Strong	Altered Expression	[433]
SIRT2	TTLKF5M	Strong	Altered Expression	[434]
SLC12A1	TTS087L	Strong	Altered Expression	[435]
SLC16A1	TTN1J82	Strong	Altered Expression	[235]
SLC16A3	TTG6VD5	Strong	Biomarker	[342]
SLC1A5	TTF7WRM	Strong	Altered Expression	[436]
SLC3A2	TT5CZSM	Strong	Altered Expression	[92]
SLC52A2	TT6TKEN	Strong	Altered Expression	[274]
SLC5A2	TTF8JAT	Strong	Altered Expression	[437]
SOCS1	TT8COJM	Strong	Altered Expression	[438]
SOD2	TT9O4C5	Strong	Altered Expression	[439]
SPARC	TTBQFM7	Strong	Biomarker	[440]
SPDEF	TT2ZUPY	Strong	Biomarker	[368]
SPHK1	TTOHFIY	Strong	Altered Expression	[441]
SPP1	TT8ME6I	Strong	Genetic Variation	[442]
SRC	TT6PKBN	Strong	Altered Expression	[443]
SST	TTWF7UG	Strong	Altered Expression	[444]
SSTR1	TTIND6G	Strong	Altered Expression	[445]
ST14	TTPRO7W	Strong	Biomarker	[446]
STAT3	TTHJT3X	Strong	Biomarker	[447]
STMN1	TT7W5OT	Strong	Altered Expression	[448]
STS	TTHM0R1	Strong	Altered Expression	[449]
SULF2	TTLQTHB	Strong	Biomarker	[450]
TACC3	TTQ4UFD	Strong	Genetic Variation	[451]
TACSTD2	TTP2HE5	Strong	Altered Expression	[452]
TCF7L2	TT80QAL	Strong	Biomarker	[453]
TGFBR1	TTP4520	Strong	Genetic Variation	[454]
TGM2	TT2F4OL	Strong	Biomarker	[455]
TKT	TT04R7I	Strong	Altered Expression	[456]
TKTL1	TTNQ1J3	Strong	Altered Expression	[456]
TLR7	TTRJ1K4	Strong	Altered Expression	[457]
TMPRSS15	TTXL0GC	Strong	Biomarker	[458]
TNF	TTF8CQI	Strong	Genetic Variation	[412]
TNFRSF10A	TT5WLRX	Strong	Biomarker	[58]
TNFSF10	TTA5MS9	Strong	Biomarker	[459]
TNKS	TTVUSO7	Strong	Genetic Variation	[460]
TNKS2	TTFQI4H	Strong	Genetic Variation	[461]
TRIM59	TT613U4	Strong	Altered Expression	[462]
TRIP10	TTKHTGE	Strong	Altered Expression	[463]
TRPM2	TTEBMN7	Strong	Altered Expression	[464]
TRPM8	TTXDKTO	Strong	Biomarker	[465]
TXNRD1	TTR7UJ3	Strong	Altered Expression	[466]
TYRP1	TTFRV98	Strong	Biomarker	[214]
UBC	TTBP3XA	Strong	Biomarker	[306]
UCHL1	TTX9IFP	Strong	Altered Expression	[467]
USP7	TTXU3EQ	Strong	Biomarker	[468]
USP8	TT1J07C	Strong	Altered Expression	[469]
VANGL1	TT18WJB	Strong	Biomarker	[470]
VEGFC	TT0QUFV	Strong	Altered Expression	[471]
VEGFD	TTOM5H4	Strong	Altered Expression	[472]
VHL	TTEMWSD	Strong	Biomarker	[473]
VTCN1	TTCK85E	Strong	Altered Expression	[220]
WNT5A	TTKG7F8	Strong	Altered Expression	[426]
XIAP	TTK3WBU	Strong	Altered Expression	[439]
YES1	TT0SQ8J	Strong	Biomarker	[345]
ACVRL1	TTGYPTC	Definitive	Genetic Variation	[474]
AMHR2	TTZDCPK	Definitive	Genetic Variation	[475]
ANGPTL4	TTWALY5	Definitive	Altered Expression	[476]
ATG7	TTLVB9Z	Definitive	Genetic Variation	[477]
AURKC	TTLYXIT	Definitive	Genetic Variation	[478]
CASP2	TT12VNG	Definitive	Biomarker	[266]
CD9	TTZEIBV	Definitive	Altered Expression	[479]
CDC25A	TTLZS4Q	Definitive	Altered Expression	[480]
CHRNB4	TTTVAFQ	Definitive	Altered Expression	[481]
CLDN6	TTKSV48	Definitive	Genetic Variation	[482]
CRTC2	TTFWETR	Definitive	Genetic Variation	[483]
CTSE	TTLXC4Q	Definitive	Altered Expression	[484]
CXCR5	TTIW59R	Definitive	Biomarker	[485]
CYP24A1	TT82UI1	Definitive	Altered Expression	[486]
DGKZ	TTSBBXL	Definitive	Altered Expression	[487]
DYRK2	TT84OS6	Definitive	Altered Expression	[488]
EREG	TTYSB89	Definitive	Altered Expression	[489]
EYA2	TTUY9C6	Definitive	Posttranslational Modification	[490]
FKBP5	TT0J5KQ	Definitive	Biomarker	[283]
FUS	TTKGYZ9	Definitive	Biomarker	[491]
GALNS	TTT9YPO	Definitive	Biomarker	[492]
GGT1	TTZVT7O	Definitive	Genetic Variation	[493]
HOXA5	TTXSVQP	Definitive	Altered Expression	[494]
HSD11B1	TTN7BL9	Definitive	Genetic Variation	[495]
HSPE1	TTWYMFE	Definitive	Altered Expression	[496]
IL15RA	TTGN89I	Definitive	Genetic Variation	[497]
ILK	TT7ALZG	Definitive	Biomarker	[498]
KCNH2	TTQ6VDM	Definitive	Biomarker	[499]
KLK4	TT4319X	Definitive	Altered Expression	[500]
LTA4H	TTXZEAJ	Definitive	Biomarker	[501]
MAP3K2	TTIX0ZU	Definitive	Posttranslational Modification	[502]
MARCKS	TTHRM39	Definitive	Biomarker	[503]
MAT2A	TTSMPXQ	Definitive	Altered Expression	[504]
METAP2	TTZL0OI	Definitive	Altered Expression	[505]
NES	TTHZ752	Definitive	Altered Expression	[506]
OLR1	TTKSND3	Definitive	Altered Expression	[507]
PDCD1LG2	TTW14O3	Definitive	Altered Expression	[508]
PLCG1	TT6T4JI	Definitive	Altered Expression	[509]
PRLR	TTBPXMA	Definitive	Biomarker	[510]
PRMT5	TTR1D7X	Definitive	Altered Expression	[511]
PTK6	TT6TH8V	Definitive	Altered Expression	[512]
RACK1	TTJ10AL	Definitive	Altered Expression	[513]
REG4	TTVZEHU	Definitive	Biomarker	[514]
RNF43	TTD91BL	Definitive	Genetic Variation	[515]
SIK1	TT1H6LC	Definitive	Altered Expression	[516]
SLCO1B3	TTU86P0	Definitive	Biomarker	[517]
SPOCK1	TTF23RE	Definitive	Altered Expression	[518]
TNNI3	TTNLDK6	Definitive	Altered Expression	[519]
TUSC2	TTJ8O14	Definitive	Altered Expression	[520]
XRCC5	TTCB9KW	Definitive	Altered Expression	[521]

This Disease Is Related to 17 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
ABCC6	DT582KR	Limited	Altered Expression	[107]
SLC26A3	DTN1FMD	Limited	Altered Expression	[522]
SLC28A1	DT0EQPW	Limited	Altered Expression	[523]
SLC39A3	DTH08M7	Limited	Altered Expression	[524]
SLC52A1	DT7NOKR	Disputed	Biomarker	[525]
SLC26A1	DTJ785O	moderate	Altered Expression	[163]
SLC43A2	DTK02I1	moderate	Biomarker	[526]
SLC4A1	DTB0Q3P	moderate	Biomarker	[527]
SLCO6A1	DTIFXNS	moderate	Altered Expression	[528]
ABCC10	DTPS120	Strong	Altered Expression	[529]
ATP12A	DT5NLZA	Strong	Altered Expression	[530]
SLC12A2	DTHKL3Q	Strong	Altered Expression	[435]
SLC16A7	DTLT3UG	Strong	Altered Expression	[531]
SLC18A1	DTM953D	Strong	Altered Expression	[532]
SLC2A10	DT3BI6S	Strong	Biomarker	[533]
SLC2A3	DT9SQ3L	Strong	Genetic Variation	[534]
SLC45A3	DTGEFXH	Strong	Biomarker	[535]

This Disease Is Related to 32 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
AKR1C2	DEOY5ZM	Limited	Biomarker	[536]
ALDH1A1	DE2JP1Y	Limited	Biomarker	[537]
GSTM1	DEYZEJA	Limited	Genetic Variation	[538]
NAT1	DE7OAB3	Limited	Biomarker	[539]
PARK7	DEPOVCH	Limited	Altered Expression	[540]
ADH1C	DEM1HNL	moderate	Genetic Variation	[541]
CES2	DETHCPD	moderate	Altered Expression	[542]
HAGH	DE05IKP	moderate	Altered Expression	[543]
HIF1AN	DEY1CBW	moderate	Biomarker	[544]
SAT1	DEMWO83	moderate	Altered Expression	[163]
ADH4	DEOCWU3	Strong	Altered Expression	[179]
ADH5	DEIOH6A	Strong	Altered Expression	[179]
AK2	DEY1FJO	Strong	Altered Expression	[545]
AKR1B10	DEP6GT1	Strong	Altered Expression	[546]
ALDH1B1	DEXI4UQ	Strong	Altered Expression	[547]
CYP1A1	DE6OQ3W	Strong	Genetic Variation	[548]
CYP27B1	DE3FYEM	Strong	Biomarker	[549]
CYP2R1	DEBIHM3	Strong	Altered Expression	[549]
CYP7B1	DE36TMY	Strong	Altered Expression	[550]
FAAH	DEUM1EX	Strong	Altered Expression	[551]
GSTT1	DE3PKUG	Strong	Genetic Variation	[552]
MAT1A	DEQ6NC9	Strong	Genetic Variation	[174]
ME1	DE97WM8	Strong	Genetic Variation	[553]
MSRA	DEU2ZBY	Strong	Altered Expression	[554]
PSAT1	DEBS17P	Strong	Biomarker	[376]
RDH14	DEWDJU4	Strong	Altered Expression	[555]
SMOX	DEOH5V3	Strong	Biomarker	[556]
UGT2B17	DEAZDL8	Strong	Biomarker	[557]
WARS1	DEPVE0M	Strong	Altered Expression	[558]
ACP3	DEDW5H6	Definitive	Biomarker	[559]
CYP2A13	DEXZA9U	Definitive	Altered Expression	[560]
HPGD	DEHKSC6	Definitive	Biomarker	[394]

This Disease Is Related to 804 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
A1BG	OTFVUGNQ	Limited	Altered Expression	[540]
ABI1	OT5H4M62	Limited	Altered Expression	[561]
ADAM12	OTZKOTDB	Limited	Altered Expression	[562]
ADAM15	OTZ7VLTP	Limited	Altered Expression	[563]
ADIPOR2	OT2HDTL8	Limited	Altered Expression	[564]
AHCYL1	OTX8L3M5	Limited	Altered Expression	[565]
AKIRIN2	OTQ6WSKW	Limited	Altered Expression	[566]
AMPD1	OTU17BCI	Limited	Biomarker	[567]
ANKRD1	OTHJ7JV9	Limited	Altered Expression	[568]
ARHGEF5	OTUVGFT9	Limited	Altered Expression	[569]
ATOH1	OTBZYG2R	Limited	Biomarker	[570]
AZIN2	OT8OB7CG	Limited	Biomarker	[571]
B4GALT1	OTBCXEK7	Limited	Biomarker	[572]
BAD	OT63ERYM	Limited	Biomarker	[573]
BID	OTOSHSHU	Limited	Genetic Variation	[574]
BOLL	OT5FAEJJ	Limited	Biomarker	[575]
BRCA1	OT5BN6VH	Limited	Genetic Variation	[576]
BTF3	OT5ZZFJL	Limited	Altered Expression	[577]
C21orf58	OTJR84YR	Limited	Altered Expression	[578]
CA8	OT9Y8GA8	Limited	Altered Expression	[154]
CAND1	OTGB6NU0	Limited	Altered Expression	[579]
CAP1	OTYM8A2N	Limited	Biomarker	[580]
CAPG	OTJ86KI6	Limited	Biomarker	[581]
CCDC6	OTXRQDYG	Limited	Biomarker	[582]
CCDC88A	OT3SSYYC	Limited	Genetic Variation	[583]
CCN4	OT69BER9	Limited	Altered Expression	[584]
CCN5	OTADU8JJ	Limited	Biomarker	[585]
CCNB2	OTIEXTDK	Limited	Biomarker	[586]
CCNY	OTK1KG5W	Limited	Altered Expression	[587]
CD63	OT2UGZA9	Limited	Biomarker	[588]
CD99	OTPUZ5DE	Limited	Altered Expression	[589]
CDC42EP3	OTUZ3U9Z	Limited	Biomarker	[590]
CDC6	OTX93FE7	Limited	Altered Expression	[591]
CDC73	OT6JASZ1	Limited	Altered Expression	[592]
CDK5RAP3	OTC0Q2QS	Limited	Biomarker	[586]
CDX1	OTOHTMJE	Limited	Altered Expression	[593]
CEACAM4	OT0C7YUD	Limited	Genetic Variation	[594]
CEACAM7	OTKFDTZY	Limited	Biomarker	[27]
CEMIP	OTK80FYN	Limited	Altered Expression	[595]
CHGA	OTXYX5JH	Limited	Altered Expression	[596]
CHPT1	OT4FJ0K3	Limited	Biomarker	[597]
CHST4	OTESMIW5	Limited	Altered Expression	[598]
CPEB4	OTW1SCZW	Limited	Altered Expression	[599]
CREM	OTJIJ5AL	Limited	Altered Expression	[66]
CTDSPL	OTZJ0CZK	Limited	Posttranslational Modification	[600]
CTNND2	OTYKE30Y	Limited	Altered Expression	[601]
CTSZ	OTSCX2LL	Limited	Biomarker	[31]
CUL2	OTPF83PG	Limited	Altered Expression	[602]
DDT	OTF5HTYL	Limited	Altered Expression	[603]
DEFA1	OT5N1B9B	Limited	Altered Expression	[604]
DEFA5	OT95CBQ9	Limited	Altered Expression	[605]
DHDDS	OTVLYBUS	Limited	Biomarker	[597]
DUOX1	OTQ2AEW0	Limited	Biomarker	[606]
DVL1	OTD67RF1	Limited	Altered Expression	[607]
E2F4	OTB3JFH4	Limited	Biomarker	[608]
EFNA1	OTU2NUA2	Limited	Altered Expression	[609]
EMX2	OT0V8OYK	Limited	Altered Expression	[610]
ERCC4	OTFIOPG1	Limited	Biomarker	[611]
ERG	OTOTX9VU	Limited	Biomarker	[612]
EVX2	OTH01KN1	Limited	Biomarker	[613]
FOXL2	OTFRQUYL	Limited	Genetic Variation	[614]
FRZB	OTTO3DPY	Limited	Altered Expression	[615]
FXR1	OTEMQ1SR	Limited	Altered Expression	[616]
GADL1	OTJM4A0R	Limited	Biomarker	[571]
GATA5	OTO81B63	Limited	Genetic Variation	[617]
GDF9	OTNTVKVU	Limited	Altered Expression	[591]
GKN2	OTR9DOYG	Limited	Altered Expression	[618]
GPX3	OT6PK94R	Limited	Genetic Variation	[619]
GSTM3	OTLA2WJT	Limited	Genetic Variation	[620]
GTF2H4	OTPD1DIU	Limited	Biomarker	[65]
GTF2IRD1	OTEG9KU1	Limited	Biomarker	[621]
GTSE1	OTPP742Z	Limited	Altered Expression	[622]
GUCA2A	OTUSF75G	Limited	Biomarker	[623]
GULP1	OT1WMVDH	Limited	Altered Expression	[624]
HAND2	OTCXYW4Y	Limited	Altered Expression	[625]
HBE1	OTJPKMX4	Limited	Altered Expression	[626]
HHIP	OT77RQYS	Limited	Altered Expression	[627]
HOXA1	OTMSOJ7D	Limited	Genetic Variation	[628]
HOXA4	OTNVTQDT	Limited	Altered Expression	[45]
IFNA17	OTHXRYG3	Limited	Biomarker	[629]
IGF2BP3	OTB97VIK	Limited	Biomarker	[630]
INHA	OT7HWCO3	Limited	Altered Expression	[631]
ISYNA1	OT49ONSE	Limited	Altered Expression	[632]
ITLN1	OT7ZLJVV	Limited	Biomarker	[633]
KIDINS220	OTLBH2MA	Limited	Genetic Variation	[634]
KLF10	OT4F4UGS	Limited	Altered Expression	[635]
KLK13	OT8LOD2U	Limited	Biomarker	[53]
KLK15	OT7BVG17	Limited	Biomarker	[636]
KRT14	OTUVZ1DW	Limited	Biomarker	[637]
KRT81	OTMKIK2S	Limited	Biomarker	[638]
LAT	OTZC1XZ1	Limited	Altered Expression	[92]
LMLN	OTQF0JPY	Limited	Posttranslational Modification	[639]
LMTK2	OT93MVIC	Limited	Genetic Variation	[640]
LPXN	OTUNV3CK	Limited	Altered Expression	[641]
LRPPRC	OTXSK5LP	Limited	Biomarker	[642]
MACC1	OTV3DLX0	Limited	Biomarker	[643]
MAGED4B	OTO37U7W	Limited	Altered Expression	[644]
MAGI3	OTDJ5QUH	Limited	Altered Expression	[645]
MAML2	OT1TSVAR	Limited	Altered Expression	[646]
MAX	OTKZ0YKM	Limited	Altered Expression	[567]
MB	OTYWYL2D	Limited	Altered Expression	[647]
MIB1	OT5C404P	Limited	Biomarker	[358]
MINDY4	OTBZ2SZB	Limited	Altered Expression	[648]
MS4A3	OT0CEJOO	Limited	Altered Expression	[649]
MT3	OTVCZ7HI	Limited	Posttranslational Modification	[650]
MUC4	OTLT11V1	Limited	Altered Expression	[651]
MXD1	OTS5CTHX	Limited	Biomarker	[567]
NAIP	OTLA925F	Limited	Altered Expression	[652]
NECTIN1	OTTE5ZR6	Limited	Biomarker	[653]
NGB	OTW0SIUY	Limited	Altered Expression	[647]
NPC1	OTRIPICX	Limited	Biomarker	[654]
NSD3	OT3677ZG	Limited	Biomarker	[655]
NTS	OTPGDNQS	Limited	Biomarker	[656]
NUP107	OTG4RDYS	Limited	Altered Expression	[578]
OCLN	OTSUTVWL	Limited	Altered Expression	[657]
P2RX5	OTLBR20R	Limited	Biomarker	[658]
PCLAF	OTMVIOUU	Limited	Altered Expression	[659]
PDIA3	OTHPQ0Q3	Limited	Biomarker	[660]
PFN1	OTHTGA1H	Limited	Altered Expression	[661]
PGRMC2	OTH6G1CV	Limited	Altered Expression	[73]
PIAS3	OT3TWH9R	Limited	Altered Expression	[662]
PITX1	OTA0UN4C	Limited	Biomarker	[663]
PLA2G2D	OTU604XM	Limited	Biomarker	[119]
PLA2G3	OT3K7TMY	Limited	Biomarker	[119]
PLXNB1	OTCA7JIT	Limited	Altered Expression	[664]
PMEPA1	OTY8Z9UF	Limited	Altered Expression	[665]
POTEF	OTV3WXYE	Limited	Altered Expression	[666]
PPIG	OTZ8BTTM	Limited	Genetic Variation	[667]
PPM1H	OTKSVU7S	Limited	Altered Expression	[668]
PRKRA	OTUTVZZU	Limited	Altered Expression	[616]
PSG2	OT2EIXAI	Limited	Biomarker	[27]
PSME2	OTYPP33T	Limited	Biomarker	[669]
PSPH	OTV1PVAX	Limited	Biomarker	[670]
PTGES3	OTPPQWI0	Limited	Altered Expression	[77]
PXN	OTVMMUOF	Limited	Altered Expression	[671]
PYCARD	OT67RON3	Limited	Altered Expression	[449]
RAB25	OTW0W6NP	Limited	Altered Expression	[672]
RAD18	OTQ9PLNT	Limited	Biomarker	[673]
RAD50	OTYMU9G1	Limited	Altered Expression	[674]
RASAL1	OTAHUNN7	Limited	Altered Expression	[675]
RBBP6	OTTVG4HU	Limited	Altered Expression	[616]
RFX1	OTZUDMPR	Limited	Altered Expression	[676]
RGS1	OTGXJYMG	Limited	Biomarker	[677]
RIN1	OTPBROUD	Limited	Altered Expression	[678]
RPL10	OTBHOZGC	Limited	Altered Expression	[679]
RREB1	OT62460U	Limited	Biomarker	[524]
SAMD14	OTLDQW51	Limited	Posttranslational Modification	[680]
SCTR	OTC80IMR	Limited	Altered Expression	[681]
SDHB	OTRE1M1T	Limited	Genetic Variation	[682]
SEL1L	OTC0FB7T	Limited	Biomarker	[683]
SERPINB4	OT88LHZ8	Limited	Altered Expression	[684]
SFRP1	OT0U9G41	Limited	Posttranslational Modification	[685]
SFRP5	OTLCVVSH	Limited	Posttranslational Modification	[686]
SFTPC	OTIZJD09	Limited	Biomarker	[687]
SFXN1	OTL66767	Limited	Biomarker	[688]
SHBG	OTPWU5IW	Limited	Altered Expression	[689]
SIDT1	OTJM5S74	Limited	Biomarker	[690]
SKAP2	OTSF44KP	Limited	Altered Expression	[691]
SMUG1	OT2YIOCQ	Limited	Biomarker	[692]
SOX7	OTOZOFAG	Limited	Altered Expression	[693]
SRCIN1	OTQZNQQ5	Limited	Biomarker	[694]
STK11IP	OTLQ6P8R	Limited	Altered Expression	[695]
STMN3	OT20F289	Limited	Altered Expression	[696]
TBP	OT6C0S52	Limited	Biomarker	[697]
TBXT	OTHCO2F0	Limited	Altered Expression	[698]
TFF3	OTJJDRTU	Limited	Altered Expression	[699]
TG	OT3ELHIJ	Limited	Biomarker	[700]
THBS4	OTA1T9KK	Limited	Biomarker	[701]
THOC1	OTVABJ4Z	Limited	Altered Expression	[702]
TMEFF2	OT1WZ2QO	Limited	Posttranslational Modification	[703]
TMPRSS13	OTMAOAP3	Limited	Posttranslational Modification	[639]
TMSB10	OTLVZ13T	Limited	Altered Expression	[704]
TNFRSF10C	OTVHOL9B	Limited	Posttranslational Modification	[575]
TNFRSF6B	OTKAN9G7	Limited	Altered Expression	[705]
TPI1	OT14KP4B	Limited	Biomarker	[706]
TRIB2	OTHSX3MX	Limited	Biomarker	[707]
TRIM29	OT2DNESG	Limited	Altered Expression	[708]
TSC1	OTFF4YZ7	Limited	Genetic Variation	[709]
ACTR3	OT05LJSH	Disputed	Biomarker	[710]
ADIPOR1	OT65ZFZN	Disputed	Altered Expression	[564]
APOBEC3A	OTYO6F5P	Disputed	Biomarker	[710]
BAG1	OTRQNIA4	Disputed	Altered Expression	[711]
BNIP3	OT4SO7J4	Disputed	Biomarker	[712]
CDCP1	OTD7RRWK	Disputed	Altered Expression	[713]
CDH20	OTJQVC1V	Disputed	Biomarker	[714]
CSMD1	OTIVDSC4	Disputed	Genetic Variation	[715]
CTNNBIP1	OTX9SBJG	Disputed	Altered Expression	[716]
DROSHA	OTCE68KZ	Disputed	Altered Expression	[717]
ELF3	OTUTLEQO	Disputed	Biomarker	[718]
GCNT1	OTF6OC66	Disputed	Altered Expression	[719]
HOXB7	OTC7WYU8	Disputed	Altered Expression	[720]
IL6ST	OT1N9C70	Disputed	Biomarker	[642]
KRT23	OTQW6UAG	Disputed	Posttranslational Modification	[721]
MCM2	OTGGORIQ	Disputed	Altered Expression	[722]
MT1B	OTUA4FFH	Disputed	Altered Expression	[723]
MTUS1	OTBPALMU	Disputed	Genetic Variation	[724]
NFYA	OTWFFOVH	Disputed	Altered Expression	[725]
NOP53	OTA2YKO6	Disputed	Biomarker	[726]
NRXN3	OTJ0I7HJ	Disputed	Genetic Variation	[714]
PLA2G10	OTRZ2L5A	Disputed	Biomarker	[119]
PPP2CB	OT24GMCM	Disputed	Genetic Variation	[724]
RECQL	OTPCH3JH	Disputed	Altered Expression	[727]
S100PBP	OT6O7Y14	Disputed	Biomarker	[728]
SH3GLB1	OTAZ5OP8	Disputed	Altered Expression	[729]
SIX3	OTP5E3VU	Disputed	Altered Expression	[730]
THBS2	OTXET551	Disputed	Biomarker	[731]
TNFAIP8	OT1G9297	Disputed	Altered Expression	[732]
TNFSF9	OTV9L89D	Disputed	Altered Expression	[733]
TSPAN1	OTZQPIYK	Disputed	Altered Expression	[734]
AASDH	OTUIAJ48	moderate	Altered Expression	[735]
ABCF2	OTXIBZ3N	moderate	Biomarker	[736]
ACIN1	OTK81F92	moderate	Posttranslational Modification	[737]
ADAR	OTQNOHR8	moderate	Biomarker	[738]
ALX4	OTNS9A29	moderate	Posttranslational Modification	[739]
AMFR	OTQRX7LC	moderate	Altered Expression	[740]
AP2A1	OTEFZB21	moderate	Altered Expression	[99]
ASCL1	OTI4X44G	moderate	Biomarker	[741]
BHLHE22	OTZUQY5L	moderate	Altered Expression	[742]
CA11	OT8RX3AJ	moderate	Altered Expression	[154]
CAGE1	OTF3HI3N	moderate	Biomarker	[743]
CASP8AP2	OTTWT68S	moderate	Genetic Variation	[744]
CDC5L	OTTPFUU5	moderate	Biomarker	[745]
CDH12	OTF2HCGA	moderate	Altered Expression	[746]
CHST2	OTV11IZF	moderate	Altered Expression	[598]
CLDN2	OTRF3D6Y	moderate	Altered Expression	[747]
COL4A5	OTHG60RE	moderate	Biomarker	[533]
CRCP	OT4K9BT7	moderate	Genetic Variation	[748]
CTNND1	OTUMPSHR	moderate	Altered Expression	[239]
CTTNBP2	OT4CL1EW	moderate	Biomarker	[749]
DSC1	OTNII6GZ	moderate	Altered Expression	[750]
DSC2	OTODVH8K	moderate	Altered Expression	[750]
DSC3	OTYG47F8	moderate	Biomarker	[750]
EEF1A2	OT9Z23K5	moderate	Altered Expression	[751]
ETFA	OTXX61VZ	moderate	Altered Expression	[752]
EVA1C	OT18YR25	moderate	Biomarker	[753]
EXT1	OTRPALJK	moderate	Biomarker	[754]
EYA4	OTINGR3Z	moderate	Posttranslational Modification	[755]
FADD	OTV7GFHH	moderate	Altered Expression	[756]
FANCC	OTTIDM3P	moderate	Biomarker	[757]
FANCG	OT7MC8TZ	moderate	Biomarker	[757]
FGF13	OTHNNVSG	moderate	Altered Expression	[758]
FRAT1	OT1PS84E	moderate	Altered Expression	[759]
FSCN3	OTVOL6GA	moderate	Biomarker	[663]
GSTK1	OTDNGWAF	moderate	Altered Expression	[528]
HEY1	OTJQL0I3	moderate	Altered Expression	[760]
HUNK	OTZR4GBH	moderate	Biomarker	[753]
KIF5B	OTT34MT8	moderate	Genetic Variation	[761]
KLK10	OTD573EL	moderate	Altered Expression	[762]
KLK12	OTNYK59J	moderate	Biomarker	[763]
KRT13	OTTYSKGX	moderate	Biomarker	[764]
LAMP3	OTN0XL3W	moderate	Biomarker	[765]
LZTS1	OTXXL864	moderate	Genetic Variation	[766]
MAP1S	OT5WUD4C	moderate	Biomarker	[767]
MBD1	OTD19VO6	moderate	Genetic Variation	[768]
MBD4	OTWR9YXE	moderate	Genetic Variation	[769]
MED1	OTOO24C4	moderate	Altered Expression	[770]
MSN	OTZJ4J6G	moderate	Biomarker	[771]
MYEOV	OTDC7UHL	moderate	Biomarker	[772]
NELFB	OTCFH88S	moderate	Altered Expression	[773]
NNAT	OTNRLO7G	moderate	Altered Expression	[774]
NOXA1	OTQDX9RY	moderate	Biomarker	[775]
NOXO1	OTW29FB4	moderate	Biomarker	[775]
NUDT6	OTCS3NYZ	moderate	Altered Expression	[758]
OPCML	OT93PQ6Y	moderate	Genetic Variation	[628]
OR2AG1	OTEITRP4	moderate	Biomarker	[776]
PA2G4	OT7IG7HT	moderate	Biomarker	[777]
PGP	OT6QQ7OR	moderate	Altered Expression	[778]
PLAG1	OTT9AJQY	moderate	Biomarker	[376]
PNPLA8	OT9V1T5W	moderate	Altered Expression	[779]
POLI	OTBA4DCE	moderate	Genetic Variation	[780]
PYGB	OT2ZTJT0	moderate	Altered Expression	[781]
RAB20	OTP9OOVS	moderate	Altered Expression	[782]
RAB32	OTTR4H7S	moderate	Posttranslational Modification	[783]
RPL10A	OTDLCJ53	moderate	Biomarker	[784]
SFN	OTLJCZ1U	moderate	Altered Expression	[785]
SFRP2	OT8GZ0CA	moderate	Posttranslational Modification	[786]
SHMT1	OTIINA3J	moderate	Genetic Variation	[787]
SLC2A4RG	OTW3LX8D	moderate	Altered Expression	[788]
SMR3B	OTL5HNM8	moderate	Altered Expression	[789]
SPRR3	OTN9QJKG	moderate	Biomarker	[790]
ST13	OTNML6UP	moderate	Altered Expression	[791]
STRADA	OTG1Z6TY	moderate	Biomarker	[792]
TBCEL	OT2PZLLL	moderate	Altered Expression	[793]
TCP1	OT1MGUX9	moderate	Altered Expression	[794]
TMED4	OTLVPY2E	moderate	Altered Expression	[795]
TRIM25	OT35SG1R	moderate	Altered Expression	[796]
A4GALT	OTPX3UGY	Strong	Genetic Variation	[797]
A4GNT	OT8GOL3T	Strong	Genetic Variation	[797]
ABCG4	OT2XJIOG	Strong	Altered Expression	[798]
ACE	OTDF1964	Strong	Biomarker	[214]
ACOT7	OT7C68YV	Strong	Biomarker	[799]
ACP1	OTJ9CKLU	Strong	Altered Expression	[800]
ACSL5	OT3L9XO3	Strong	Altered Expression	[801]
ACTBL2	OTD6B81U	Strong	Biomarker	[799]
ACTG2	OTRDWUO0	Strong	Biomarker	[799]
ADCY10	OTYSTB0R	Strong	Biomarker	[802]
ADGRE2	OTUYJVYG	Strong	Altered Expression	[260]
ADGRE5	OTTSB84Q	Strong	Altered Expression	[803]
AGR3	OTONJPDP	Strong	Posttranslational Modification	[181]
AKAP13	OTOZAR14	Strong	Altered Expression	[804]
ALOX15B	OTWQQ08W	Strong	Altered Expression	[805]
AMELX	OTIN26MM	Strong	Biomarker	[806]
AMIGO2	OTPAIT1O	Strong	Altered Expression	[807]
AMY1A	OT6G4B8O	Strong	Biomarker	[808]
ANKRD36B	OT3MW415	Strong	Genetic Variation	[407]
ANP32A	OTRHPFO2	Strong	Altered Expression	[809]
ANP32B	OT3SQMLU	Strong	Genetic Variation	[810]
ANTXR1	OT5W1GPC	Strong	Altered Expression	[811]
ANXA4	OTUCRYXL	Strong	Altered Expression	[812]
ANXA7	OTLMD0TK	Strong	Altered Expression	[813]
APBA1	OTUH9JPD	Strong	Posttranslational Modification	[814]
APBA2	OTXD8ID1	Strong	Posttranslational Modification	[814]
APH1A	OT97F1TU	Strong	Altered Expression	[815]
API5	OTYX9YCZ	Strong	Altered Expression	[816]
APOBEC3B	OTHLNI51	Strong	Biomarker	[222]
ARFIP2	OTK9JXIJ	Strong	Genetic Variation	[817]
ARHGAP24	OTCQCEZS	Strong	Altered Expression	[818]
ARHGDIB	OT9PD6CS	Strong	Altered Expression	[819]
ARHGEF1	OTXU4HBW	Strong	Altered Expression	[820]
ARHGEF7	OT9BPJCL	Strong	Altered Expression	[821]
ARTN	OTWIWGL6	Strong	Biomarker	[822]
ATF2	OTNIZPEA	Strong	Altered Expression	[823]
ATF6	OTAFHAVI	Strong	Altered Expression	[144]
ATF7IP	OTU6ZA7F	Strong	Biomarker	[824]
ATP2A3	OTFYDEES	Strong	Altered Expression	[825]
ATP5F1B	OTLFZUQK	Strong	Altered Expression	[826]
ATP6AP2	OT0IABVV	Strong	Biomarker	[827]
ATRX	OT77RSQW	Strong	Altered Expression	[828]
AXIN1	OTRGZGZ5	Strong	Genetic Variation	[829]
B3GALT1	OTWIRR5U	Strong	Altered Expression	[830]
B3GALT5	OTWXPEMU	Strong	Altered Expression	[831]
BAGE4	OT2LPTMI	Strong	Genetic Variation	[832]
BARX2	OT0R3QD3	Strong	Altered Expression	[833]
BCAR1	OTKT2C2N	Strong	Altered Expression	[239]
BCL10	OT47MCLI	Strong	Altered Expression	[834]
BPIFA1	OTQFD2J5	Strong	Biomarker	[835]
BRD8	OTIKS3PC	Strong	Biomarker	[375]
BUB1B	OT8KME51	Strong	Biomarker	[836]
C1GALT1	OT2ZSZ6P	Strong	Biomarker	[64]
CADM1	OTRWG9QS	Strong	Posttranslational Modification	[837]
CADM4	OT0TFMFE	Strong	Altered Expression	[838]
CAMKMT	OTLJBRUW	Strong	Altered Expression	[839]
CARD16	OT4NUHWB	Strong	Biomarker	[491]
CARTPT	OTTE4V9S	Strong	Biomarker	[840]
CBFA2T2	OTNOIB23	Strong	Altered Expression	[821]
CBX5	OT8VYY84	Strong	Genetic Variation	[841]
CCDC80	OTOZSYEM	Strong	Biomarker	[842]
CCL1	OT23NON8	Strong	Altered Expression	[317]
CCN3	OTOW5YL4	Strong	Biomarker	[843]
CCT3	OTL6EOS1	Strong	Biomarker	[844]
CD151	OTF3UZS7	Strong	Altered Expression	[845]
CD164	OTZ7FIU8	Strong	Altered Expression	[846]
CD82	OTH8MC64	Strong	Biomarker	[847]
CDH10	OTK3D5WP	Strong	Genetic Variation	[848]
CDH17	OT9EV2XK	Strong	Altered Expression	[849]
CFL1	OTT6D5MH	Strong	Biomarker	[850]
CHD1L	OT7CZK7C	Strong	Biomarker	[851]
CHFR	OTRAD2TT	Strong	Altered Expression	[852]
CHL1	OT6E6E8P	Strong	Altered Expression	[853]
CIP2A	OTVS2GXA	Strong	Biomarker	[854]
CISH	OT8T5NYL	Strong	Genetic Variation	[855]
CKAP2	OTCLTC0J	Strong	Altered Expression	[856]
CKB	OTUCKOTT	Strong	Biomarker	[191]
CLEC3B	OTFD29NF	Strong	Biomarker	[857]
CLIC4	OT6KTPKD	Strong	Altered Expression	[858]
CLPTM1L	OTDJWQXI	Strong	Genetic Variation	[859]
CNPY2	OTGY8ESX	Strong	Biomarker	[860]
CNTNAP1	OT5Y03EU	Strong	Altered Expression	[861]
COL14A1	OTLNJ13O	Strong	Altered Expression	[862]
COL17A1	OTID5AH2	Strong	Altered Expression	[863]
COMMD3	OT1UTJH4	Strong	Altered Expression	[864]
COP1	OT6J2K12	Strong	Biomarker	[491]
CORO1A	OTVAZOHC	Strong	Altered Expression	[226]
CORO2A	OTVK7PK3	Strong	Altered Expression	[865]
COX1	OTG3O9BN	Strong	Altered Expression	[866]
COX7A1	OTHV25GG	Strong	Altered Expression	[867]
CRB3	OTQKPTMU	Strong	Biomarker	[868]
CRISP3	OTBSWMPL	Strong	Altered Expression	[869]
CSTA	OT1K68KE	Strong	Altered Expression	[870]
CT45A1	OT80VTZO	Strong	Altered Expression	[871]
CTAG2	OT8HISP4	Strong	Altered Expression	[348]
CTTN	OTJRG4ES	Strong	Biomarker	[872]
CTU1	OTNTM9D1	Strong	Biomarker	[873]
CUL5	OTMTZD47	Strong	Altered Expression	[874]
CXCL5	OTZOUPCA	Strong	Biomarker	[875]
CYLD	OT37FKH0	Strong	Altered Expression	[876]
DAB2	OTRMQTMZ	Strong	Biomarker	[633]
DAXX	OTX6O7PL	Strong	Biomarker	[877]
DCAF4	OTQU0EUO	Strong	Altered Expression	[878]
DCC	OT2C1SHW	Strong	Genetic Variation	[879]
DCDC2	OTSUFH1H	Strong	Biomarker	[880]
DCTN4	OTM7C943	Strong	Biomarker	[164]
DCUN1D1	OT8UJLZU	Strong	Biomarker	[881]
DDX3X	OTDO4TRX	Strong	Altered Expression	[882]
DDX53	OTHK3EGZ	Strong	Biomarker	[883]
DEAF1	OTCLX3ZW	Strong	Biomarker	[884]
DKK4	OTWCCVF6	Strong	Genetic Variation	[885]
DLD	OT378CU9	Strong	Biomarker	[868]
DMBT1	OTVNU9D9	Strong	Altered Expression	[886]
DMP1	OTBWBWW7	Strong	Biomarker	[887]
DNAJB6	OTMHIIAN	Strong	Altered Expression	[888]
DNTTIP1	OTAP29SS	Strong	Biomarker	[889]
DOC2A	OT5G9V94	Strong	Altered Expression	[890]
DOK2	OTIJ38UF	Strong	Altered Expression	[80]
DSP	OTB2MOP8	Strong	Altered Expression	[891]
DST	OTHZBM4X	Strong	Altered Expression	[892]
DUOX2	OTU14HCN	Strong	Biomarker	[893]
DUSP2	OTH54FMR	Strong	Biomarker	[178]
EBAG9	OTTQLQCP	Strong	Altered Expression	[894]
EDIL3	OTDVVNS0	Strong	Biomarker	[895]
EEF1G	OTW7DH2F	Strong	Altered Expression	[896]
EEF2	OTZ7SZ39	Strong	Biomarker	[897]
EFEMP1	OTZVUOOB	Strong	Altered Expression	[898]
EFNB1	OT7JJW8P	Strong	Altered Expression	[899]
EIF3A	OTFABY9G	Strong	Biomarker	[900]
EIF5B	OTZTT22W	Strong	Genetic Variation	[901]
EIF6	OTEXMUED	Strong	Biomarker	[902]
ELOVL5	OT375W1Z	Strong	Altered Expression	[903]
EN2	OT7EZCM2	Strong	Altered Expression	[904]
ENO1	OTB1KWJS	Strong	Genetic Variation	[391]
ENO2	OTRODL0T	Strong	Biomarker	[27]
EPC1	OT3Q25ND	Strong	Genetic Variation	[905]
EPC2	OTTG0W9R	Strong	Genetic Variation	[905]
ERCC2	OT1C8HQ4	Strong	Genetic Variation	[906]
ERCC5	OTQAKFJM	Strong	Biomarker	[197]
ERRFI1	OT7VZ2IZ	Strong	Biomarker	[907]
ETV1	OT6PMJIK	Strong	Biomarker	[908]
ETV4	OT8C98UZ	Strong	Altered Expression	[909]
EVA1A	OTCY3Q2M	Strong	Biomarker	[910]
EXO1	OTI87RS5	Strong	Altered Expression	[911]
FA2H	OT8HA13U	Strong	Altered Expression	[912]
FAM3B	OTC2S91N	Strong	Altered Expression	[913]
FAM83A	OTBI16V7	Strong	Biomarker	[914]
FANCD2	OTVEB5LF	Strong	Biomarker	[915]
FAT4	OT7QONNV	Strong	Biomarker	[336]
FAU	OTGTVOWK	Strong	Biomarker	[916]
FBN2	OT3KYJQL	Strong	Genetic Variation	[917]
FGF5	OTQXGHBY	Strong	Altered Expression	[918]
FGF9	OT2SKDGM	Strong	Altered Expression	[919]
FHL5	OT6C00Z1	Strong	Biomarker	[799]
FLCN	OTVM78XM	Strong	Genetic Variation	[920]
FOXA1	OTEBY0TD	Strong	Altered Expression	[921]
FRY	OT74IAG2	Strong	Biomarker	[922]
GAGE1	OT53E50E	Strong	Biomarker	[923]
GAL3ST1	OTSFFZRD	Strong	Altered Expression	[924]
GALNT3	OT7M67WT	Strong	Altered Expression	[925]
GALNT6	OTOQQVH1	Strong	Altered Expression	[926]
GBP5	OTS4AO4A	Strong	Altered Expression	[558]
GDE1	OTU6FSBF	Strong	Altered Expression	[927]
GINS3	OT8NVXTD	Strong	Altered Expression	[928]
GK5	OT65U8L1	Strong	Biomarker	[929]
GKN1	OT7ZYFQ9	Strong	Altered Expression	[618]
GMPR2	OTKZSZPE	Strong	Biomarker	[191]
GNA12	OT3IRZH3	Strong	Biomarker	[930]
GORASP1	OTQS91S7	Strong	Altered Expression	[931]
GOT2	OT6XBWN0	Strong	Biomarker	[932]
GPC1	OTQKRSSV	Strong	Biomarker	[933]
GPR68	OT1NXSMN	Strong	Altered Expression	[934]
GPRC5A	OTPOCWR7	Strong	Altered Expression	[935]
GPX4	OTRAFFX2	Strong	Altered Expression	[936]
GRB7	OTF8Y9XY	Strong	Biomarker	[214]
GSDME	OT1ZWY32	Strong	Altered Expression	[937]
GTF2H1	OTCRXC6B	Strong	Biomarker	[164]
GUCA2B	OTZERX04	Strong	Biomarker	[623]
GYPA	OTABU4YV	Strong	Genetic Variation	[938]
HABP2	OTAUIPW0	Strong	Biomarker	[939]
HAS1	OTJIAG1W	Strong	Altered Expression	[940]
HAS2	OTTD3PAL	Strong	Altered Expression	[940]
HAS3	OTPM8IL8	Strong	Altered Expression	[940]
HEY2	OTU4J3ZI	Strong	Altered Expression	[941]
HGD	OTTKLQOO	Strong	Biomarker	[942]
HIC1	OTI9TWY4	Strong	Biomarker	[943]
HLTF	OTRX2OSF	Strong	Genetic Variation	[944]
HNRNPU	OTLQN1E2	Strong	Biomarker	[375]
HOXA10	OTB6GQ09	Strong	Biomarker	[945]
HPSE2	OTGEPP8V	Strong	Biomarker	[946]
HSPA2	OTSDET7B	Strong	Altered Expression	[947]
HSPH1	OTVRR73T	Strong	Biomarker	[948]
HYAL2	OTTVINXW	Strong	Biomarker	[949]
ID3	OTUULW5Z	Strong	Biomarker	[214]
ID4	OTPMJ39I	Strong	Posttranslational Modification	[950]
IER3	OTZJI5FZ	Strong	Altered Expression	[951]
IFITM1	OTECO1G8	Strong	Biomarker	[250]
IFITM2	OTAT6TI6	Strong	Altered Expression	[952]
IFNA1	OTPMKY0L	Strong	Therapeutic	[953]
IFNGR1	OTCTQBWW	Strong	Biomarker	[954]
IGBP1	OTTHH4YE	Strong	Altered Expression	[955]
IGF2BP1	OT9G360P	Strong	Altered Expression	[956]
IGSF1	OT3XD6U2	Strong	Biomarker	[375]
IHH	OT1DWGXC	Strong	Altered Expression	[957]
IL17B	OTS86H50	Strong	Biomarker	[958]
IL17RA	OTVVI8ER	Strong	Biomarker	[959]
IL4I1	OTK54C63	Strong	Altered Expression	[960]
ING1	OTEZBRKW	Strong	Altered Expression	[961]
ING4	OT0VVG4V	Strong	Altered Expression	[962]
ING5	OTRNNSFM	Strong	Altered Expression	[963]
INPP4B	OTLROA7G	Strong	Biomarker	[964]
INTU	OTXB13E6	Strong	Biomarker	[965]
ITGA3	OTBCH21D	Strong	Biomarker	[966]
ITIH5	OTP46PZM	Strong	Biomarker	[967]
JAG1	OT3LGT6K	Strong	Biomarker	[968]
JPT1	OT6CRZEU	Strong	Biomarker	[969]
KCTD12	OTPYKT4Z	Strong	Altered Expression	[810]
KDM4D	OTN6KAE6	Strong	Biomarker	[970]
KHSRP	OTDHZARB	Strong	Biomarker	[971]
KIFC1	OTNQDS00	Strong	Biomarker	[972]
KLC1	OTSTTTW7	Strong	Genetic Variation	[973]
KLF6	OTQY9S7F	Strong	Biomarker	[178]
KLHL1	OTAX6SAD	Strong	Altered Expression	[974]
KMT2B	OTMMAZQX	Strong	Genetic Variation	[975]
KMT2C	OTC59BCO	Strong	Biomarker	[336]
KMT2E	OTYOLNOG	Strong	Altered Expression	[976]
KRIT1	OT58AP1I	Strong	Altered Expression	[839]
KRT15	OTS6WLF7	Strong	Biomarker	[258]
KRT16	OTGA0EQN	Strong	Altered Expression	[977]
KRT18	OTVLQFIP	Strong	Altered Expression	[978]
KRT4	OT24PHPM	Strong	Altered Expression	[979]
KRT8	OTTM4X11	Strong	Biomarker	[191]
LAMB1	OT6J9LJR	Strong	Biomarker	[980]
LAMTOR5	OTER0U8L	Strong	Altered Expression	[981]
LARP4B	OT2HI0QE	Strong	Genetic Variation	[901]
LAT2	OTWJDKIH	Strong	Altered Expression	[982]
LBR	OT1HG3HG	Strong	Altered Expression	[983]
LDHB	OT9B1CT3	Strong	Biomarker	[984]
LEFTY2	OT3RX4QF	Strong	Altered Expression	[985]
LGALS4	OTKQCG0H	Strong	Biomarker	[549]
LGR6	OTPZ1PWR	Strong	Altered Expression	[986]
LIMA1	OTONPC9R	Strong	Altered Expression	[987]
LPCAT1	OTCV7AGV	Strong	Genetic Variation	[988]
LTBP4	OTC8WL2V	Strong	Altered Expression	[989]
LXN	OTZQ2M6Y	Strong	Biomarker	[990]
MAD2L1	OTXNGZCG	Strong	Altered Expression	[991]
MAGEB6	OTOTV1FU	Strong	Genetic Variation	[347]
MAGI2	OTXDDKZS	Strong	Biomarker	[992]
MAL	OTBM30SW	Strong	Biomarker	[993]
MAP1LC3A	OTPMGIU4	Strong	Altered Expression	[994]
MAP1LC3B	OTUYHB84	Strong	Biomarker	[164]
MAP2K4	OTZPZX11	Strong	Altered Expression	[995]
MARVELD2	OTKB96L5	Strong	Altered Expression	[996]
MCAT	OTH07FIW	Strong	Altered Expression	[235]
MCC	OTQVI1EM	Strong	Genetic Variation	[997]
MCM5	OTAHLB62	Strong	Altered Expression	[998]
MCTS1	OT7SAOJP	Strong	Altered Expression	[235]
MEF2C	OTZGF1Y5	Strong	Genetic Variation	[999]
MFAP5	OT46VXSG	Strong	Altered Expression	[1000]
MGP	OTZWU3FU	Strong	Altered Expression	[1001]
MIEN1	OTCQ8DAD	Strong	Altered Expression	[1002]
MKS1	OT83W5PB	Strong	Genetic Variation	[553]
MMP19	OTLSTT2B	Strong	Biomarker	[1003]
MPP1	OTA2ENZQ	Strong	Biomarker	[214]
MRE11	OTGU8TZM	Strong	Genetic Variation	[1004]
MSH3	OTD3YPVL	Strong	Genetic Variation	[173]
MSH6	OT46FP09	Strong	Biomarker	[1005]
MST1	OTOC4UNG	Strong	Biomarker	[236]
MUC2	OT3X4QVX	Strong	Biomarker	[1006]
MUC3A	OTI4XUDY	Strong	Genetic Variation	[1007]
MUC5B	OTPW6K5C	Strong	Altered Expression	[1008]
MUC7	OTSTMP0X	Strong	Altered Expression	[1009]
MVP	OTJGHJRB	Strong	Altered Expression	[1010]
MXI1	OTUQ9E0D	Strong	Altered Expression	[991]
MYH9	OT94Z706	Strong	Altered Expression	[1011]
NAA25	OTS3QVF1	Strong	Biomarker	[375]
NANOG	OTUEY1FM	Strong	Altered Expression	[537]
NBAS	OTW9IBRI	Strong	Genetic Variation	[370]
NDC80	OTS7D306	Strong	Biomarker	[1012]
NET1	OTZHNMJV	Strong	Altered Expression	[1013]
NEU1	OTH9BY8Y	Strong	Biomarker	[1014]
NEURL1	OT2C4P70	Strong	Biomarker	[1014]
NFIB	OTX94PD0	Strong	Biomarker	[1015]
NFS1	OT0HUS40	Strong	Altered Expression	[1016]
NHLH1	OTXN5B9R	Strong	Genetic Variation	[1017]
NLRP2	OTJA81JU	Strong	Altered Expression	[1018]
NLRP4	OT864X7M	Strong	Altered Expression	[555]
NME2	OTCYGLHV	Strong	Biomarker	[1019]
NOX1	OTZPJQCC	Strong	Altered Expression	[1020]
NPAS2	OTMRT2TS	Strong	Altered Expression	[1021]
NPPA	OTMQNTNX	Strong	Therapeutic	[1022]
NRL	OT65MFKQ	Strong	Biomarker	[1023]
NSUN5	OTBN7RS8	Strong	Biomarker	[375]
NUP62	OTMN63DH	Strong	Biomarker	[164]
OCIAD2	OTSWB4SZ	Strong	Altered Expression	[1024]
OR10A4	OTYYB8SY	Strong	Genetic Variation	[1025]
ORM1	OTZKSBRE	Strong	Altered Expression	[1026]
OTUD7B	OTMVM8R7	Strong	Altered Expression	[1027]
OTX1	OTRGSGH9	Strong	Altered Expression	[1028]
OTX2	OTTV05B1	Strong	Altered Expression	[1028]
PACC1	OTKBS8CC	Strong	Altered Expression	[1029]
PALB2	OT6DNDBG	Strong	Altered Expression	[1030]
PALLD	OTZ2MUJZ	Strong	Altered Expression	[1031]
PAN2	OTB65N2I	Strong	Altered Expression	[555]
PDGFRL	OTJPRECT	Strong	Biomarker	[1032]
PDLIM7	OTAZVODU	Strong	Biomarker	[1033]
PDPN	OTBUV19I	Strong	Biomarker	[358]
PDYN	OTEJ6430	Strong	Genetic Variation	[1034]
PDZK1IP1	OTWA6M5K	Strong	Altered Expression	[1035]
PEG10	OTWD2278	Strong	Biomarker	[376]
PELI1	OTMLBCLC	Strong	Biomarker	[1036]
PENK	OT8P3HMP	Strong	Posttranslational Modification	[1037]
PFKM	OT1QY9JM	Strong	Biomarker	[391]
PFKP	OTFP7AA8	Strong	Biomarker	[391]
PGAM1	OTZ5DB06	Strong	Biomarker	[191]
PHF14	OTZT3GV1	Strong	Altered Expression	[1038]
PIGR	OT6GLSUL	Strong	Altered Expression	[626]
PIK3R2	OTZSUQK5	Strong	Altered Expression	[821]
PINK1	OT50NR57	Strong	Altered Expression	[1039]
PIP	OTH719AH	Strong	Biomarker	[1040]
PKP1	OT9HSQ8F	Strong	Biomarker	[258]
PKP2	OTJOVF68	Strong	Biomarker	[1041]
PLCB2	OTPAHDGO	Strong	Altered Expression	[402]
PLCB3	OT0OMDEM	Strong	Altered Expression	[402]
PLCB4	OTPA0QHW	Strong	Altered Expression	[402]
PLCE1	OTJISZOX	Strong	Altered Expression	[1042]
PLEC	OTU4XDEG	Strong	Altered Expression	[1043]
PLXNA1	OTN0BING	Strong	Biomarker	[843]
PMS2	OTNLWTMI	Strong	Genetic Variation	[1044]
PODXL	OTPNQXF3	Strong	Biomarker	[1045]
POTEM	OT7L2HGH	Strong	Biomarker	[799]
PPA1	OTHZK1QB	Strong	Altered Expression	[810]
PPA2	OTRKV8WW	Strong	Altered Expression	[810]
PPP1R12C	OT9Q86JO	Strong	Altered Expression	[821]
PPP1R13B	OTC88VQO	Strong	Altered Expression	[821]
PPP1R1A	OTGTAGCV	Strong	Genetic Variation	[1046]
PRAP1	OT48QD82	Strong	Altered Expression	[1047]
PRDX1	OTZ3BEC4	Strong	Biomarker	[1048]
PRKD2	OTIFSVI8	Strong	Genetic Variation	[1049]
PRKD3	OT987HJI	Strong	Genetic Variation	[1049]
PROS1	OTXQWNOI	Strong	Biomarker	[376]
PRR15L	OT6J9UKK	Strong	Genetic Variation	[1050]
PSMG1	OTZ5I6UM	Strong	Biomarker	[178]
PTMA	OT2W4T1M	Strong	Biomarker	[1051]
PTMS	OT9PS4Q0	Strong	Biomarker	[1052]
PTOV1	OT94WT5X	Strong	Altered Expression	[1053]
PTPRF	OTH5KF2D	Strong	Altered Expression	[1054]
PVR	OT3N91T7	Strong	Altered Expression	[1055]
QSOX1	OT4ZPK4P	Strong	Altered Expression	[1056]
RAB11B	OT6GI23M	Strong	Biomarker	[1057]
RAB40B	OTCA9ZF5	Strong	Altered Expression	[79]
RAD21	OTQS84ZF	Strong	Biomarker	[418]
RAD52	OT0OTDHI	Strong	Biomarker	[1058]
RAET1E	OTLR3CEC	Strong	Altered Expression	[1059]
RAMP2	OTGQXLH5	Strong	Biomarker	[423]
RASSF6	OT25GVWY	Strong	Altered Expression	[1060]
RBM10	OTES2MES	Strong	Altered Expression	[1061]
RBM5	OTCBWHHV	Strong	Altered Expression	[1062]
RBP1	OTRP1MFC	Strong	Altered Expression	[1063]
RCAN3	OTTS3CQA	Strong	Altered Expression	[1064]
RCHY1	OTAE7504	Strong	Biomarker	[1065]
REG1A	OTMHUH1D	Strong	Altered Expression	[1066]
REM1	OTUXL0HC	Strong	Genetic Variation	[261]
RETREG1	OTYOSLZX	Strong	Posttranslational Modification	[1067]
RFXANK	OTDX1026	Strong	Altered Expression	[1068]
RGL1	OTY6ZHVA	Strong	Biomarker	[1069]
RGN	OTD04KB1	Strong	Altered Expression	[1070]
RHBDF1	OTCQ7UDS	Strong	Altered Expression	[1071]
RHOT2	OTV8WT2L	Strong	Biomarker	[1072]
RIOX2	OT2YFPI2	Strong	Altered Expression	[1073]
RIPK3	OTL1D484	Strong	Biomarker	[1074]
ROMO1	OTIEYVBW	Strong	Altered Expression	[1075]
RPL36A	OT1LYV85	Strong	Biomarker	[907]
RRM2B	OTE8GBUR	Strong	Genetic Variation	[1076]
RSPO2	OT3HHXU0	Strong	Genetic Variation	[1050]
RTN1	OTCX1SMK	Strong	Altered Expression	[1077]
S100A1	OT1F2G4J	Strong	Biomarker	[427]
S100A10	OTI71243	Strong	Altered Expression	[1078]
S100A11	OTI57KDN	Strong	Altered Expression	[1079]
S100A14	OTVFJJ91	Strong	Genetic Variation	[1080]
S100A7	OTJFVJRF	Strong	Biomarker	[1081]
S100A7A	OTNM8DCP	Strong	Genetic Variation	[1080]
S100P	OTJCXNJG	Strong	Biomarker	[473]
SAA2	OTYAVJWG	Strong	Altered Expression	[428]
SAT2	OT28QL7H	Strong	Posttranslational Modification	[1082]
SCG2	OTXWUQQL	Strong	Altered Expression	[1083]
SCGB3A2	OTB63PHR	Strong	Biomarker	[1084]
SCN7A	OTK05PXY	Strong	Genetic Variation	[370]
SCO2	OTJQQDRS	Strong	Altered Expression	[171]
SELENBP1	OT3NZNTR	Strong	Altered Expression	[1085]
SEMA4A	OT8901H3	Strong	Biomarker	[1086]
SEPTIN9	OT1VMRFQ	Strong	Altered Expression	[1087]
SERPINB2	OT72QLZB	Strong	Biomarker	[87]
SERPINE2	OTYF5340	Strong	Biomarker	[1088]
SETD1A	OTVVWRIC	Strong	Biomarker	[1089]
SFPQ	OTLCIAPJ	Strong	Altered Expression	[815]
SFTPB	OTOHS07E	Strong	Biomarker	[1090]
SHARPIN	OTU1J2KH	Strong	Biomarker	[1091]
SIRT4	OT5S0J23	Strong	Altered Expression	[1092]
SLC12A9	OTR7VRAK	Strong	Biomarker	[1093]
SLC16A4	OT1YXBKC	Strong	Biomarker	[342]
SMARCC1	OTUOMBE7	Strong	Biomarker	[214]
SMC3	OTWGFRHD	Strong	Biomarker	[1094]
SNAI2	OT7Y8EJ2	Strong	Biomarker	[1095]
SNED1	OTBQVXY5	Strong	Altered Expression	[444]
SOX11	OT4LG7LA	Strong	Altered Expression	[1096]
SOX17	OT9H4WWE	Strong	Posttranslational Modification	[1097]
SOX18	OTPUMHWA	Strong	Altered Expression	[1098]
SOX30	OTGT38E3	Strong	Altered Expression	[1099]
SOX4	OTSS40SS	Strong	Altered Expression	[1100]
SPINK1	OTSUVAL2	Strong	Biomarker	[1101]
SPINT1	OT1CLR5L	Strong	Altered Expression	[303]
SPINT2	OTQV7BKQ	Strong	Altered Expression	[892]
SPON2	OTE7JLNM	Strong	Biomarker	[1102]
SPRR1B	OTXNW3P6	Strong	Altered Expression	[1103]
SRPX	OT5B9LXS	Strong	Altered Expression	[1104]
SRRM4	OTALUISN	Strong	Biomarker	[1105]
SRSF5	OTC5WP98	Strong	Altered Expression	[1106]
SS18	OTDKHN1E	Strong	Biomarker	[999]
ST6GAL1	OT7US3NO	Strong	Biomarker	[1107]
ST8SIA2	OTRBBBD8	Strong	Genetic Variation	[1108]
STAT5A	OTBSJGN3	Strong	Altered Expression	[1109]
SYCE1L	OTXU44F3	Strong	Altered Expression	[974]
SYCP1	OTWFV4KA	Strong	Biomarker	[923]
SYNE1	OTSBSLUH	Strong	Biomarker	[1069]
SYP	OTFJKMO4	Strong	Altered Expression	[1110]
SYT1	OTVTPOI6	Strong	Altered Expression	[931]
TCN1	OTW6A49Y	Strong	Altered Expression	[1111]
TENM1	OTSKSU4V	Strong	Biomarker	[1112]
TENM3	OTWY13GR	Strong	Genetic Variation	[1113]
TET1	OTZDHT1D	Strong	Altered Expression	[1114]
TFF2	OTRXB19X	Strong	Altered Expression	[1115]
TGFBI	OTR443C5	Strong	Biomarker	[226]
TGFBR3	OTQOOUC4	Strong	Altered Expression	[1116]
TIMM8A	OTDX9687	Strong	Biomarker	[1117]
TIMP2	OT8S1RRP	Strong	Biomarker	[60]
TIMP3	OTDGQAD1	Strong	Biomarker	[60]
TMED2	OTBLO7RW	Strong	Altered Expression	[941]
TMEM54	OTPQEFR0	Strong	Biomarker	[1118]
TP73	OT0LUO47	Strong	Altered Expression	[818]
TPM3	OT5RU5G6	Strong	Biomarker	[1119]
TPTE	OT0JNP52	Strong	Genetic Variation	[1120]
TRAF1	OTTLM5RU	Strong	Altered Expression	[1121]
TRAP1	OTNG0L8J	Strong	Altered Expression	[1122]
TRIM44	OT0B1T2B	Strong	Altered Expression	[1123]
TRIO	OT71X1AK	Strong	Biomarker	[1124]
TRIP13	OTFM3TI9	Strong	Altered Expression	[204]
ALDH1A3	OT1C9NKQ	Definitive	Altered Expression	[1125]
APOBEC1	OTY8QX2R	Definitive	Biomarker	[1126]
ATG12	OTJRO09Y	Definitive	Genetic Variation	[492]
ATP2C1	OTQN51T3	Definitive	Biomarker	[519]
ATP6	OTPHOGLX	Definitive	Genetic Variation	[1127]
BRMS1	OTV5A6LL	Definitive	Posttranslational Modification	[1128]
CBFB	OTIAC6W4	Definitive	Genetic Variation	[1129]
CDK2AP2	OTR99SJ8	Definitive	Posttranslational Modification	[160]
CLCA2	OTF191LZ	Definitive	Biomarker	[1130]
CNNM4	OTUXJRM1	Definitive	Genetic Variation	[1131]
COL4A6	OTUREU5Z	Definitive	Genetic Variation	[714]
CRABP2	OTY01V9G	Definitive	Biomarker	[1132]
CREB3L4	OTSGQGT2	Definitive	Biomarker	[1133]
CRISP2	OT8HLTV5	Definitive	Biomarker	[837]
CT83	OTQEGHAB	Definitive	Altered Expression	[1134]
CXCL14	OTM189TA	Definitive	Altered Expression	[1135]
ECT2	OTQDUCT6	Definitive	Altered Expression	[1136]
EPB41L3	OTS6CHG2	Definitive	Posttranslational Modification	[837]
FOXA2	OTJOCVOY	Definitive	Altered Expression	[1137]
FOXF1	OT2CJZ5K	Definitive	Biomarker	[1138]
GRP	OT8JDFNI	Definitive	Altered Expression	[1139]
IGFBP4	OT2HZRBD	Definitive	Altered Expression	[1140]
ING2	OT6H0EWF	Definitive	Altered Expression	[1141]
ING3	OTDIJXFP	Definitive	Altered Expression	[1142]
ITGB4	OT28UK84	Definitive	Altered Expression	[1143]
JMJD6	OTILR7E4	Definitive	Biomarker	[1144]
KDM2B	OTDMCVW7	Definitive	Biomarker	[1145]
KDM4B	OT5P1UPY	Definitive	Altered Expression	[1146]
KIF14	OTXHT4JM	Definitive	Altered Expression	[1147]
LAMA3	OTFME7HT	Definitive	Genetic Variation	[714]
LAMTOR2	OTHEDISB	Definitive	Posttranslational Modification	[160]
LIPH	OTRGYLKL	Definitive	Altered Expression	[1148]
LUM	OTSRC874	Definitive	Biomarker	[1149]
LYPD5	OTGP7UKA	Definitive	Biomarker	[1150]
MAVS	OTTQ0J64	Definitive	Biomarker	[1151]
NOX5	OTHTH59G	Definitive	Altered Expression	[1152]
NPRL2	OTOB10MO	Definitive	Biomarker	[520]
NRIP1	OTIZOJQV	Definitive	Altered Expression	[1153]
PAGR1	OTXR5PQ8	Definitive	Biomarker	[492]
PALD1	OTLGUM8H	Definitive	Altered Expression	[1031]
PAX1	OT0Y3MIM	Definitive	Biomarker	[1154]
PAX2	OTKP1N8F	Definitive	Biomarker	[1155]
PELP1	OTVXQNOT	Definitive	Altered Expression	[1156]
PHLPP1	OTIFXW8D	Definitive	Biomarker	[1157]
PLAGL1	OTZAO900	Definitive	Altered Expression	[1158]
PLCH1	OT6Z1L2E	Definitive	Genetic Variation	[1159]
POU3F2	OT30NFOC	Definitive	Altered Expression	[371]
PPP1R1B	OTSIJMQ9	Definitive	Altered Expression	[1160]
PRSS55	OTXXWI5Y	Definitive	Biomarker	[837]
RABEP2	OTO61X27	Definitive	Altered Expression	[1161]
RASSF2	OT2JHDO4	Definitive	Posttranslational Modification	[837]
RBL2	OTBQSOE6	Definitive	Altered Expression	[1162]
RPL17	OTTYMPS6	Definitive	Altered Expression	[508]
RPL35	OTFZX52Q	Definitive	Altered Expression	[1163]
RPP14	OT4OYFSK	Definitive	Posttranslational Modification	[160]
RPS23	OTAJMUPF	Definitive	Altered Expression	[1163]
SAFB	OTGRV2LW	Definitive	Biomarker	[1164]
SEMA3B	OTCZCPMS	Definitive	Posttranslational Modification	[1165]
SF3B6	OTPRKS6S	Definitive	Posttranslational Modification	[160]
SGSM3	OTIB1P8A	Definitive	Biomarker	[1166]
SIX1	OT70YYWM	Definitive	Altered Expression	[1167]
SLC22A18	OT9C3KR4	Definitive	Biomarker	[1164]
SLPI	OTUNFUU8	Definitive	Genetic Variation	[474]
SMARCB1	OT2LP7LJ	Definitive	Altered Expression	[1168]
SPATA2	OTOA45GL	Definitive	Altered Expression	[508]
SPOP	OTP0107S	Definitive	Genetic Variation	[1169]
SPZ1	OTQH8HJ5	Definitive	Biomarker	[837]
STAG2	OTR6X1Q7	Definitive	Altered Expression	[1170]
SUB1	OTK71JYU	Definitive	Posttranslational Modification	[160]
TEX101	OTNO747E	Definitive	Biomarker	[478]
TRA2B	OTZYQW52	Definitive	Altered Expression	[1171]

References

• [1] Bevacizumab in metastatic small-bowel adenocarcinoma: A systematic review and meta-analysis. Rare Tumors. 2019 May 14;11:2036361318825413.
• [2] Capecitabine FDA Label
• [3] Carboplatin FDA Label
• [4] Cisplatin FDA Label
• [5] Dacarbazine FDA Label
• [6] Fluorouracil FDA Label
• [7] Irinotecan FDA Label
• [8] Oxaliplatin FDA Label
• [9] Sorafenib FDA Label
• [10] Temozolomide FDA Label
• [11] Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals. Int J Mol Sci. 2020 Sep 3;21(17):6451.
• [12] In vitro cytotoxicity of zoledronate (nitrogen-containing bisphosphonate: NBP) and/or etidronate (non-NBP) in tumour cells and periodontal cells. Arch Oral Biol. 2013 Jun;58(6):628-37.
• [13] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [14] ClinicalTrials.gov (NCT03302403) Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors
• [15] A case of pulmonary adenocarcinoma with overexpression of multidrug resistance-associated protein and p53 aberration.Anticancer Res. 2000 May-Jun;20(3B):1921-5.
• [16] Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells.Hum Pathol. 2010 Nov;41(11):1550-7. doi: 10.1016/j.humpath.2010.04.008.
• [17] Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers. Nat Commun. 2018 Sep 26;9(1):3931.
• [18] New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.Am J Surg Pathol. 2008 Feb;32(2):188-96. doi: 10.1097/PAS.0b013e31815701f3.
• [19] PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1918-25. doi: 10.1007/s00259-010-1497-y. Epub 2010 Jun 4.
• [20] Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice.Neoplasia. 2011 Mar;13(3):254-65. doi: 10.1593/neo.101388.
• [21] MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.Biochem Biophys Res Commun. 2009 Oct 23;388(3):483-9. doi: 10.1016/j.bbrc.2009.07.143. Epub 2009 Aug 3.
• [22] Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer.Eur J Cancer. 2010 May;46(8):1438-44. doi: 10.1016/j.ejca.2010.01.033. Epub 2010 Feb 23.
• [23] Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer.J Gastrointest Surg. 1999 Mar-Apr;3(2):134-40. doi: 10.1016/s1091-255x(99)80022-5.
• [24] Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.Cancer Immunol Immunother. 2008 Mar;57(3):325-36. doi: 10.1007/s00262-007-0372-6. Epub 2007 Aug 1.
• [25] Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma.Pathology. 2019 Aug;51(5):474-480. doi: 10.1016/j.pathol.2019.03.009. Epub 2019 Jun 20.
• [26] CD83 polymorphisms and cervical cancer risk.Gynecol Oncol. 2009 Aug;114(2):319-22. doi: 10.1016/j.ygyno.2009.04.033. Epub 2009 May 15.
• [27] The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.J Transl Med. 2019 Mar 8;17(1):74. doi: 10.1186/s12967-019-1828-0.
• [28] Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk.Clin Cancer Res. 2009 Mar 1;15(5):1837-42. doi: 10.1158/1078-0432.CCR-08-2107. Epub 2009 Feb 17.
• [29] Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.J Immunol. 2008 Dec 15;181(12):8441-9. doi: 10.4049/jimmunol.181.12.8441.
• [30] Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.Cell Biol Toxicol. 2006 Mar;22(2):73-80. doi: 10.1007/s10565-006-0156-3. Epub 2006 Mar 9.
• [31] Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.Prostate. 2004 Jul 1;60(2):109-19. doi: 10.1002/pros.20046.
• [32] Disturbed expression of the apoptosis regulators XIAP, XAF1, and Smac/DIABLO in gastric adenocarcinomas.Diagn Mol Pathol. 2007 Mar;16(1):1-8. doi: 10.1097/01.pdm.0000213471.92925.51.
• [33] Clinicopathological features of younger (aged ?50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.Thorac Cancer. 2018 May;9(5):563-570. doi: 10.1111/1759-7714.12616. Epub 2018 Mar 8.
• [34] Anti-EpCAM antibodies for detection of metastatic carcinoma in effusions and peritoneal wash.Oncol Lett. 2019 Aug;18(2):2019-2024. doi: 10.3892/ol.2019.10468. Epub 2019 Jun 12.
• [35] Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma.PLoS One. 2013 Oct 14;8(10):e77459. doi: 10.1371/journal.pone.0077459. eCollection 2013.
• [36] Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.J Clin Oncol. 2007 Jun 1;25(16):2281-7. doi: 10.1200/JCO.2006.09.0795.
• [37] Distinct patterns of expression of keratinocyte growth factor and its receptor in endometrial carcinoma.Cancer. 1997 Mar 15;79(6):1166-71. doi: 10.1002/(sici)1097-0142(19970315)79:6<1166::aid-cncr15>3.0.co;2-y.
• [38] Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies.Oncotarget. 2017 Dec 15;9(4):4485-4495. doi: 10.18632/oncotarget.23321. eCollection 2018 Jan 12.
• [39] FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT.PLoS One. 2012;7(6):e39937. doi: 10.1371/journal.pone.0039937. Epub 2012 Jun 28.
• [40] Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.Int J Cancer. 2008 Feb 1;122(3):509-19. doi: 10.1002/ijc.23136.
• [41] Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels.Cancer Sci. 2009 Dec;100(12):2325-30. doi: 10.1111/j.1349-7006.2009.01321.x. Epub 2009 Aug 25.
• [42] Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors.J Clin Endocrinol Metab. 2012 Feb;97(2):482-8. doi: 10.1210/jc.2011-2454. Epub 2011 Nov 23.
• [43] Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival.Br J Cancer. 2012 Jun 26;107(1):91-9. doi: 10.1038/bjc.2012.217. Epub 2012 May 29.
• [44] Activity of glutathione-metabolizing and antioxidant enzymes in malignant and benign tumors of human lungs.Bull Exp Biol Med. 2002 Jun;133(6):606-8. doi: 10.1023/a:1020206514239.
• [45] Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.Differentiation. 2009 Feb;77(2):162-71. doi: 10.1016/j.diff.2008.09.018. Epub 2008 Oct 25.
• [46] Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.Clin Cancer Res. 2011 Jun 15;17(12):4155-66. doi: 10.1158/1078-0432.CCR-10-3381. Epub 2011 May 3.
• [47] IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.Int J Cancer. 2009 Dec 1;125(11):2673-8. doi: 10.1002/ijc.24623.
• [48] Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray.Mol Carcinog. 2006 Nov;45(11):814-27. doi: 10.1002/mc.20203.
• [49] Aberrant expression of interferon regulatory factor 3 in human lung cancer.Biochem Biophys Res Commun. 2010 Jun 25;397(2):202-7. doi: 10.1016/j.bbrc.2010.05.085. Epub 2010 May 23.
• [50] Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA.Clin Chem. 2009 Aug;55(8):1559-63. doi: 10.1373/clinchem.2008.122937. Epub 2009 Jun 18.
• [51] The Notch pathway in ovarian carcinomas and adenomas.Br J Cancer. 2005 Sep 19;93(6):709-18. doi: 10.1038/sj.bjc.6602719.
• [52] Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation.Pancreas. 2009 Aug;38(6):649-54. doi: 10.1097/MPA.0b013e3181a56ebf.
• [53] Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung.Biol Chem. 2008 Jun;389(6):781-6. doi: 10.1515/BC.2008.089.
• [54] Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.Pathol Res Pract. 2018 Oct;214(10):1707-1712. doi: 10.1016/j.prp.2018.07.037. Epub 2018 Aug 2.
• [55] Mixed mucinous-type and non-mucinous-type adenocarcinoma of the lung: immunohistochemical examination and K- ras gene mutation.Virchows Arch. 2002 Jun;440(6):598-603. doi: 10.1007/s00428-002-0629-6. Epub 2002 Apr 26.
• [56] Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.BMC Cancer. 2008 Nov 17;8:337. doi: 10.1186/1471-2407-8-337.
• [57] Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma.Tumour Biol. 2012 Feb;33(1):173-82. doi: 10.1007/s13277-011-0260-8. Epub 2011 Nov 12.
• [58] Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.Neoplasia. 2011 Apr;13(4):386-92. doi: 10.1593/neo.101722.
• [59] Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.J Obstet Gynaecol Res. 2018 Jul;44(7):1274-1283. doi: 10.1111/jog.13659. Epub 2018 May 16.
• [60] Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.Anticancer Agents Med Chem. 2012 Sep;12(7):744-52. doi: 10.2174/187152012802650156.
• [61] Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome.Fam Cancer. 2018 Jan;17(1):71-77. doi: 10.1007/s10689-017-0006-x.
• [62] Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.Am J Surg Pathol. 2005 Nov;29(11):1497-504. doi: 10.1097/01.pas.0000170349.47680.e8.
• [63] Intracholecystic Papillary-Tubular Neoplasms (ICPN) of the Gallbladder: A Short Review of Literature.Appl Immunohistochem Mol Morphol. 2020 Jan;28(1):57-61. doi: 10.1097/PAI.0000000000000711.
• [64] Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer.J Exp Med. 2020 Jan 6;217(1):e20182325. doi: 10.1084/jem.20182325.
• [65] Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells.Cancer Biol Ther. 2009 Aug;8(16):1567-76. doi: 10.4161/cbt.8.16.8961. Epub 2009 Aug 8.
• [66] NR4A2 is regulated by gastrin and influences cellular responses of gastric adenocarcinoma cells.PLoS One. 2013 Sep 27;8(9):e76234. doi: 10.1371/journal.pone.0076234. eCollection 2013.
• [67] Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.Cancer Res. 2005 May 1;65(9):3664-70. doi: 10.1158/0008-5472.CAN-04-2229.
• [68] Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma.Clin Cancer Res. 2008 Dec 15;14(24):8052-60. doi: 10.1158/1078-0432.CCR-08-1520.
• [69] An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.PLoS One. 2012;7(10):e47086. doi: 10.1371/journal.pone.0047086. Epub 2012 Oct 9.
• [70] Genetic instability on chromosome 17 in the epithelium of non-polypoid colorectal carcinomas compared to polypoid lesions.Cancer Sci. 2006 Dec;97(12):1335-42. doi: 10.1111/j.1349-7006.2006.00334.x. Epub 2006 Oct 9.
• [71] A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.Cancer Res. 2009 Oct 1;69(19):7689-95. doi: 10.1158/0008-5472.CAN-08-2472. Epub 2009 Sep 22.
• [72] Association of human papillomavirus type 16 E7 and HLA class I antigen expression in cervical premalignant and malignant lesions.Int J Biol Markers. 2007 Apr-Jun;22(2):124-31. doi: 10.1177/172460080702200206.
• [73] Transcriptional analysis of novel hormone receptors PGRMC1 and PGRMC2 as potential biomarkers of breast adenocarcinoma staging.J Surg Res. 2011 Dec;171(2):615-22. doi: 10.1016/j.jss.2010.04.034. Epub 2010 May 20.
• [74] Modulator of the PI3K/Akt oncogenic pathway affects mTOR complex 2 in human adenocarcinoma cells.Invest New Drugs. 2019 Oct;37(5):902-911. doi: 10.1007/s10637-018-0705-7. Epub 2018 Dec 13.
• [75] Overexpression of CD 133 and BCL-2 in non-small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement-positive adenocarcinoma.Pathol Int. 2019 May;69(5):294-299. doi: 10.1111/pin.12782. Epub 2019 Mar 22.
• [76] Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation.Cancer. 2008 Sep 15;113(6):1396-403. doi: 10.1002/cncr.23694.
• [77] Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth.PLoS One. 2011 May 12;6(5):e19209. doi: 10.1371/journal.pone.0019209.
• [78] Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.Int J Colorectal Dis. 2007 Oct;22(10):1179-84. doi: 10.1007/s00384-007-0303-1. Epub 2007 Apr 18.
• [79] Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence.Surgery. 2001 Mar;129(3):267-76. doi: 10.1067/msy.2001.110856.
• [80] Co-expression and significance of Dok2 and Ras p21 protein activator 1 in breast cancer.Oncol Lett. 2017 Nov;14(5):5386-5392. doi: 10.3892/ol.2017.6844. Epub 2017 Aug 28.
• [81] Altered expression of NFY-C and RORA in colorectal adenocarcinomas.Acta Histochem. 2012 Oct;114(6):553-61. doi: 10.1016/j.acthis.2011.10.005. Epub 2011 Nov 21.
• [82] Analysis of the status of EGFR, ROS1 and MET genes in non-small cell lung adenocarcinoma.J BUON. 2017 Jul-Aug;22(4):1053-1060.
• [83] Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.Front Biosci. 2008 Jan 1;13:1050-61. doi: 10.2741/2742.
• [84] Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases.Oncology. 2002;63(2):192-200. doi: 10.1159/000063812.
• [85] Mammaglobin 1: not only a breast-specific and tumour-specific marker, but also a hormone-responsive endometrial protein.Histopathology. 2012 Nov;61(5):955-65. doi: 10.1111/j.1365-2559.2012.04290.x. Epub 2012 Sep 20.
• [86] Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells.Cancer Res. 1999 May 1;59(9):2127-35.
• [87] The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.Oncotarget. 2017 Apr 4;8(14):23099-23109. doi: 10.18632/oncotarget.15485.
• [88] Secreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers.BMC Cell Biol. 2012 Oct 8;13:25. doi: 10.1186/1471-2121-13-25.
• [89] DNA methylation markers of surfactant proteins in lung cancer.Int J Oncol. 2007 Jul;31(1):181-91.
• [90] High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.J Thorac Oncol. 2012 May;7(5):833-40. doi: 10.1097/JTO.0b013e31824de09c.
• [91] Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.Cancer Invest. 2008 Oct;26(8):852-9. doi: 10.1080/07357900801956363.
• [92] Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.Hum Pathol. 2019 Feb;84:142-149. doi: 10.1016/j.humpath.2018.09.020. Epub 2018 Oct 6.
• [93] A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas.Dev Cell. 2019 Oct 7;51(1):113-128.e9. doi: 10.1016/j.devcel.2019.07.022. Epub 2019 Aug 22.
• [94] Mechanisms of inhibition of growth of human pancreatic carcinoma implanted in nude mice by somatostatin receptor subtype 2.Pancreas. 2004 Aug;29(2):141-51. doi: 10.1097/00006676-200408000-00009.
• [95] [Somatostatin receptor subtype 3 (SSTR3) mRNA level in gastric mucosa of patients with dyspepsia].Pol Merkur Lekarski. 2007 May;22(131):341-5.
• [96] Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors.Pancreas. 2010 Nov;39(8):1147-54. doi: 10.1097/MPA.0b013e3181e78120.
• [97] Stomatin-like protein 2 is overexpressed and related to cell growth in human endometrial adenocarcinoma.Oncol Rep. 2007 Apr;17(4):829-33.
• [98] Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology.J Cancer Res Clin Oncol. 2008 Nov;134(11):1219-27. doi: 10.1007/s00432-008-0398-y. Epub 2008 Apr 30.
• [99] Down-regulation of the polymeric immunoglobulin receptor in non-small cell lung carcinoma: correlation with dysregulated expression of the transcription factors USF and AP2.J Biomed Sci. 2005;12(1):65-77. doi: 10.1007/s11373-004-8185-5.
• [100] Activation of STAT3 signaling is mediated by TFF1 silencing in gastric neoplasia.Nat Commun. 2019 Jul 10;10(1):3039. doi: 10.1038/s41467-019-11011-4.
• [101] Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma.Cancer Lett. 2012 May 1;318(1):99-105. doi: 10.1016/j.canlet.2011.12.007. Epub 2011 Dec 11.
• [102] The role of TRPV6 in breast carcinogenesis.Mol Cancer Ther. 2008 Feb;7(2):271-9. doi: 10.1158/1535-7163.MCT-07-0478. Epub 2008 Feb 1.
• [103] Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.Pathol Oncol Res. 2011 Dec;17(4):859-66. doi: 10.1007/s12253-011-9394-7. Epub 2011 Apr 1.
• [104] Differential anti-tumor activities of curcumin against Ras- and Src-activated human adenocarcinoma cells.Biochem Biophys Res Commun. 2013 Jun 28;436(2):186-91. doi: 10.1016/j.bbrc.2013.05.071. Epub 2013 May 29.
• [105] Target-based molecular signature characteristics of cervical adenocarcinoma and squamous cell carcinoma.Int J Oncol. 2013 Aug;43(2):539-47. doi: 10.3892/ijo.2013.1961. Epub 2013 May 27.
• [106] Polymorphisms of the DNA repair gene XPA and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in North China.J Clin Gastroenterol. 2008 Sep;42(8):910-5. doi: 10.1097/MCG.0b013e3180f6262c.
• [107] Expression and localization of ATP binding cassette (ABC) family of drug transporters in gastric hepatoid adenocarcinomas.Histopathology. 2008 May;52(6):747-54. doi: 10.1111/j.1365-2559.2008.03026.x.
• [108] Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.Cancer Immunol Immunother. 2013 Oct;62(10):1609-18. doi: 10.1007/s00262-013-1463-1. Epub 2013 Aug 17.
• [109] The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells.J Cell Physiol. 2010 Apr;223(1):178-86. doi: 10.1002/jcp.22026.
• [110] A simple two-gene prognostic model for adenocarcinoma of the lung.J Thorac Cardiovasc Surg. 2008 Mar;135(3):627-34. doi: 10.1016/j.jtcvs.2007.10.058. Epub 2008 Jan 18.
• [111] Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.Pancreas. 2008 Aug;37(2):154-8. doi: 10.1097/MPA.0b013e31816618ce.
• [112] Small-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing "wax-and-wane" transformation.BMC Cancer. 2013 Nov 7;13:529. doi: 10.1186/1471-2407-13-529.
• [113] The ubiquitin-proteasome pathway mediates gelsolin protein downregulation in pancreatic cancer.Mol Med. 2008 Sep-Oct;14(9-10):582-9. doi: 10.2119/2008-00020.Ni.
• [114] HOXA11 hypermethylation is associated with progression of non-small cell lung cancer.Oncotarget. 2013 Dec;4(12):2317-25. doi: 10.18632/oncotarget.1464.
• [115] Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer.Am J Pathol. 2009 Sep;175(3):976-87. doi: 10.2353/ajpath.2009.081004. Epub 2009 Aug 13.
• [116] Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.Cancer Res. 2008 Jun 15;68(12):4541-50. doi: 10.1158/0008-5472.CAN-07-6345.
• [117] Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition.Cancer Res. 2009 Sep 15;69(18):7252-61. doi: 10.1158/0008-5472.CAN-09-0577. Epub 2009 Aug 25.
• [118] Expression of peptidylarginine deiminase type 4 in ovarian tumors.Int J Biol Sci. 2010 Aug 27;6(5):454-64. doi: 10.7150/ijbs.6.454.
• [119] Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.Br J Cancer. 2008 Feb 12;98(3):587-95. doi: 10.1038/sj.bjc.6604184. Epub 2008 Jan 22.
• [120] Immunohistochemical expression of cytosolic phospholipase A2 in non-small cell lung carcinoma.Asian Pac J Cancer Prev. 2010;11(5):1367-72.
• [121] Tumor-associated neoexpression of the pS2 peptide and MUC5AC mucin in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.Histol Histopathol. 2008 May;23(5):539-48. doi: 10.14670/HH-23.539.
• [122] Expression of prostaglandin E synthase in Barrett's cancer.Dis Esophagus. 2008;21(4):304-8. doi: 10.1111/j.1442-2050.2007.00801.x.
• [123] Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine.Br J Cancer. 2008 May 20;98(10):1710-5. doi: 10.1038/sj.bjc.6604344. Epub 2008 Apr 15.
• [124] Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.Pancreas. 2008 Nov;37(4):440-4. doi: 10.1097/MPA.0b013e31817c5113.
• [125] Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations.Mol Cancer. 2010 Jul 30;9:203. doi: 10.1186/1476-4598-9-203.
• [126] Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors.Mol Cell Endocrinol. 2006 Mar 27;248(1-2):182-91. doi: 10.1016/j.mce.2005.12.009. Epub 2006 Jan 18.
• [127] ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells.Exp Cell Res. 2007 Feb 1;313(3):473-85. doi: 10.1016/j.yexcr.2006.10.024. Epub 2006 Oct 28.
• [128] Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.Pathol Int. 2018 Apr;68(4):232-240. doi: 10.1111/pin.12646. Epub 2018 Feb 12.
• [129] PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.Lung Cancer. 2019 Mar;129:41-47. doi: 10.1016/j.lungcan.2019.01.004. Epub 2019 Jan 16.
• [130] Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance.Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):659-65. doi: 10.1158/1078-0432.CCR-06-1385.
• [131] Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas.Int J Gynecol Pathol. 2007 Oct;26(4):410-7. doi: 10.1097/pgp.0b013e31804630a7.
• [132] Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma.Cancer Res. 2006 Mar 1;66(5):2553-61. doi: 10.1158/0008-5472.CAN-05-2645.
• [133] Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.Cancer Res. 2006 Sep 1;66(17):8581-9. doi: 10.1158/0008-5472.CAN-06-0975.
• [134] Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction.J Clin Endocrinol Metab. 2007 May;92(5):1863-70. doi: 10.1210/jc.2006-2338. Epub 2007 Feb 13.
• [135] Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.Cancer Res. 2006 Apr 15;66(8):4516-24. doi: 10.1158/0008-5472.CAN-05-3796.
• [136] The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.Cancer Res. 2006 Apr 15;66(8):4149-58. doi: 10.1158/0008-5472.CAN-05-3089.
• [137] Nuclear overexpression of the E2F3 transcription factor in human lung cancer.Lung Cancer. 2006 Nov;54(2):155-62. doi: 10.1016/j.lungcan.2006.07.005. Epub 2006 Aug 30.
• [138] HIF-2 not HIF-1 overexpression confers poor prognosis in non-small cell lung cancer.Tumour Biol. 2017 Jun;39(6):1010428317709637. doi: 10.1177/1010428317709637.
• [139] EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.Cancer Sci. 2006 Nov;97(11):1211-6. doi: 10.1111/j.1349-7006.2006.00313.x. Epub 2006 Sep 5.
• [140] Expression of estrogen receptor-related receptor isoforms and clinical significance in endometrial adenocarcinoma.Int J Gynecol Cancer. 2006 Mar-Apr;16(2):827-33. doi: 10.1111/j.1525-1438.2006.00527.x.
• [141] Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma.Clin Cancer Res. 2007 Feb 1;13(3):799-805. doi: 10.1158/1078-0432.CCR-06-1654.
• [142] The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-- catenin signaling axis.Oncotarget. 2017 Mar 28;8(13):21754-21769. doi: 10.18632/oncotarget.15567.
• [143] Expression of glutathione S-transferase pi and glutathione synthase correlates with survival in early stage non-small cell carcinomas of the lung.Hum Pathol. 2007 Feb;38(2):220-7. doi: 10.1016/j.humpath.2006.07.006.
• [144] Expressions of ATF6, XBP1, and GRP78 in normal tissue, atypical adenomatous hyperplasia, and adenocarcinoma of the lung.Hum Pathol. 2019 Jan;83:22-28. doi: 10.1016/j.humpath.2018.08.009. Epub 2018 Aug 16.
• [145] Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells.Int J Oncol. 2006 Oct;29(4):869-76.
• [146] The role of beta1 integrin subfamily in anchorage-dependent apoptosis of breast carcinoma cells differing in multidrug resistance.Biochemistry (Mosc). 2006 May;71(5):489-95. doi: 10.1134/s000629790605004x.
• [147] Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.Int J Cancer. 2005 Apr 20;114(4):531-43. doi: 10.1002/ijc.20778.
• [148] KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer.Biochem Biophys Res Commun. 2005 Apr 22;329(4):1260-6. doi: 10.1016/j.bbrc.2005.02.100.
• [149] Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.Gynecol Oncol. 2005 Jul;98(1):11-8. doi: 10.1016/j.ygyno.2005.03.043.
• [150] Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.Cancer Res. 2006 May 15;66(10):5165-72. doi: 10.1158/0008-5472.CAN-05-3012.
• [151] MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.Nutrients. 2019 Sep 4;11(9):2096. doi: 10.3390/nu11092096.
• [152] Primary Vaginal Gastric-type Adenocarcinoma and Vaginal Adenosis Exhibiting Gastric Differentiation: Report of a Series With Detailed Immunohistochemical Analysis.Am J Surg Pathol. 2018 Jul;42(7):958-970. doi: 10.1097/PAS.0000000000001068.
• [153] Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors.BMC Cancer. 2019 Jan 7;19(1):19. doi: 10.1186/s12885-018-5214-8.
• [154] Carbonic anhydrase-related protein VIII increases invasiveness of non-small cell lung adenocarcinoma.Virchows Arch. 2006 Jun;448(6):830-7. doi: 10.1007/s00428-006-0199-0. Epub 2006 Apr 12.
• [155] Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis.Cancer Sci. 2007 Mar;98(3):321-8. doi: 10.1111/j.1349-7006.2007.00390.x.
• [156] Characterization of genome-wide copy number aberrations in colonic mixed adenoneuroendocrine carcinoma and neuroendocrine carcinoma reveals recurrent amplification of PTGER4 and MYC genes.Hum Pathol. 2018 Mar;73:16-25. doi: 10.1016/j.humpath.2017.08.036. Epub 2017 Sep 9.
• [157] F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells.Endocrinology. 2007 Aug;148(8):3635-44. doi: 10.1210/en.2006-1517. Epub 2007 May 3.
• [158] Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.Am J Pathol. 2005 Dec;167(6):1763-75. doi: 10.1016/S0002-9440(10)61257-6.
• [159] Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma.Int J Cancer. 2006 Oct 1;119(7):1648-53. doi: 10.1002/ijc.22011.
• [160] EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.Cell Oncol (Dordr). 2011 Jun;34(3):209-14. doi: 10.1007/s13402-011-0028-6. Epub 2011 May 3.
• [161] The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells.Oncol Rep. 2009 Feb;21(2):425-30.
• [162] Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer.Int J Clin Oncol. 2005 Dec;10(6):405-10. doi: 10.1007/s10147-005-0520-y.
• [163] GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.Cancer Sci. 2007 Oct;98(10):1625-32. doi: 10.1111/j.1349-7006.2007.00578.x. Epub 2007 Aug 16.
• [164] Prognostic Significance of LC3B and p62/SQSTM1 Expression in Gastric Adenocarcinoma.Anticancer Res. 2019 Dec;39(12):6711-6722. doi: 10.21873/anticanres.13886.
• [165] Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations.Int J Cancer. 2006 Apr 1;118(7):1653-9. doi: 10.1002/ijc.21556.
• [166] Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.Oncol Rep. 2005 May;13(5):837-46.
• [167] Expression of the Bax inhibitor-1 gene in pulmonary adenocarcinoma.Cancer. 2006 Feb 1;106(3):648-53. doi: 10.1002/cncr.21639.
• [168] TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate.Hum Pathol. 2011 Jan;42(1):11-7. doi: 10.1016/j.humpath.2010.05.026. Epub 2010 Oct 30.
• [169] Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma.Int J Cancer. 2007 Nov 15;121(10):2132-9. doi: 10.1002/ijc.22898.
• [170] beta-Catenin regulates the expression of tenascin-C in human colorectal tumors.Oncogene. 2005 Dec 8;24(55):8200-4. doi: 10.1038/sj.onc.1208960.
• [171] Tumor-related gene expression levels in pulmonary pleomorphic carcinoma.J Cardiothorac Surg. 2015 Jun 3;10:79. doi: 10.1186/s13019-015-0282-1.
• [172] Centromeric chromosomal translocations show tissue-specific differences between squamous cell carcinomas and adenocarcinomas.Oncogene. 2005 Feb 24;24(9):1571-9. doi: 10.1038/sj.onc.1208294.
• [173] Clinical relevance of the multidrug resistanceassociated protein1 gene in nonsmall cell lung cancer: A systematic review and metaanalysis.Oncol Rep. 2018 Nov;40(5):3078-3091. doi: 10.3892/or.2018.6652. Epub 2018 Aug 17.
• [174] Deuteration of Hyperpolarized (13) C-Labeled Zymonic Acid Enables Sensitivity-Enhanced Dynamic MRI of pH.Chemphyschem. 2017 Sep 20;18(18):2422-2425. doi: 10.1002/cphc.201700779. Epub 2017 Aug 17.
• [175] Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer.Acad Radiol. 2018 Oct;25(10):1240-1251. doi: 10.1016/j.acra.2018.01.012. Epub 2018 Mar 9.
• [176] Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.Gastroenterology. 2016 Jan;150(1):218-228.e12. doi: 10.1053/j.gastro.2015.09.013. Epub 2015 Sep 25.
• [177] ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma.Br J Cancer. 2004 Mar 8;90(5):1053-8. doi: 10.1038/sj.bjc.6601645.
• [178] PACAP and PAC1 receptor expression in pancreatic ductal carcinoma.Oncol Lett. 2019 Dec;18(6):5725-5730. doi: 10.3892/ol.2019.10971. Epub 2019 Oct 8.
• [179] Distinct Prognostic Values of Alcohol Dehydrogenase Family Members for Non-Small Cell Lung Cancer.Med Sci Monit. 2018 May 29;24:3578-3590. doi: 10.12659/MSM.910026.
• [180] Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours.APMIS. 2014 May;122(5):418-26. doi: 10.1111/apm.12160. Epub 2013 Aug 13.
• [181] Extracellular AGR3 regulates breast cancer cells migration via Src signaling.Oncol Lett. 2019 Nov;18(5):4449-4456. doi: 10.3892/ol.2019.10849. Epub 2019 Sep 10.
• [182] Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer.Urology. 1995 Aug;46(2):227-37. doi: 10.1016/s0090-4295(99)80198-8.
• [183] 15-lipoxygenase-1 overexpression in prostate adenocarcinoma.Adv Exp Med Biol. 2002;507:133-45. doi: 10.1007/978-1-4615-0193-0_22.
• [184] Expression of angiopoietin-2 is correlated with vascularization and tumor size in human colorectal adenocarcinoma.Tohoku J Exp Med. 2007 Sep;213(1):33-40. doi: 10.1620/tjem.213.33.
• [185] Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effects.J Cell Physiol. 2019 Jun;234(6):8698-8708. doi: 10.1002/jcp.27529. Epub 2018 Oct 28.
• [186] Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.J Cancer Res Ther. 2015 Jan-Mar;11(1):223-8. doi: 10.4103/0973-1482.138007.
• [187] Expression profiles of Annexin A1, formylated peptide receptors and cyclooxigenase-2 in gastroesophageal inflammations and neoplasias.Pathol Res Pract. 2018 Feb;214(2):181-186. doi: 10.1016/j.prp.2017.12.003. Epub 2017 Dec 7.
• [188] LRP1 expression in colon cancer predicts clinical outcome.Oncotarget. 2018 Jan 13;9(10):8849-8869. doi: 10.18632/oncotarget.24225. eCollection 2018 Feb 6.
• [189] High levels of ANXA2 are characteristic of malignant salivary gland tumors.J Oral Pathol Med. 2019 Nov;48(10):929-934. doi: 10.1111/jop.12932. Epub 2019 Aug 5.
• [190] Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma.Eur Arch Otorhinolaryngol. 2017 Aug;274(8):3203-3209. doi: 10.1007/s00405-017-4605-9. Epub 2017 May 18.
• [191] Diverse proteomic alterations in gastric adenocarcinoma.Proteomics. 2004 Oct;4(10):3276-87. doi: 10.1002/pmic.200300916.
• [192] Pharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitro.J Exp Clin Cancer Res. 2016 Feb 24;35:36. doi: 10.1186/s13046-016-0310-6.
• [193] Transcriptome-wide association study reveals candidate causal genes for lung cancer.Int J Cancer. 2020 Apr 1;146(7):1862-1878. doi: 10.1002/ijc.32771. Epub 2019 Dec 9.
• [194] Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.Carcinogenesis. 2004 Apr;25(4):527-33. doi: 10.1093/carcin/bgh049. Epub 2003 Dec 19.
• [195] Transcriptional Response of Ovine Lung to Infection with Jaagsiekte Sheep Retrovirus.J Virol. 2019 Oct 15;93(21):e00876-19. doi: 10.1128/JVI.00876-19. Print 2019 Nov 1.
• [196] The Protein Expression of PDL1 Is Highly Correlated with Those of eIF2 and ATF4 in Lung Cancer.Dis Markers. 2018 Sep 16;2018:5068701. doi: 10.1155/2018/5068701. eCollection 2018.
• [197] Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.Carcinogenesis. 2016 Dec;37(12):1180-1189. doi: 10.1093/carcin/bgw097. Epub 2016 Sep 13.
• [198] Effect of sodium salt of Butrin, a novel compound isolated from Butea monosperma flowers on suppressing the expression of SIRT1 and Aurora B kinase-mediated apoptosis in colorectal cancer cells.Biomed Pharmacother. 2017 Jun;90:402-413. doi: 10.1016/j.biopha.2017.03.086. Epub 2017 Apr 5.
• [199] Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas.Mol Cancer. 2019 Feb 11;18(1):24. doi: 10.1186/s12943-019-0953-y.
• [200] AZGP1 mRNA levels in normal human lung tissue correlate with lung cancer disease status.Oncogene. 2008 Mar 6;27(11):1650-6. doi: 10.1038/sj.onc.1210775. Epub 2007 Aug 27.
• [201] MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia.Cancer. 2001 May 15;91(10):1882-8.
• [202] Mutations of the BAK gene are infrequent in advanced gastric adenocarcinomas in Koreans.Cancer Lett. 2003 May 30;195(1):87-91. doi: 10.1016/s0304-3835(02)00585-2.
• [203] TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.Br J Cancer. 2015 Sep 15;113(6):878-85. doi: 10.1038/bjc.2015.283. Epub 2015 Aug 20.
• [204] Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.Dis Markers. 2019 Apr 9;2019:5451290. doi: 10.1155/2019/5451290. eCollection 2019.
• [205] Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma.Biosci Rep. 2019 Dec 20;39(12):BSR20191770. doi: 10.1042/BSR20191770.
• [206] Low BUB1 expression is an adverse prognostic marker in gastric adenocarcinoma.Oncotarget. 2017 Jul 18;8(44):76329-76339. doi: 10.18632/oncotarget.19357. eCollection 2017 Sep 29.
• [207] Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy.Front Oncol. 2019 Oct 11;9:1042. doi: 10.3389/fonc.2019.01042. eCollection 2019.
• [208] Carbonic anhydrase isozymes II, IX, and XII in uterine tumors.APMIS. 2012 Feb;120(2):117-29. doi: 10.1111/j.1600-0463.2011.02820.x. Epub 2011 Oct 25.
• [209] Characterization of prostate cancer cell progression in zebrafish xenograft model.Int J Oncol. 2018 Jan;52(1):252-260. doi: 10.3892/ijo.2017.4189. Epub 2017 Nov 6.
• [210] Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling.Cell Death Dis. 2013 Mar 7;4(3):e522. doi: 10.1038/cddis.2013.51.
• [211] Serum gastrin and cholecystokinin are associated with subsequent development of gastric cancer in a prospective cohort of Finnish smokers.Int J Epidemiol. 2017 Jun 1;46(3):914-923. doi: 10.1093/ije/dyx030.
• [212] Gastrin activates autophagy and increases migration and survival of gastric adenocarcinoma cells.BMC Cancer. 2017 Jan 21;17(1):68. doi: 10.1186/s12885-017-3055-5.
• [213] Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.Eur J Cancer. 2017 Nov;86:15-27. doi: 10.1016/j.ejca.2017.08.026. Epub 2017 Sep 23.
• [214] Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.Int J Biol Sci. 2011 Apr 28;7(5):551-66. doi: 10.7150/ijbs.7.551.
• [215] Cyclin D1 protein affecting global women's health by regulating HPV mediated adenocarcinoma of the uterine cervix.Sci Rep. 2019 Mar 22;9(1):5019. doi: 10.1038/s41598-019-41394-9.
• [216] Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.PLoS One. 2013 Dec 18;8(12):e82241. doi: 10.1371/journal.pone.0082241. eCollection 2013.
• [217] The essential roles of CCR7 in epithelial-to-mesenchymal transition induced by hypoxia in epithelial ovarian carcinomas.Tumour Biol. 2014 Dec;35(12):12293-8. doi: 10.1007/s13277-014-2540-6. Epub 2014 Aug 29.
• [218] CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas.Virchows Arch. 2019 Jan;474(1):105-109. doi: 10.1007/s00428-018-2437-7. Epub 2018 Aug 21.
• [219] Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.PLoS One. 2017 Apr 3;12(4):e0175039. doi: 10.1371/journal.pone.0175039. eCollection 2017.
• [220] Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.J Thorac Oncol. 2018 Jun;13(6):779-791. doi: 10.1016/j.jtho.2018.03.002. Epub 2018 Mar 8.
• [221] A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer.Oncotarget. 2017 Jan 24;8(4):6216-6221. doi: 10.18632/oncotarget.14053.
• [222] Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22730-22736. doi: 10.1073/pnas.1911385116. Epub 2019 Oct 17.
• [223] Tumor endothelial cell-derived cadherin-2 promotes angiogenesis and has prognostic significance for lung adenocarcinoma.Mol Cancer. 2019 Mar 4;18(1):34. doi: 10.1186/s12943-019-0987-1.
• [224] Expression of cyclinB1, D1 and K in nonsmall cell lung cancer H1299 cells following treatment with sulforaphane.Oncol Rep. 2019 Feb;41(2):1313-1323. doi: 10.3892/or.2018.6919. Epub 2018 Dec 7.
• [225] Differences in the early stage gene expression profiles of lung adenocarcinoma and lung squamous cell carcinoma.Oncol Lett. 2019 Dec;18(6):6572-6582. doi: 10.3892/ol.2019.11013. Epub 2019 Oct 21.
• [226] Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer lung cancer: Epigenetic control of the RUNX2 P1 promoter.Tumour Biol. 2019 May;41(5):1010428319851014. doi: 10.1177/1010428319851014.
• [227] Genetic alterations and expression pattern of CEACAM1 in colorectal adenomas and cancers.Pathol Oncol Res. 2011 Mar;17(1):67-74. doi: 10.1007/s12253-010-9282-6. Epub 2010 Jun 4.
• [228] CEACAM 6, a novel marker for the diagnosis of Barrett's esophagus.Dis Esophagus. 2017 Jul 1;30(7):1-5. doi: 10.1093/dote/dox026.
• [229] Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies?.Oncotarget. 2017 Dec 22;9(15):12513-12533. doi: 10.18632/oncotarget.23619. eCollection 2018 Feb 23.
• [230] Instant evaluation of contrast enhanced endoscopic ultrasound helps to differentiate various solid pancreatic lesions in daily routine.World J Clin Cases. 2019 Jan 6;7(1):19-27. doi: 10.12998/wjcc.v7.i1.19.
• [231] Ectopic expression of a GlcNAc 6-O-sulfotransferase, GlcNAc6ST-2, in colonic mucinous adenocarcinoma.Glycobiology. 2002 Jun;12(6):379-88. doi: 10.1093/glycob/12.6.379.
• [232] RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach.Mod Pathol. 2019 Apr;32(4):568-575. doi: 10.1038/s41379-018-0181-9. Epub 2018 Nov 13.
• [233] Biomarkers in the diagnosis of pleural diseases: a 2018 update.Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618808660. doi: 10.1177/1753466618808660.
• [234] CLIC1 overexpression is associated with poor prognosis in pancreatic ductal adenocarcinomas.J Cancer Res Ther. 2016 Apr-Jun;12(2):892-6. doi: 10.4103/0973-1482.154057.
• [235] Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.Oncotarget. 2017 Apr 4;8(14):22894-22902. doi: 10.18632/oncotarget.15284.
• [236] Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.Clin Proteomics. 2017 Aug 15;14:31. doi: 10.1186/s12014-017-9166-9. eCollection 2017.
• [237] Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patients.Am J Hematol. 2004 Jul;76(3):214-9. doi: 10.1002/ajh.20079.
• [238] CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway.Endocrinology. 2002 Mar;143(3):807-13. doi: 10.1210/endo.143.3.8694.
• [239] Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus.Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):552-556. doi: 10.1097/PAI.0000000000000464.
• [240] Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.Clin Lung Cancer. 2013 Nov;14(6):666-673.e2. doi: 10.1016/j.cllc.2013.04.010. Epub 2013 Jul 17.
• [241] Protein kinase CK2 in mammary gland tumorigenesis.Oncogene. 2001 May 31;20(25):3247-57. doi: 10.1038/sj.onc.1204411.
• [242] Inhibition of Lipopolysaccharide-Induced Interleukin 8 in Human Adenocarcinoma Cell Line HT-29 by Spore Probiotics: B. coagulans and B. subtilis (natto).Probiotics Antimicrob Proteins. 2017 Mar;9(1):56-63. doi: 10.1007/s12602-016-9234-x.
• [243] CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population.Life Sci. 2009 May 22;84(21-22):779-84. doi: 10.1016/j.lfs.2009.03.008. Epub 2009 Mar 28.
• [244] Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.PLoS One. 2009 May 21;4(5):e5652. doi: 10.1371/journal.pone.0005652.
• [245] A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma. Oncogene. 2008 May 8;27(21):2951-60.
• [246] A polymorphism in the 5'-flanking region of the CYP2E1 gene and elevated lung adenocarcinoma risk in a Japanese population.Oncol Rep. 2005 Oct;14(4):919-23.
• [247] Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer.Oncotarget. 2017 May 23;8(21):34773-34786. doi: 10.18632/oncotarget.16718.
• [248] Nintedanib treatment delays prostate dorsolateral lobe cancer progression in the TRAMP model: contribution to the epithelial-stromal interaction balance.Cell Biol Int. 2018 Feb;42(2):153-168. doi: 10.1002/cbin.10881. Epub 2017 Nov 3.
• [249] Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer.J Cancer Res Clin Oncol. 2017 Aug;143(8):1449-1459. doi: 10.1007/s00432-017-2405-7. Epub 2017 Apr 5.
• [250] DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.Pathol Oncol Res. 2019 Jan;25(1):157-167. doi: 10.1007/s12253-017-0314-3. Epub 2017 Oct 17.
• [251] Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer.Oncotarget. 2015 Jan 30;6(3):1806-20. doi: 10.18632/oncotarget.2809.
• [252] Expression of PCNA, Ki-67 and COX-2 in breast cancer based on DCE-MRI image information.J Infect Public Health. 2020 Dec;13(12):2032-2037. doi: 10.1016/j.jiph.2019.06.024. Epub 2019 Jul 6.
• [253] The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer.Tumour Biol. 2013 Jun;34(3):1865-71. doi: 10.1007/s13277-013-0728-9. Epub 2013 Mar 22.
• [254] The clinicopathological and prognostic significances of Dkk3 expression in cancers: A bioinformatics analysis.Cancer Biomark. 2018;23(3):323-331. doi: 10.3233/CBM-181245.
• [255] The clinicopathological significance of Jagged1 and DLL4 in gallbladder cancer.Tumori. 2017 Nov 23;103(6):557-565. doi: 10.5301/tj.5000519. Epub 2016 May 6.
• [256] Different susceptibility of increased DNMT1 expression by exposure to tobacco smoke according to histology in primary non-small cell lung cancer.J Cancer Res Clin Oncol. 2007 Apr;133(4):219-26. doi: 10.1007/s00432-006-0160-2. Epub 2006 Oct 20.
• [257] Association of the DNMT3B polymorphism with colorectal adenomatous polyps and adenocarcinoma.Mol Biol Rep. 2010 Jan;37(1):219-25. doi: 10.1007/s11033-009-9626-z. Epub 2009 Jul 22.
• [258] The value of desmosomal plaque-related markers to distinguish squamous cell carcinoma and adenocarcinoma of the lung.Ups J Med Sci. 2020 Feb;125(1):19-29. doi: 10.1080/03009734.2019.1692101. Epub 2019 Dec 6.
• [259] E2F transcription factors and digestive system malignancies: how much do we know?.World J Gastroenterol. 2013 Jun 7;19(21):3189-98. doi: 10.3748/wjg.v19.i21.3189.
• [260] miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.Cell Death Dis. 2017 Oct 26;8(10):e3141. doi: 10.1038/cddis.2017.544.
• [261] Overexpressed MALAT1 promotes invasion and metastasis of gastric cancer cells via increasing EGFL7 expression.Life Sci. 2016 Jul 15;157:38-44. doi: 10.1016/j.lfs.2016.05.041. Epub 2016 May 31.
• [262] Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer.Oncotarget. 2018 Apr 13;9(28):19945-19960. doi: 10.18632/oncotarget.24977. eCollection 2018 Apr 13.
• [263] Direct inhibition of eIF4E reduced cell growth in endometrial adenocarcinoma.J Cancer Res Clin Oncol. 2011 Mar;137(3):463-9. doi: 10.1007/s00432-010-0902-z. Epub 2010 May 13.
• [264] Proteomic analysis of eIF-5A in lung adenocarcinomas.Proteomics. 2003 Apr;3(4):496-504. doi: 10.1002/pmic.200390063.
• [265] Early detection of pancreatic cancers in liquid biopsies by ultrasensitive fluorescence nanobiosensors.Nanomedicine. 2018 Aug;14(6):1823-1832. doi: 10.1016/j.nano.2018.04.020. Epub 2018 May 18.
• [266] Attenuation of the ELAV1-like protein HuR sensitizes adenocarcinoma cells to the intrinsic apoptotic pathway by increasing the translation of caspase-2L.Cell Death Dis. 2014 Jul 10;5(7):e1321. doi: 10.1038/cddis.2014.279.
• [267] Crk-like adapter protein is required for TGF--induced AKT and ERK-signaling pathway in epithelial ovarian carcinomas.Tumour Biol. 2015 Feb;36(2):915-9. doi: 10.1007/s13277-014-2724-0. Epub 2014 Oct 12.
• [268] Eosinophil peroxidase over-expression predicts the clinical outcome of patients with primary lung adenocarcinoma.J Cancer. 2019 Jan 29;10(4):1032-1038. doi: 10.7150/jca.24314. eCollection 2019.
• [269] Mechanisms behind signet ring cell carcinoma formation.Biochem Biophys Res Commun. 2014 Aug 8;450(4):1231-3. doi: 10.1016/j.bbrc.2014.07.025. Epub 2014 Jul 11.
• [270] Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro.BMC Cancer. 2018 Feb 1;18(1):121. doi: 10.1186/s12885-018-4030-5.
• [271] Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer.Cancer Gene Ther. 2009 Feb;16(2):137-48. doi: 10.1038/cgt.2008.65. Epub 2008 Sep 5.
• [272] ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.Prostate. 2018 Sep;78(12):896-904. doi: 10.1002/pros.23646. Epub 2018 May 15.
• [273] Multimodal treatment in locally advanced gastric cancer.Updates Surg. 2018 Jun;70(2):173-179. doi: 10.1007/s13304-018-0539-z. Epub 2018 Jun 26.
• [274] Hepatocyte Antigen Expression in Barrett Esophagus and Associated Neoplasia.Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):557-561. doi: 10.1097/PAI.0000000000000491.
• [275] Expression of protease-activated-receptor 2 (PAR-2) in human esophageal mucosa.Scand J Gastroenterol. 2009;44(6):664-71. doi: 10.1080/00365520902783683.
• [276] Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients.Thromb Res. 2018 May;165:1-5. doi: 10.1016/j.thromres.2018.03.001. Epub 2018 Mar 7.
• [277] FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.Int J Oncol. 2015 Mar;46(3):999-1006. doi: 10.3892/ijo.2015.2817. Epub 2015 Jan 7.
• [278] Fatty acid synthase expression and esophageal cancer.Mol Biol Rep. 2012 Oct;39(10):9733-9. doi: 10.1007/s11033-012-1838-y. Epub 2012 Jun 22.
• [279] LUBAC determines chemotherapy resistance in squamous cell lung cancer.J Exp Med. 2019 Feb 4;216(2):450-465. doi: 10.1084/jem.20180742. Epub 2019 Jan 14.
• [280] A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma.Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12410-5. doi: 10.1073/pnas.95.21.12410.
• [281] Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.Int J Cancer. 2018 Aug 15;143(4):886-896. doi: 10.1002/ijc.31366. Epub 2018 Mar 30.
• [282] Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas.Cells. 2019 Sep 16;8(9):1092. doi: 10.3390/cells8091092.
• [283] FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt.Oncotarget. 2017 Jun 30;8(46):80405-80415. doi: 10.18632/oncotarget.18903. eCollection 2017 Oct 6.
• [284] Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas.BMC Cancer. 2015 Nov 2;15:835. doi: 10.1186/s12885-015-1842-4.
• [285] The carboxy-terminus of the formin FMNL1 bundles actin to potentiate adenocarcinoma migration.J Cell Biochem. 2019 Sep;120(9):14383-14404. doi: 10.1002/jcb.28694. Epub 2019 Apr 11.
• [286] Why Targeting PSMA Is a Game Changer in the Management of Prostate Cancer.J Nucl Med. 2018 Feb;59(2):177-182. doi: 10.2967/jnumed.117.191874. Epub 2017 Oct 6.
• [287] FOSL1 Promotes Kras-induced Lung Cancer through Amphiregulin and Cell Survival Gene Regulation.Am J Respir Cell Mol Biol. 2018 May;58(5):625-635. doi: 10.1165/rcmb.2017-0164OC.
• [288] Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression.BMC Cancer. 2016 Jan 13;16:16. doi: 10.1186/s12885-016-2056-0.
• [289] Immunohistochemical expression of Fascin-1 in colorectal cancer in relation to clinical and pathological parameters.Folia Histochem Cytobiol. 2018;1(2):106-112. doi: 10.5603/FHC.a2018.0011. Epub 2018 Jun 11.
• [290] A pilot study of mRNA expressions of 5-fluorouracil pathway genes in peripheral blood mononuclear cells and tumor tissues in patients with lung adenocarcinoma.Lung Cancer. 2011 Feb;71(2):199-204. doi: 10.1016/j.lungcan.2010.04.021. Epub 2010 May 21.
• [291] Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.Horm Cancer. 2018 Feb;9(1):40-54. doi: 10.1007/s12672-017-0311-8. Epub 2017 Oct 4.
• [292] Integrated genomic characterization of oesophageal carcinoma.Nature. 2017 Jan 12;541(7636):169-175. doi: 10.1038/nature20805. Epub 2017 Jan 4.
• [293] Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.J Clin Endocrinol Metab. 2002 Oct;87(10):4707-14. doi: 10.1210/jc.2002-020347.
• [294] Altered expression and localization of connexin32 in human and murine gastric carcinogenesis.Dig Dis Sci. 2011 May;56(5):1323-32. doi: 10.1007/s10620-010-1467-z. Epub 2010 Nov 17.
• [295] The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines.Oncotarget. 2016 Sep 20;7(38):61021-61035. doi: 10.18632/oncotarget.10477.
• [296] The role of the obestatin/GPR39 system in human gastric adenocarcinomas.Oncotarget. 2016 Feb 2;7(5):5957-71. doi: 10.18632/oncotarget.6718.
• [297] GRK5 functions as an oncogenic factor in non-small-cell lung cancer.Cell Death Dis. 2018 Feb 20;9(3):295. doi: 10.1038/s41419-018-0299-1.
• [298] Inhibition of metabotropic glutamate receptor 1 suppresses tumor growth and angiogenesis in experimental non-small cell lung cancer.Eur J Pharmacol. 2016 Jul 15;783:103-11. doi: 10.1016/j.ejphar.2016.04.053. Epub 2016 Apr 29.
• [299] The miR-487b-3p/GRM3/TGF signaling axis is an important regulator of colon cancer tumorigenesis.Oncogene. 2017 Jun 15;36(24):3477-3489. doi: 10.1038/onc.2016.499. Epub 2017 Jan 23.
• [300] Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma.Antioxidants (Basel). 2019 Apr 11;8(4):97. doi: 10.3390/antiox8040097.
• [301] Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells.Gastroenterology. 2006 Apr;130(4):1191-206. doi: 10.1053/j.gastro.2005.12.032.
• [302] Genome Wide Methylome Alterations in Lung Cancer. PLoS One. 2015 Dec 18;10(12):e0143826.
• [303] Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front.Cancer Sci. 2004 Sep;95(9):728-35. doi: 10.1111/j.1349-7006.2004.tb03253.x.
• [304] Association of HLA-G 3' UTR polymorphism and expression with the progression of cervical lesions in human papillomavirus 18 infections.Infect Agent Cancer. 2018 Dec 29;13:42. doi: 10.1186/s13027-018-0217-2. eCollection 2018.
• [305] HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma.Clin Cancer Res. 2008 Mar 1;14(5):1470-7. doi: 10.1158/1078-0432.CCR-07-1450.
• [306] Epigenetic alterations in TRAMP mice: epigenome DNA methylation profiling using MeDIP-seq.Cell Biosci. 2018 Jan 12;8:3. doi: 10.1186/s13578-018-0201-y. eCollection 2018.
• [307] High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF.J Gastrointest Surg. 2008 Oct;12(10):1674-81; discussion 1681-2. doi: 10.1007/s11605-008-0628-2. Epub 2008 Aug 13.
• [308] Deletion and down-regulation of HRH4 gene in gastric carcinomas: a potential correlation with tumor progression. PLoS One. 2012;7(2):e31207. doi: 10.1371/journal.pone.0031207. Epub 2012 Feb 20.
• [309] Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.J Steroid Biochem Mol Biol. 1995 Dec;55(3-4):375-83. doi: 10.1016/0960-0760(95)00184-0.
• [310] Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients.Indian J Med Res. 2009 Nov;130(5):533-41.
• [311] Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.Medicine (Baltimore). 2017 Feb;96(6):e5903. doi: 10.1097/MD.0000000000005903.
• [312] Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications.Virchows Arch. 2019 Feb;474(2):159-168. doi: 10.1007/s00428-018-2483-1. Epub 2018 Nov 17.
• [313] Bioinformatics and functional analyses of key genes in smoking-associated lung adenocarcinoma.Oncol Lett. 2019 Oct;18(4):3613-3622. doi: 10.3892/ol.2019.10733. Epub 2019 Aug 7.
• [314] Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk.J Cell Biochem. 2019 Apr;120(4):5510-5518. doi: 10.1002/jcb.27834. Epub 2018 Oct 18.
• [315] Decreased expression of insulin-like growth factor binding protein 6 is associated with gastric adenocarcinoma prognosis.Oncol Lett. 2017 Jun;13(6):4161-4168. doi: 10.3892/ol.2017.5993. Epub 2017 Apr 5.
• [316] Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma.Gut Liver. 2020 Nov 15;14(6):727-734. doi: 10.5009/gnl19135.
• [317] IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).J Thorac Oncol. 2016 Dec;11(12):2183-2192. doi: 10.1016/j.jtho.2016.07.026. Epub 2016 Aug 12.
• [318] Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines.BMC Cancer. 2018 Feb 27;18(1):222. doi: 10.1186/s12885-018-4145-8.
• [319] Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.Hum Pathol. 2019 Jun;88:27-38. doi: 10.1016/j.humpath.2019.03.006. Epub 2019 Apr 1.
• [320] Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol.Mol Cell Endocrinol. 2002 Jun 28;192(1-2):187-95. doi: 10.1016/s0303-7207(01)00648-7.
• [321] Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis.Gut. 2019 Nov;68(11):1942-1952. doi: 10.1136/gutjnl-2018-316691. Epub 2019 Mar 6.
• [322] Integrin alpha 6 beta 4 promotes migration, invasion through Tiam1 upregulation, and subsequent Rac activation.Neoplasia. 2008 May;10(5):408-17. doi: 10.1593/neo.07868.
• [323] Density of CD8-positive tumor-infiltrating T-lymphocytes is an independent prognostic factor in adenocarcinoma of the esophagogastric junction.Histol Histopathol. 2019 Oct;34(10):1121-1129. doi: 10.14670/HH-18-109. Epub 2019 Apr 2.
• [324] Immunohistochemically defined lymphocyte function-associated antigen 1 (LFA-1) on an adenocarcinoma cell line is a distinct molecule from LFA-1 on leukocytes.Cell Immunol. 1995 Dec;166(2):254-60. doi: 10.1006/cimm.1995.9972.
• [325] Integrin1 modulates tumour resistance to gemcitabine and serves as an independent prognostic factor in pancreatic adenocarcinomas.Tumour Biol. 2016 Sep;37(9):12315-12327. doi: 10.1007/s13277-016-5061-7. Epub 2016 Jun 11.
• [326] Expression heterogeneity research of ITGB3 and BCL-2 in lung adenocarcinoma tissue and adenocarcinoma cell line.Asian Pac J Trop Med. 2014 Jun;7(6):473-7. doi: 10.1016/S1995-7645(14)60077-8.
• [327] The role of KCNQ1 in mouse and human gastrointestinal cancers.Oncogene. 2014 Jul 17;33(29):3861-8. doi: 10.1038/onc.2013.350. Epub 2013 Aug 26.
• [328] Influence of the KDM4A rs586339 polymorphism on overall survival in Asian non-small-cell lung cancer patients.Pharmacogenet Genomics. 2017 Mar;27(3):120-123. doi: 10.1097/FPC.0000000000000266.
• [329] Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.Lancet Oncol. 2019 Mar;20(3):420-435. doi: 10.1016/S1470-2045(18)30791-5. Epub 2019 Feb 1.
• [330] Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment.Cell Metab. 2018 Apr 3;27(4):935-943.e4. doi: 10.1016/j.cmet.2018.02.006. Epub 2018 Mar 8.
• [331] Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.Tumori. 2014 Nov-Dec;100(6):667-74. doi: 10.1700/1778.19276.
• [332] Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein.Biochemistry. 1992 Jan 28;31(3):818-24. doi: 10.1021/bi00118a026.
• [333] Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.Tumour Biol. 2014 May;35(5):4673-85. doi: 10.1007/s13277-014-1612-y. Epub 2014 Jan 16.
• [334] Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.Biol Chem. 2014 Sep;395(9):1075-86. doi: 10.1515/hsz-2014-0142.
• [335] The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.Am J Obstet Gynecol. 2004 Jan;190(1):60-6. doi: 10.1016/j.ajog.2003.07.020.
• [336] Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.Nat Genet. 2012 May;44(5):570-4. doi: 10.1038/ng.2246.
• [337] Cytokeratin 17 Expression is Associated With Poor Prognosis in Gallbladder Adenocarcinoma.Appl Immunohistochem Mol Morphol. 2017 May/Jun;25(5):346-350. doi: 10.1097/PAI.0000000000000307.
• [338] Clinical and radiological characteristics of central pulmonary adenocarcinoma: a comparison with central squamous cell carcinoma and small cell lung cancer and the impact on treatment response.Onco Targets Ther. 2018 May 4;11:2509-2517. doi: 10.2147/OTT.S154385. eCollection 2018.
• [339] Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes.Cancer Res. 2019 Jan 1;79(1):61-71. doi: 10.1158/0008-5472.CAN-18-1087. Epub 2018 Nov 6.
• [340] Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer.Ann Surg Oncol. 2017 Apr;24(4):1110-1119. doi: 10.1245/s10434-016-5671-8. Epub 2016 Nov 10.
• [341] LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.Sci Rep. 2015 Sep 7;5:13846. doi: 10.1038/srep13846.
• [342] Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasms.Pancreatology. 2018 Jan;18(1):46-53. doi: 10.1016/j.pan.2017.11.006. Epub 2017 Nov 14.
• [343] Hypoxiainduced galectin? enhances RhoA function to activate the motility of tumor cells in nonsmall cell lung cancer.Oncol Rep. 2019 Feb;41(2):853-862. doi: 10.3892/or.2018.6915. Epub 2018 Dec 7.
• [344] Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2.Oncogene. 2015 Aug 20;34(34):4519-30. doi: 10.1038/onc.2014.386. Epub 2014 Dec 8.
• [345] LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients.Oncotarget. 2016 Dec 13;7(50):82876-82888. doi: 10.18632/oncotarget.12657.
• [346] Expression of MAGE-1, MAGE-2, MAGE-3/-6 and MAGE-4a/-4b genes in ovarian tumors.Int J Cancer. 1995 Dec 20;64(6):388-93. doi: 10.1002/ijc.2910640607.
• [347] Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients.Acta Oncol. 2019 Nov;58(11):1640-1647. doi: 10.1080/0284186X.2019.1648865. Epub 2019 Aug 9.
• [348] [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].Zhonghua Yi Xue Za Zhi. 2004 Mar 17;84(6):464-8.
• [349] Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy.J Neural Transm (Vienna). 2018 Nov;125(11):1553-1566. doi: 10.1007/s00702-018-1927-8. Epub 2018 Sep 27.
• [350] Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-B activation.Cell Death Dis. 2015 Apr 9;6(4):e1718. doi: 10.1038/cddis.2015.83.
• [351] Prognostic role of TPL2 in earlystage nonsmall cell lung cancer.Mol Med Rep. 2017 Jun;15(6):3451-3458. doi: 10.3892/mmr.2017.6430. Epub 2017 Apr 3.
• [352] Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence.Int J Med Sci. 2019 Jun 2;16(6):813-821. doi: 10.7150/ijms.32599. eCollection 2019.
• [353] Expression of ICAM-1, E-cadherin, periostin and midkine in metastases of pancreatic ductal adenocarcinomas.Exp Mol Pathol. 2018 Apr;104(2):109-113. doi: 10.1016/j.yexmp.2018.01.005. Epub 2018 Feb 2.
• [354] Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK.BMC Cancer. 2018 May 21;18(1):578. doi: 10.1186/s12885-018-4463-x.
• [355] Flaxleaf Fleabane Leaves (Conyza bonariensis), A New Functional Nonconventional Edible Plant?.J Food Sci. 2019 Dec;84(12):3473-3482. doi: 10.1111/1750-3841.14848. Epub 2019 Nov 13.
• [356] Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma.Cell Death Dis. 2018 Jan 18;9(2):36. doi: 10.1038/s41419-017-0188-z.
• [357] The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30mm.J Surg Oncol. 2018 Mar;117(3):451-456. doi: 10.1002/jso.24857. Epub 2017 Nov 11.
• [358] Organoid culture containing cancer cells and stromal cells reveals that podoplanin-positive cancer-associated fibroblasts enhance proliferation of lung cancer cells.Lung Cancer. 2019 Aug;134:100-107. doi: 10.1016/j.lungcan.2019.04.007. Epub 2019 Apr 8.
• [359] Clinicopathological features and phenotypic classification of de novo-type colorectal carcinomas differ from those of colorectal carcinomas derived from flat adenomas.Pathol Int. 2019 Jun;69(6):331-340. doi: 10.1111/pin.12803. Epub 2019 Jul 7.
• [360] MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung Adenocarcinoma.PLoS One. 2015 Jul 20;10(7):e0132960. doi: 10.1371/journal.pone.0132960. eCollection 2015.
• [361] Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.Pathol Oncol Res. 2015 Sep;21(4):1133-40. doi: 10.1007/s12253-015-9943-6. Epub 2015 May 14.
• [362] Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.Nature. 2016 Jun 16;534(7607):407-411. doi: 10.1038/nature17988. Epub 2016 Jun 6.
• [363] Molecular Imaging of Mesothelin-Expressing Ovarian Cancer with a Human and Mouse Cross-Reactive Nanobody.Mol Pharm. 2018 Apr 2;15(4):1403-1411. doi: 10.1021/acs.molpharmaceut.7b00789. Epub 2018 Feb 28.
• [364] Differences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomas.J Thorac Cardiovasc Surg. 2018 Oct;156(4):1679-1688.e2. doi: 10.1016/j.jtcvs.2018.05.053. Epub 2018 Jun 4.
• [365] RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.Cancer Biol Ther. 2011 Jul 1;12(1):9-46. doi: 10.4161/cbt.12.1.15747. Epub 2011 Jul 1.
• [366] mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer.Oncogene. 2019 Jan;38(5):622-636. doi: 10.1038/s41388-018-0479-6. Epub 2018 Aug 31.
• [367] Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia.Pancreas. 2003 Apr;26(3):e48-54. doi: 10.1097/00006676-200304000-00022.
• [368] SPDEF Induces Quiescence of Colorectal Cancer Cells byChanging the Transcriptional Targets of -catenin.Gastroenterology. 2017 Jul;153(1):205-218.e8. doi: 10.1053/j.gastro.2017.03.048. Epub 2017 Apr 5.
• [369] Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer.Clin Cancer Res. 2018 Feb 1;24(3):696-707. doi: 10.1158/1078-0432.CCR-17-1872. Epub 2017 Nov 14.
• [370] Are Helicobacter pylori highly cytotoxic genotypes and cardia gastric adenocarcinoma linked? Lessons from Iran.Cancer Biomark. 2017 Dec 12;21(1):235-246. doi: 10.3233/CBM-170701.
• [371] Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer.Am J Pathol. 2015 Dec;185(12):3164-77. doi: 10.1016/j.ajpath.2015.08.018. Epub 2015 Oct 23.
• [372] Reactive Oxygen Species Deficiency Due to Ncf1-Mutation Leads to Development of Adenocarcinoma and Metabolomic and Lipidomic Remodeling in a New Mouse Model of Dextran Sulfate Sodium-Induced Colitis.Front Immunol. 2018 May 14;9:701. doi: 10.3389/fimmu.2018.00701. eCollection 2018.
• [373] Overexpression and gender-specific differences of SRC-3 (SRC-3/AIB1) immunoreactivity in human non-small cell lung cancer: an in vivo study.J Histochem Cytochem. 2010 Dec;58(12):1121-7. doi: 10.1369/jhc.2010.956979. Epub 2010 Sep 17.
• [374] Strong NFB Expression is Associated With High-grade Dysplasia in Barrett's Esophagus.Appl Immunohistochem Mol Morphol. 2017 May/Jun;25(5):329-333. doi: 10.1097/PAI.0000000000000359.
• [375] Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.Clin Cancer Res. 1997 Oct;3(10):1873-7.
• [376] PEG10 is associated with treatment-induced neuroendocrine prostate cancer.J Mol Endocrinol. 2019 Jul 1;63(1):39-49. doi: 10.1530/JME-18-0226.
• [377] LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.Thorac Cancer. 2018 Dec;9(12):1725-1732. doi: 10.1111/1759-7714.12887. Epub 2018 Oct 1.
• [378] Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.J Oral Pathol Med. 2016 Feb;45(2):101-10. doi: 10.1111/jop.12329. Epub 2015 May 20.
• [379] Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.Virchows Arch. 2017 Oct;471(4):521-530. doi: 10.1007/s00428-017-2215-y. Epub 2017 Aug 24.
• [380] Morphine Suppresses Lung Cancer Cell Proliferation Through the Interaction with Opioid Growth Factor Receptor: An In Vitro and Human Lung Tissue Study.Anesth Analg. 2016 Dec;123(6):1429-1436. doi: 10.1213/ANE.0000000000001293.
• [381] Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based Chemotherapy.Pathol Oncol Res. 2019 Oct;25(4):1327-1340. doi: 10.1007/s12253-017-0372-6. Epub 2017 Dec 5.
• [382] Whole genome amplification and molecular genetic analysis of DNA from paraffin-embedded prostate adenocarcinoma tumor tissue.J Urol. 1999 Oct;162(4):1512-8.
• [383] Role of purinergic receptors in hepatobiliary carcinoma in Pakistani population: an approach towards proinflammatory role of P2X4 and P2X7 receptors.Purinergic Signal. 2019 Sep;15(3):367-374. doi: 10.1007/s11302-019-09675-0. Epub 2019 Aug 10.
• [384] Targeting PKC-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.Cell Commun Signal. 2019 Oct 28;17(1):137. doi: 10.1186/s12964-019-0446-z.
• [385] Prognostic value of p21-activated kinase 4 in resected pancreatic cancer.APMIS. 2017 Aug;125(8):699-707. doi: 10.1111/apm.12705. Epub 2017 May 30.
• [386] Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.Cancer Res. 2001 Feb 1;61(3):1196-206.
• [387] Tumour-suppression activity of the proapoptotic regulator Par4.EMBO Rep. 2005 Jun;6(6):577-83. doi: 10.1038/sj.embor.7400421.
• [388] Strong decrease in biotin content may correlate with metabolic alterations in colorectal adenocarcinoma.Int J Cancer. 1997 Sep 4;72(5):768-75. doi: 10.1002/(sici)1097-0215(19970904)72:5<768::aid-ijc11>3.0.co;2-5.
• [389] PDE3A is hypermethylated in cisplatin resistant non-small cell lung cancer cells and is a modulator of chemotherapy response.Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2635-2641.
• [390] Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors.Mod Pathol. 2008 Feb;21(2):115-24. doi: 10.1038/modpathol.3800984. Epub 2007 Dec 14.
• [391] Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer.Sci Rep. 2016 Oct 21;6:35603. doi: 10.1038/srep35603.
• [392] Loss of Raf kinase inhibitor protein expression is associated with human papillomavirus 16 infection in anal tumors.Oncol Lett. 2018 Aug;16(2):1785-1790. doi: 10.3892/ol.2018.8828. Epub 2018 May 30.
• [393] Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer.Int J Oncol. 2016 Jan;48(1):215-24. doi: 10.3892/ijo.2015.3225. Epub 2015 Nov 2.
• [394] Expression of PGDH correlates with cell growth in both esophageal squamous cell carcinoma and adenocarcinoma.Asian Pac J Cancer Prev. 2015;16(3):997-1000. doi: 10.7314/apjcp.2015.16.3.997.
• [395] PlGF expression in pre-invasive and invasive lesions of uterine cervix is associated with angiogenesis and lymphangiogenesis.APMIS. 2009 Nov;117(11):831-8. doi: 10.1111/j.1600-0463.2009.02538.x.
• [396] MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.Cancer Lett. 2009 Jan 18;273(2):233-42. doi: 10.1016/j.canlet.2008.08.003. Epub 2008 Sep 13.
• [397] c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.Oncotarget. 2016 Nov 15;7(46):75585-75602. doi: 10.18632/oncotarget.12310.
• [398] Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.J Exp Clin Cancer Res. 2019 Feb 11;38(1):66. doi: 10.1186/s13046-019-1053-y.
• [399] Limited Clinical Significance of Dimeric Form of Pyruvate Kinase as a Diagnostic and Prognostic Biomarker in Non-small Cell Lung Cancer.Adv Exp Med Biol. 2017;955:51-57. doi: 10.1007/5584_2016_92.
• [400] Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology.Int J Gynecol Cancer. 2017 May;27(4):784-790. doi: 10.1097/IGC.0000000000000957.
• [401] High expression of uPA related to p38MAPK in esophageal cancer indicates poor prognosis.Onco Targets Ther. 2018 Nov 29;11:8427-8434. doi: 10.2147/OTT.S181701. eCollection 2018.
• [402] Distinct Prognostic Values of Phospholipase C Beta Family Members for Non-Small Cell Lung Carcinoma.Biomed Res Int. 2019 Apr 7;2019:4256524. doi: 10.1155/2019/4256524. eCollection 2019.
• [403] Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.Neoplasia. 2018 Mar;20(3):244-255. doi: 10.1016/j.neo.2018.01.004. Epub 2018 Feb 12.
• [404] Differential modulation of chemosensitivity to alkylating agents and platinum compounds by DNA repair modulators in human lung cancer cell lines.J Cancer Res Clin Oncol. 2000 Apr;126(4):198-204. doi: 10.1007/s004320050033.
• [405] Functional characterization of peroxisome proliferator-activated receptor-/ expression in colon cancer. Mol Carcinog. 2011 Nov;50(11):884-900. doi: 10.1002/mc.20757. Epub 2011 Mar 11.
• [406] Significance of positive and inhibitory regulators in the TGF- signaling pathway in colorectal cancers.Hum Pathol. 2017 Aug;66:34-39. doi: 10.1016/j.humpath.2017.05.021. Epub 2017 Jun 7.
• [407] Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients.Asia Pac J Clin Oncol. 2017 Oct;13(5):e212-e223. doi: 10.1111/ajco.12586. Epub 2016 Aug 12.
• [408] The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma.Int J Med Sci. 2019 Aug 14;16(9):1199-1206. doi: 10.7150/ijms.36071. eCollection 2019.
• [409] Motility analysis of pancreatic adenocarcinoma cells reveals a role for the atypical zeta isoform of protein kinase C in cancer cell movement.Lab Invest. 2003 Aug;83(8):1155-63. doi: 10.1097/01.lab.0000081390.92179.f3.
• [410] The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.Am J Surg Pathol. 2018 Feb;42(2):e11-e27. doi: 10.1097/PAS.0000000000000980.
• [411] Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ER(+) Mammary Carcinomas.Cancer Res. 2018 Apr 1;78(7):1672-1684. doi: 10.1158/0008-5472.CAN-17-0985. Epub 2018 Jan 23.
• [412] Association of high-evidence gastric cancer susceptibility loci and somatic gene expression levels with survival.Carcinogenesis. 2017 Oct 26;38(11):1119-1128. doi: 10.1093/carcin/bgx090.
• [413] Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.Cancer. 2002 Feb 15;94(4):1023-31.
• [414] Matrix stiffening and 1 integrin drive subtype-specific fibroblast accumulation in lung cancer.Mol Cancer Res. 2015 Jan;13(1):161-73. doi: 10.1158/1541-7786.MCR-14-0155. Epub 2014 Oct 3.
• [415] PTK7 expression is associated with lymph node metastasis, ALK and EGFR mutations in lung adenocarcinomas.Histol Histopathol. 2020 May;35(5):489-495. doi: 10.14670/HH-18-183. Epub 2019 Nov 8.
• [416] SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development.Oncotarget. 2016 Oct 4;7(40):65676-65695. doi: 10.18632/oncotarget.11601.
• [417] Implication of a protein-tyrosine-phosphatase in human lung cancer.Cell Mol Biol (Noisy-le-grand). 1994 Jul;40(5):677-85.
• [418] Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.Anticancer Res. 2018 Oct;38(10):5665-5669. doi: 10.21873/anticanres.12902.
• [419] High PTPRQ Expression and Its Relationship to Expression of PTPRZ1 and the Presence of KRAS Mutations in Colorectal Cancer Tissues.Anticancer Res. 2016 Feb;36(2):677-81.
• [420] Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.PLoS One. 2017 Jan 18;12(1):e0167868. doi: 10.1371/journal.pone.0167868. eCollection 2017.
• [421] Association between Retinoic acid receptor- hypermethylation and NSCLC risk: a meta-analysis and literature review.Oncotarget. 2017 Jan 24;8(4):5814-5822. doi: 10.18632/oncotarget.14023.
• [422] Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.Am J Pathol. 2003 Sep;163(3):923-33. doi: 10.1016/s0002-9440(10)63452-9.
• [423] Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4336-44. doi: 10.1158/1078-0432.CCR-07-0015.
• [424] ROCK2 inhibition triggers the collective invasion of colorectal adenocarcinomas.EMBO J. 2019 Jul 15;38(14):e99299. doi: 10.15252/embj.201899299. Epub 2019 Jun 18.
• [425] Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.Cancer Res. 2013 Jun 15;73(12):3649-60. doi: 10.1158/0008-5472.CAN-12-3832.
• [426] Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder.World J Gastroenterol. 2017 Apr 14;23(14):2601-2612. doi: 10.3748/wjg.v23.i14.2601.
• [427] Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.Hum Pathol. 2013 Nov;44(11):2501-8. doi: 10.1016/j.humpath.2013.06.010. Epub 2013 Sep 10.
• [428] Platelets contribute to the initiation of colitis-associated cancer by promoting immunosuppression.J Thromb Haemost. 2018 Apr;16(4):762-777. doi: 10.1111/jth.13959. Epub 2018 Mar 2.
• [429] The expression of special AT-rich binding protein 1 in cervical cancer and its clinical significance.Onco Targets Ther. 2019 Jan 30;12:945-951. doi: 10.2147/OTT.S191414. eCollection 2019.
• [430] Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells.Cancer Lett. 2017 Oct 10;406:93-104. doi: 10.1016/j.canlet.2017.07.027. Epub 2017 Aug 7.
• [431] Pathobiology of Notch2 in lung cancer.Pathology. 2017 Aug;49(5):486-493. doi: 10.1016/j.pathol.2017.05.005. Epub 2017 Jun 27.
• [432] 1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression.Int J Oncol. 2017 Jun;50(6):1955-1964. doi: 10.3892/ijo.2017.3962. Epub 2017 Apr 18.
• [433] The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.Mol Oncol. 2019 May;13(5):1166-1179. doi: 10.1002/1878-0261.12475. Epub 2019 Apr 10.
• [434] Immunohistochemistry and clinical value of sirtuin 2 in non-metastasized non-small cell lung cancer.J Thorac Dis. 2019 Sep;11(9):3973-3979. doi: 10.21037/jtd.2019.08.102.
• [435] Expression of Na+-K+-2Cl- cotransporter isoform 1 (NKCC1) predicts poor prognosis in lung adenocarcinoma and EGFR-mutated adenocarcinoma patients.QJM. 2016 Apr;109(4):237-44. doi: 10.1093/qjmed/hcv207. Epub 2015 Nov 11.
• [436] Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.Thorac Cancer. 2019 Dec;10(12):2289-2299. doi: 10.1111/1759-7714.13226. Epub 2019 Oct 30.
• [437] Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.Sci Transl Med. 2018 Nov 14;10(467):eaat5933. doi: 10.1126/scitranslmed.aat5933.
• [438] Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells.Mol Oncol. 2014 Jul;8(5):942-55. doi: 10.1016/j.molonc.2014.03.014. Epub 2014 Mar 25.
• [439] Oxidative and cytotoxic stress induced by inorganic granular and fibrous particles.Mol Med Rep. 2018 Jun;17(6):8518-8529. doi: 10.3892/mmr.2018.8923. Epub 2018 Apr 23.
• [440] The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.Tumour Biol. 2017 Oct;39(10):1010428317718403. doi: 10.1177/1010428317718403.
• [441] Involvement of released sphingosine 1-phosphate/sphingosine 1-phosphate receptor axis in skeletal muscle atrophy.Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3598-3614. doi: 10.1016/j.bbadis.2018.08.040. Epub 2018 Sep 1.
• [442] Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.Oncotarget. 2016 Jan 26;7(4):3905-20. doi: 10.18632/oncotarget.6678.
• [443] Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras-driven lung tumours.J Pathol. 2018 May;245(1):101-113. doi: 10.1002/path.5059. Epub 2018 Apr 2.
• [444] Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.J Cancer Res Clin Oncol. 2018 Oct;144(10):1921-1932. doi: 10.1007/s00432-018-2722-5. Epub 2018 Aug 3.
• [445] Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines.Life Sci. 1994;55(23):1797-806. doi: 10.1016/0024-3205(94)90090-6.
• [446] Decreased matriptase/HAI-1 ratio in advanced colorectal adenocarcinoma of Chinese patients.Chin J Physiol. 2007 Oct 31;50(5):225-31.
• [447] Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.Gynecol Endocrinol. 2018 Feb;34(2):171-174. doi: 10.1080/09513590.2017.1379494. Epub 2017 Sep 22.
• [448] Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.Ann Thorac Surg. 2019 Jul;108(1):235-243. doi: 10.1016/j.athoracsur.2019.02.040. Epub 2019 Mar 22.
• [449] ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.Br J Cancer. 2014 Apr 15;110(8):2030-9. doi: 10.1038/bjc.2014.88. Epub 2014 Mar 6.
• [450] SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.PLoS One. 2016 Feb 16;11(2):e0148911. doi: 10.1371/journal.pone.0148911. eCollection 2016.
• [451] Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients.Lung Cancer. 2017 Sep;111:61-64. doi: 10.1016/j.lungcan.2017.07.006. Epub 2017 Jul 11.
• [452] Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.Oncotarget. 2017 Apr 25;8(17):28725-28735. doi: 10.18632/oncotarget.15647.
• [453] Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.Nat Genet. 2011 Sep 4;43(10):964-968. doi: 10.1038/ng.936.
• [454] Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.Gastroenterology. 2020 Jan;158(1):238-252. doi: 10.1053/j.gastro.2019.09.023. Epub 2019 Oct 1.
• [455] TGM2: a cell surface marker in esophageal adenocarcinomas.J Thorac Oncol. 2014 Jun;9(6):872-81. doi: 10.1097/JTO.0000000000000229.
• [456] Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance.Lung Cancer. 2018 Aug;122:124-130. doi: 10.1016/j.lungcan.2018.06.015. Epub 2018 Jun 10.
• [457] Toll-like receptors TLR-2, TLR-4, TLR-7, and TLR-9 in tumor tissue and serum of the patients with esophageal squamous cell carcinoma and gastro-esophageal junction cancer.Adv Clin Exp Med. 2019 Apr;28(4):515-522. doi: 10.17219/acem/87012.
• [458] Expression of enteropeptidase in differentiated enterocytes, goblet cells, and the tumor cells in human duodenum.Am J Physiol Gastrointest Liver Physiol. 2003 Dec;285(6):G1235-41. doi: 10.1152/ajpgi.00198.2003. Epub 2003 Aug 7.
• [459] CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumors.J Immunol. 2010 Jul 1;185(1):532-41. doi: 10.4049/jimmunol.0903624. Epub 2010 May 26.
• [460] Tankyrase 1 polymorphism associated with an increased risk in developing non-small cell lung cancer in a Chinese population: a proof-of-principle study.Int J Clin Exp Pathol. 2015 Sep 1;8(9):10500-11. eCollection 2015.
• [461] Tankyrase 2 (TNKS2) polymorphism associated with risk in developing non-small cell lung cancer in a Chinese population.Pathol Res Pract. 2015 Oct;211(10):766-71. doi: 10.1016/j.prp.2015.07.003. Epub 2015 Jul 8.
• [462] TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis.Oncol Lett. 2017 Aug;14(2):2153-2164. doi: 10.3892/ol.2017.6467. Epub 2017 Jun 22.
• [463] CIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis.Oncogene. 2015 Jul;34(27):3527-35. doi: 10.1038/onc.2014.280. Epub 2014 Sep 1.
• [464] TRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer.J Cancer Res Clin Oncol. 2019 May;145(5):1297-1311. doi: 10.1007/s00432-019-02898-z. Epub 2019 Mar 19.
• [465] Silencing of TRPM8 inhibits aggressive tumor phenotypes and enhances gemcitabine sensitivity in pancreatic cancer.Pancreatology. 2018 Dec;18(8):935-944. doi: 10.1016/j.pan.2018.08.011. Epub 2018 Aug 22.
• [466] The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer.Oncotarget. 2017 Dec 14;8(70):115270-115279. doi: 10.18632/oncotarget.23252. eCollection 2017 Dec 29.
• [467] Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma.J Exp Clin Cancer Res. 2011 Aug 30;30(1):79. doi: 10.1186/1756-9966-30-79.
• [468] USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma.Tumour Biol. 2015 Mar;36(3):1721-9. doi: 10.1007/s13277-014-2773-4. Epub 2014 Dec 18.
• [469] Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma.Pathol Int. 2017 Jun;67(6):292-301. doi: 10.1111/pin.12546. Epub 2017 May 19.
• [470] Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.Clin Cancer Res. 2016 Mar 1;22(5):1284-94. doi: 10.1158/1078-0432.CCR-15-0306. Epub 2015 Nov 2.
• [471] Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.Cancer. 2005 Oct 15;104(8):1668-77. doi: 10.1002/cncr.21366.
• [472] The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma.APMIS. 2013 Feb;121(2):95-104. doi: 10.1111/j.1600-0463.2012.02942.x. Epub 2012 Aug 17.
• [473] Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis.Am J Surg Pathol. 2008 Jan;32(1):78-91. doi: 10.1097/PAS.0b013e31815701d1.
• [474] Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: evaluation of five different ALK antibody clones and ALK FISH.Histopathology. 2014 Sep;65(3):398-407. doi: 10.1111/his.12399. Epub 2014 May 2.
• [475] Wild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival.Endocrinology. 2012 Apr;153(4):1638-48. doi: 10.1210/en.2011-2131. Epub 2012 Mar 6.
• [476] Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis.Oncol Rep. 2011 Apr;25(4):929-35. doi: 10.3892/or.2011.1176. Epub 2011 Feb 9.
• [477] Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism.Autophagy. 2014 Feb;10(2):384-5. doi: 10.4161/auto.27320. Epub 2013 Dec 17.
• [478] Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.Tumour Biol. 2015 Sep;36(10):8201-6. doi: 10.1007/s13277-015-3546-4. Epub 2015 May 21.
• [479] The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels.Int J Nanomedicine. 2013;8:351-63. doi: 10.2147/IJN.S37465. Epub 2013 Jan 20.
• [480] Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.Sci Rep. 2017 Nov 14;7(1):15511. doi: 10.1038/s41598-017-15840-5.
• [481] Unmethylation of the CHRNB4 gene is an unfavorable prognostic factor in non-small cell lung cancer.Lung Cancer. 2014 Oct;86(1):85-90. doi: 10.1016/j.lungcan.2014.08.002. Epub 2014 Aug 12.
• [482] Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.Int J Cancer. 2014 Nov 1;135(9):2206-14. doi: 10.1002/ijc.28857. Epub 2014 Apr 8.
• [483] Identification and validation of PROM1 and CRTC2 mutations in lung cancer patients.Mol Cancer. 2014 Jan 31;13:19. doi: 10.1186/1476-4598-13-19.
• [484] High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.Ann Surg Oncol. 2015 Jul;22(7):2431-8. doi: 10.1245/s10434-014-4155-y. Epub 2014 Oct 28.
• [485] Expression and clinical significance of CXCR5/CXCL13 in human nonsmall cell lung carcinoma.Int J Oncol. 2014 Dec;45(6):2232-40. doi: 10.3892/ijo.2014.2688. Epub 2014 Sep 30.
• [486] The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis.J Histochem Cytochem. 2010 Mar;58(3):277-85. doi: 10.1369/jhc.2009.954339. Epub 2009 Nov 9.
• [487] Increased diacylglycerol kinase expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion.BMC Cancer. 2014 Mar 19;14:208. doi: 10.1186/1471-2407-14-208.
• [488] Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.Int J Biol Macromol. 2015 Nov;81:809-17. doi: 10.1016/j.ijbiomac.2015.08.067. Epub 2015 Sep 2.
• [489] Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.Oncogene. 2013 Aug 22;32(34):4034-42. doi: 10.1038/onc.2012.402. Epub 2012 Sep 10.
• [490] Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.Oncotarget. 2014 May 15;5(9):2575-87. doi: 10.18632/oncotarget.1842.
• [491] COP1 is downregulated in renal cell carcinoma (RCC) and inhibits the migration of RCC ACHN cells invitro.Mol Med Rep. 2016 Aug;14(2):1371-8. doi: 10.3892/mmr.2016.5373. Epub 2016 Jun 7.
• [492] Immunohistochemical evidence for an impairment of autophagy in tumorigenesis of gastric carcinoids and adenocarcinomas in rodent models and patients.Histol Histopathol. 2013 Apr;28(4):531-42. doi: 10.14670/HH-28.531. Epub 2013 Feb 7.
• [493] Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology?.Int J Biol Markers. 2017 Oct 31;32(4):e474-e477. doi: 10.5301/ijbm.5000273.
• [494] HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer.J Cancer. 2017 Apr 9;8(6):1071-1081. doi: 10.7150/jca.17295. eCollection 2017.
• [495] NNK reduction pathway gene polymorphisms and risk of lung cancer.Mol Carcinog. 2015 Jun;54 Suppl 1(Suppl 1):E94-E102. doi: 10.1002/mc.22187. Epub 2014 Jun 29.
• [496] Comparative analysis of Hsp10 and Hsp90 expression in healthy mucosa and adenocarcinoma of the large bowel.Anticancer Res. 2014 Aug;34(8):4153-9.
• [497] Interleukin 15 receptor alpha rs2228059 A > C polymorphism decreased risk of gastric cardiac adenocarcinoma in a Chinese population.Tumour Biol. 2014 Jul;35(7):6593-600. doi: 10.1007/s13277-014-1872-6. Epub 2014 Apr 3.
• [498] ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.Tumour Biol. 2013 Feb;34(1):359-68. doi: 10.1007/s13277-012-0557-2. Epub 2012 Oct 13.
• [499] hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance.Oncotarget. 2016 Sep 13;7(37):59535-59547. doi: 10.18632/oncotarget.11149.
• [500] Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.Clin Cancer Res. 2001 Aug;7(8):2363-71.
• [501] Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin.J Natl Cancer Inst. 2003 Jul 16;95(14):1053-61. doi: 10.1093/jnci/95.14.1053.
• [502] Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway.Bioessays. 2014 Dec;36(12):1162-9. doi: 10.1002/bies.201400120. Epub 2014 Sep 2.
• [503] Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity.Int J Oncol. 2015 Mar;46(3):1079-88. doi: 10.3892/ijo.2014.2799. Epub 2014 Dec 17.
• [504] Polyamine and methionine adenosyltransferase 2A crosstalk in human colon and liver cancer.Exp Cell Res. 2013 Jul 15;319(12):1902-1911. doi: 10.1016/j.yexcr.2013.04.005. Epub 2013 Apr 12.
• [505] Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers.Adv Clin Exp Med. 2016 Jan-Feb;25(1):117-28. doi: 10.17219/acem/60715.
• [506] Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma.Int J Oncol. 2014 Apr;44(4):1118-30. doi: 10.3892/ijo.2014.2278. Epub 2014 Jan 24.
• [507] Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cells.PLoS One. 2014 Aug 29;9(8):e106219. doi: 10.1371/journal.pone.0106219. eCollection 2014.
• [508] Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.Cancer Immunol Res. 2015 Oct;3(10):1123-1129. doi: 10.1158/2326-6066.CIR-15-0046. Epub 2015 Jun 16.
• [509] Metastasis of human gastric adenocarcinoma partly depends on phosphoinositide-specific phospholipase 1 expression.Folia Histochem Cytobiol. 2014;52(3):178-86. doi: 10.5603/FHC.2014.0021.
• [510] Fibroblast growth factor, estrogen, and prolactin receptor features in different grades of prostatic adenocarcinoma in elderly men.Microsc Res Tech. 2013 Mar;76(3):321-30. doi: 10.1002/jemt.22170. Epub 2013 Jan 30.
• [511] Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.Hum Pathol. 2014 Jul;45(7):1397-405. doi: 10.1016/j.humpath.2014.02.013. Epub 2014 Feb 28.
• [512] PTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling.PLoS One. 2014 May 1;9(5):e96060. doi: 10.1371/journal.pone.0096060. eCollection 2014.
• [513] Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma.Ann Surg Oncol. 2013 Mar;20(3):1044-52. doi: 10.1245/s10434-012-2377-4. Epub 2012 May 17.
• [514] Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation.Appl Immunohistochem Mol Morphol. 2015 Oct;23(9):633-45. doi: 10.1097/PAI.0000000000000122.
• [515] RNF43 is frequently mutated in colorectal and endometrial cancers.Nat Genet. 2014 Dec;46(12):1264-6. doi: 10.1038/ng.3127. Epub 2014 Oct 26.
• [516] Salt-inducible kinase 1 (SIK1) is induced by gastrin and inhibits migration of gastric adenocarcinoma cells.PLoS One. 2014 Nov 10;9(11):e112485. doi: 10.1371/journal.pone.0112485. eCollection 2014.
• [517] Organic anion transporting polypeptides expressed in pancreatic cancer may serve as potential diagnostic markers and therapeutic targets for early stage adenocarcinomas.Pharm Res. 2013 Sep;30(9):2260-9. doi: 10.1007/s11095-012-0962-7. Epub 2013 Jan 11.
• [518] Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression.Tumour Biol. 2015 Dec;36(12):9567-77. doi: 10.1007/s13277-015-3628-3. Epub 2015 Jul 4.
• [519] Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells.Int J Clin Exp Pathol. 2014 Mar 15;7(4):1314-24. eCollection 2014.
• [520] Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.Respir Res. 2015 Jun 26;16(1):76. doi: 10.1186/s12931-015-0230-6.
• [521] Ku80 is differentially expressed in human lung carcinomas and upregulated in response to irradiation in mice.DNA Cell Biol. 2011 Dec;30(12):987-94. doi: 10.1089/dna.2010.1196. Epub 2011 Jun 11.
• [522] Down-regulation of the down-regulated in adenoma (DRA) gene correlates with colon tumor progression.Clin Cancer Res. 1998 Aug;4(8):1857-63.
• [523] Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors.Int J Cancer. 2004 Dec 20;112(6):959-66. doi: 10.1002/ijc.20524.
• [524] Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.Cancer Biol Ther. 2011 Aug 15;12(4):297-303. doi: 10.4161/cbt.12.4.16356. Epub 2011 Aug 15.
• [525] Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.Cancer Res. 2008 Sep 1;68(17):7219-27. doi: 10.1158/0008-5472.CAN-08-0419.
• [526] L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.J Nucl Med. 2007 Dec;48(12):2063-71. doi: 10.2967/jnumed.107.043620.
• [527] Expression of anion exchanger 1 sequestrates p16 in the cytoplasm in gastric and colonic adenocarcinoma.Neoplasia. 2007 Oct;9(10):812-9. doi: 10.1593/neo.07403.
• [528] Expression of maspin and glutathionine-S-transferase-pi in normal human prostate and prostatic carcinomas.Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):429-32. doi: 10.1097/PAI.0b013e3181dbc77e.
• [529] Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines.Int J Oncol. 2007 Feb;30(2):393-401.
• [530] Expression of ATP1AL1, a non-gastric proton pump, in human colorectum.Jpn J Physiol. 2002 Jun;52(3):317-21. doi: 10.2170/jjphysiol.52.317.
• [531] Expression of enzymes related to glucose metabolism in non-small cell lung cancer and prognosis.Exp Lung Res. 2017 May-Jun;43(4-5):167-174. doi: 10.1080/01902148.2017.1328714. Epub 2017 Jun 23.
• [532] Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):387-393. doi: 10.21873/cgp.20097.
• [533] Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients.Thorac Cancer. 2017 Nov;8(6):600-605. doi: 10.1111/1759-7714.12489. Epub 2017 Sep 20.
• [534] Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection.Gene. 2019 Jun 30;703:58-64. doi: 10.1016/j.gene.2019.04.013. Epub 2019 Apr 4.
• [535] Diagnostic Utility of Prostein, Uroplakin II and SATB2 for Diagnosing Carcinoma of Unknown Primary Origin: A Systematic Immunohistochemical Profiling.Anticancer Res. 2018 Aug;38(8):4759-4766. doi: 10.21873/anticanres.12784.
• [536] Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma.J Proteome Res. 2008 May;7(5):1953-62. doi: 10.1021/pr7007835. Epub 2008 Apr 9.
• [537] ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.J Cancer Res Clin Oncol. 2019 Jun;145(6):1427-1436. doi: 10.1007/s00432-019-02906-2. Epub 2019 Mar 28.
• [538] Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population.Cancer Epidemiol. 2015 Dec;39(6):947-55. doi: 10.1016/j.canep.2015.10.014. Epub 2015 Nov 9.
• [539] [The research the relationship between N-acetyltransferase 1 gene polymorphisms and genetic susceptibility to sporadic colorectal adenocarcinoma].Zhonghua Nei Ke Za Zhi. 2002 Nov;41(11):746-9.
• [540] Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.BMC Cancer. 2008 Aug 16;8:241. doi: 10.1186/1471-2407-8-241.
• [541] Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas.Cancer Causes Control. 2007 Nov;18(9):1039-46. doi: 10.1007/s10552-007-9046-0. Epub 2007 Jul 31.
• [542] Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas.Neoplasia. 2005 Apr;7(4):407-16. doi: 10.1593/neo.04715.
• [543] Overexpression of glyoxalase system enzymes in human kidney tumor.Cancer J. 2006 May-Jun;12(3):222-8. doi: 10.1097/00130404-200605000-00011.
• [544] Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas.Clin Cancer Res. 2005 Feb 1;11(3):993-9.
• [545] Prognostic and therapeutic potential of Adenylate kinase 2 in lung adenocarcinoma.Sci Rep. 2019 Nov 28;9(1):17757. doi: 10.1038/s41598-019-53594-4.
• [546] Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.Mod Pathol. 2012 May;25(5):758-66. doi: 10.1038/modpathol.2011.191. Epub 2012 Jan 6.
• [547] Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.Drug Des Devel Ther. 2015 Sep 3;9:5087-97. doi: 10.2147/DDDT.S87197. eCollection 2015.
• [548] Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers.Int J Biol Markers. 2016 Dec 23;31(4):e402-e412. doi: 10.5301/jbm.5000221.
• [549] Strategies and limitations associated with in vitro characterization of vitamin D receptor activators.Biochem Pharmacol. 2018 Sep;155:547-561. doi: 10.1016/j.bcp.2018.07.015. Epub 2018 Jul 18.
• [550] Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.Prostate. 2007 Sep 15;67(13):1439-46. doi: 10.1002/pros.20630.
• [551] Down-regulation of anandamide hydrolase in mouse uterus by sex hormones.Eur J Biochem. 2000 May;267(10):2991-7. doi: 10.1046/j.1432-1033.2000.01316.x.
• [552] The associations between two vital GSTs genetic polymorphisms and lung cancer risk in the Chinese population: evidence from 71 studies.PLoS One. 2014 Jul 18;9(7):e102372. doi: 10.1371/journal.pone.0102372. eCollection 2014.
• [553] Benzyl isothiocyanate induces protective autophagy in human lung cancer cells through an endoplasmic reticulum stress-mediated mechanism.Acta Pharmacol Sin. 2017 Apr;38(4):539-550. doi: 10.1038/aps.2016.146. Epub 2017 Jan 23.
• [554] Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.Int J Cancer. 2019 Aug 1;145(3):621-631. doi: 10.1002/ijc.32128. Epub 2019 Feb 1.
• [555] Biologic instability of pancreatic cancer xenografts in the nude mouse.Carcinogenesis. 2000 Jun;21(6):1121-7.
• [556] Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase.Oncogene. 2015 Jun;34(26):3429-40. doi: 10.1038/onc.2014.273. Epub 2014 Sep 1.
• [557] UGT2B17 and miR-224 contribute to hormone dependency trends in adenocarcinoma and squamous cell carcinoma of esophagus.Biosci Rep. 2019 Jul 5;39(7):BSR20190472. doi: 10.1042/BSR20190472. Print 2019 Jul 31.
• [558] Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma.Histopathology. 2018 Jul;73(1):124-136. doi: 10.1111/his.13504. Epub 2018 Apr 17.
• [559] Establishing prostate cancer patient derived xenografts: lessons learned from older studies.Prostate. 2015 May;75(6):628-36. doi: 10.1002/pros.22946. Epub 2015 Jan 5.
• [560] Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer-Its implication in mutagenesis of non-small cell lung carcinoma.Cancer Epidemiol. 2013 Oct;37(5):653-9. doi: 10.1016/j.canep.2013.04.010. Epub 2013 Jun 7.
• [561] E3B1/ABI-1 isoforms are down-regulated in cancers of human gastrointestinal tract.Dis Markers. 2012;32(4):273-9. doi: 10.3233/DMA-2011-0881.
• [562] Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2'-deoxycytidine.PLoS One. 2012;7(9):e43456. doi: 10.1371/journal.pone.0043456. Epub 2012 Sep 11.
• [563] ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.Neoplasia. 2006 Apr;8(4):319-29. doi: 10.1593/neo.05682.
• [564] Adiponectin and adiponectin receptor in relation to colorectal cancer progression.Int J Cancer. 2010 Dec 15;127(12):2758-67. doi: 10.1002/ijc.25301.
• [565] Paradoxical expression of AHCYL1 affecting ovarian carcinogenesis between chickens and women.Exp Biol Med (Maywood). 2012 Jul;237(7):758-67. doi: 10.1258/ebm.2012.011433. Epub 2012 Jul 23.
• [566] Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.J Biol Chem. 2009 May 8;284(19):12633-44. doi: 10.1074/jbc.M809794200. Epub 2009 Feb 25.
• [567] Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network.Br J Cancer. 2008 Jun 17;98(12):1985-92. doi: 10.1038/sj.bjc.6604398. Epub 2008 May 20.
• [568] Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer.Clin Cancer Res. 2008 Nov 1;14(21):6924-32. doi: 10.1158/1078-0432.CCR-07-5189.
• [569] Co-expression of Rho guanine nucleotide exchange factor 5 and Src associates with poor prognosis of patients with resected non-small cell lung cancer.Oncol Rep. 2013 Dec;30(6):2864-70. doi: 10.3892/or.2013.2797. Epub 2013 Oct 14.
• [570] Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors.Int J Biol Markers. 2007 Apr-Jun;22(2):114-23. doi: 10.1177/172460080702200205.
• [571] Significance of (18)F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non-small-cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.Clin Lung Cancer. 2019 Jan;20(1):e9-e23. doi: 10.1016/j.cllc.2018.08.018. Epub 2018 Aug 30.
• [572] Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors.Genes Chromosomes Cancer. 2012 Dec;51(12):1133-43. doi: 10.1002/gcc.21998. Epub 2012 Aug 25.
• [573] Inactivating mutations of proapoptotic Bad gene in human colon cancers.Carcinogenesis. 2004 Aug;25(8):1371-6. doi: 10.1093/carcin/bgh145. Epub 2004 Mar 19.
• [574] Spatio-temporal dynamic analysis of bid activation and apoptosis induced by alkaline condition in human lung adenocarcinoma cell.Cell Physiol Biochem. 2007;20(5):569-78. doi: 10.1159/000107540.
• [575] Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers.Carcinogenesis. 2009 Jul;30(7):1132-8. doi: 10.1093/carcin/bgp114. Epub 2009 May 12.
• [576] A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population.J Ovarian Res. 2015 Mar 27;8:1. doi: 10.1186/s13048-015-0124-8.
• [577] Basic transcription factor 3 (BTF3) regulates transcription of tumor-associated genes in pancreatic cancer cells.Cancer Biol Ther. 2007 Mar;6(3):367-76. doi: 10.4161/cbt.6.3.3704. Epub 2007 Mar 13.
• [578] Isolation and characterization of human lung cancer antigens by serological screening with autologous antibodies.Cancer Lett. 2011 Feb 1;301(1):57-62. doi: 10.1016/j.canlet.2010.10.024. Epub 2010 Nov 20.
• [579] CAND1 promotes PLK4-mediated centriole overduplication and is frequently disrupted in prostate cancer.Neoplasia. 2012 Sep;14(9):799-806. doi: 10.1593/neo.12580.
• [580] Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer.Oncol Rep. 2013 Oct;30(4):1639-44. doi: 10.3892/or.2013.2607. Epub 2013 Jul 9.
• [581] Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas.Int J Cancer. 2008 Nov 1;123(9):2130-7. doi: 10.1002/ijc.23758.
• [582] RET, ROS1 and ALK fusions in lung cancer.Nat Med. 2012 Feb 12;18(3):378-81. doi: 10.1038/nm.2658.
• [583] Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).Anticancer Res. 2009 Apr;29(4):1389-93.
• [584] Tp53 Mutation Inhibits Ubiquitination and Degradation of WISP1 via Down-Regulation of Siah1 in Pancreatic Carcinogenesis.Front Pharmacol. 2018 Aug 3;9:857. doi: 10.3389/fphar.2018.00857. eCollection 2018.
• [585] Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition.Cancer Lett. 2007 Aug 28;254(1):63-70. doi: 10.1016/j.canlet.2007.02.012. Epub 2007 Mar 26.
• [586] Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma.Int J Biol Markers. 2007 Apr-Jun;22(2):108-13. doi: 10.1177/172460080702200204.
• [587] Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.Clin Lung Cancer. 2011 Jan;12(1):43-50. doi: 10.3816/CLC.2011.n.006.
• [588] CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung.Lung Cancer. 2007 Jul;57(1):46-53. doi: 10.1016/j.lungcan.2007.01.032. Epub 2007 Mar 12.
• [589] Clinical significance of CD99 down-regulation in gastric adenocarcinoma.Clin Cancer Res. 2007 May 1;13(9):2584-91. doi: 10.1158/1078-0432.CCR-06-1785.
• [590] A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens.J Cancer Res Clin Oncol. 2012 Sep;138(9):1541-9. doi: 10.1007/s00432-012-1232-0. Epub 2012 Apr 27.
• [591] Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder.Cancer Biomark. 2012;11(2-3):107-14. doi: 10.3233/CBM-2012-0267.
• [592] Parafibromin expression in lung normal tissue and carcinoma: its comparison with clinicopathological parameters of carcinoma.Histol Histopathol. 2011 Aug;26(8):1039-47. doi: 10.14670/HH-26.1039.
• [593] Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes.Histopathology. 2005 Jun;46(6):649-58. doi: 10.1111/j.1365-2559.2005.02170.x.
• [594] The protein core of the NCA-related pancreatic adenocarcinoma-associated antigen (DD9-Ag) is NCA-50.Pancreas. 1993 Mar;8(2):166-70. doi: 10.1097/00006676-199303000-00005.
• [595] Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells.Br J Cancer. 2011 Aug 9;105(4):552-61. doi: 10.1038/bjc.2011.268. Epub 2011 Jul 19.
• [596] American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples - Gastrointestinal mucosal biopsies.Ann Diagn Pathol. 2020 Feb;44:151419. doi: 10.1016/j.anndiagpath.2019.151419. Epub 2019 Nov 15.
• [597] Gene-specific damage produced by topoisomerase inhibitors in human lung cancer cells and peripheral mononuclear cells as assayed by polymerase chain reaction-stop assay.Anticancer Res. 1998 Sep-Oct;18(5A):3389-93.
• [598] Ectopic expression of N-acetylglucosamine 6-O-sulfotransferase 2 in chemotherapy-resistant ovarian adenocarcinomas.Glycoconj J. 2006 Jul;23(5-6):453-60. doi: 10.1007/s10719-006-6979-6.
• [599] Key contribution of CPEB4-mediated translational control to cancer progression.Nat Med. 2011 Dec 4;18(1):83-90. doi: 10.1038/nm.2540.
• [600] Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.BMC Cancer. 2010 Mar 1;10:75. doi: 10.1186/1471-2407-10-75.
• [601] Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates -catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer.Mol Cancer. 2010 Nov 24;9:304. doi: 10.1186/1476-4598-9-304.
• [602] CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer.Pharmacogenomics. 2010 Aug;11(8):1105-13. doi: 10.2217/pgs.10.76.
• [603] Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.J Immunol. 2008 Aug 15;181(4):2330-7. doi: 10.4049/jimmunol.181.4.2330.
• [604] Human -defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.BMC Cancer. 2012 Oct 11;12:465. doi: 10.1186/1471-2407-12-465.
• [605] Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway.Hum Pathol. 2009 Jun;40(6):872-80. doi: 10.1016/j.humpath.2008.12.003. Epub 2009 Mar 9.
• [606] Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer.Cancer Res. 2008 Feb 15;68(4):1037-45. doi: 10.1158/0008-5472.CAN-07-5782.
• [607] Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression.Lung Cancer. 2008 Nov;62(2):181-92. doi: 10.1016/j.lungcan.2008.06.018. Epub 2008 Aug 9.
• [608] Microsatellite instability and alteration of E2F-4 gene in adenosquamous and squamous cell carcinomas of the stomach.Pathol Int. 2000 Sep;50(9):690-5. doi: 10.1046/j.1440-1827.2000.01105.x.
• [609] Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.Lung Cancer. 2012 Jun;76(3):431-8. doi: 10.1016/j.lungcan.2011.12.004. Epub 2012 Jan 10.
• [610] Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients.Clin Lung Cancer. 2011 Jul;12(4):237-44. doi: 10.1016/j.cllc.2011.03.025. Epub 2011 Apr 24.
• [611] Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses.Ann Oncol. 2012 Sep;23(9):2245-2252. doi: 10.1093/annonc/mdr624. Epub 2012 Jan 23.
• [612] Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.J Pathol. 2016 Jan;238(1):31-41. doi: 10.1002/path.4628. Epub 2015 Oct 14.
• [613] Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC).BMC Cancer. 2011 Apr 20;11:147. doi: 10.1186/1471-2407-11-147.
• [614] FOXL2 C402G mutation detection using MALDI-TOF-MS in DNA extracted from Israeli granulosa cell tumors.Gynecol Oncol. 2011 Sep;122(3):580-4. doi: 10.1016/j.ygyno.2011.05.008.
• [615] Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.Epigenetics. 2018;13(3):214-227. doi: 10.1080/15592294.2016.1229730. Epub 2018 Apr 18.
• [616] Overexpression of Dicer in precursor lesions of lung adenocarcinoma.Cancer Res. 2007 Mar 1;67(5):2345-50. doi: 10.1158/0008-5472.CAN-06-3533.
• [617] Epigenetic subgroups of esophageal and gastric adenocarcinoma with differential GATA5 DNA methylation associated with clinical and lifestyle factors.PLoS One. 2011;6(10):e25985. doi: 10.1371/journal.pone.0025985. Epub 2011 Oct 20.
• [618] Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis.Clin Cancer Res. 2008 Jul 1;14(13):4161-7. doi: 10.1158/1078-0432.CCR-07-4381.
• [619] Association of Antioxidative Enzymes Polymorphisms with Efficacy of Platin and Fluorouracil-Based Adjuvant Therapy in Gastric Cancer.Cell Physiol Biochem. 2018;48(6):2247-2257. doi: 10.1159/000492642. Epub 2018 Aug 16.
• [620] Role of GSTM3 polymorphism in the risk of developing esophageal cancer.Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):178-81. doi: 10.1158/1055-9965.EPI-06-0542.
• [621] Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.Apoptosis. 2008 Sep;13(9):1172-83. doi: 10.1007/s10495-008-0246-1.
• [622] Up-regulation of GTSE1 lacks a relationship with clinical data in lung cancer.Asian Pac J Cancer Prev. 2011;12(8):2039-43.
• [623] Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.Cancer Res. 2000 Sep 15;60(18):5151-7.
• [624] Engulfment protein GULP is regulator of transforming growth factor- response in ovarian cells.J Biol Chem. 2012 Jun 8;287(24):20636-51. doi: 10.1074/jbc.M111.314997. Epub 2012 Mar 26.
• [625] Expression analysis of angiogenesis-related genes in Bulgarian patients with early-stage non-small cell lung cancer.Tumori. 2011 Jan-Feb;97(1):86-94. doi: 10.1177/030089161109700116.
• [626] Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis.Eur Respir J. 2012 May;39(5):1171-80. doi: 10.1183/09031936.00184410. Epub 2011 Sep 29.
• [627] Sonic hedgehog-Gli1 pathway in colorectal adenocarcinomas.World J Gastroenterol. 2007 Mar 21;13(11):1659-65. doi: 10.3748/wjg.v13.i11.1659.
• [628] Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma.Mol Cancer. 2007 Oct 29;6:70. doi: 10.1186/1476-4598-6-70.
• [629] Genetics and lung carcinoma in Okinawa Prefecture, Japan.Anticancer Res. 1999 Nov-Dec;19(6C):5611-4.
• [630] Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas.Acta Cytol. 2008 Mar-Apr;52(2):133-8. doi: 10.1159/000325470.
• [631] Inhibin alpha-subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma.Eur J Endocrinol. 2005 Feb;152(2):277-84. doi: 10.1530/eje.1.01849.
• [632] Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor.Carcinogenesis. 2008 Aug;29(8):1608-13. doi: 10.1093/carcin/bgn152. Epub 2008 Jun 20.
• [633] Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma.Am J Surg Pathol. 2017 Aug;41(8):1045-1052. doi: 10.1097/PAS.0000000000000852.
• [634] Comparison of three methods for detecting epidermal growth factor receptor mutations in plasma DNA samples of Chinese patients with advanced non-small cell lung cancer.Chin Med J (Engl). 2011 Mar;124(6):887-91.
• [635] Klf10 induces cell apoptosis through modulation of BI-1 expression and Ca2+ homeostasis in estrogen-responding adenocarcinoma cells.Int J Biochem Cell Biol. 2011 Apr;43(4):666-73. doi: 10.1016/j.biocel.2011.01.010. Epub 2011 Jan 22.
• [636] KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.Int J Cancer. 2010 Nov 15;127(10):2386-94. doi: 10.1002/ijc.25435.
• [637] The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer.Oncology. 2011;80(5-6):333-40. doi: 10.1159/000329098. Epub 2011 Jul 26.
• [638] A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.PLoS One. 2011;6(7):e22509. doi: 10.1371/journal.pone.0022509. Epub 2011 Jul 25.
• [639] MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.Br J Cancer. 2008 Dec 2;99(11):1802-7. doi: 10.1038/sj.bjc.6604777. Epub 2008 Nov 11.
• [640] Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.BMC Cancer. 2010 Jun 22;10:315. doi: 10.1186/1471-2407-10-315.
• [641] Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression.Oncogene. 2009 Nov 12;28(45):3971-82. doi: 10.1038/onc.2009.254. Epub 2009 Aug 24.
• [642] Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.Am J Pathol. 2010 Jan;176(1):435-45. doi: 10.2353/ajpath.2010.090403. Epub 2009 Dec 11.
• [643] MACC1 is related to colorectal cancer initiation and early-stage invasive growth.Am J Clin Pathol. 2013 Nov;140(5):701-7. doi: 10.1309/AJCPRH1H5RWWSXRB.
• [644] Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.Lung Cancer. 2006 Jan;51(1):79-88. doi: 10.1016/j.lungcan.2005.08.012. Epub 2005 Oct 12.
• [645] MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.Gastroenterology. 2011 Mar;140(3):924-34. doi: 10.1053/j.gastro.2010.11.054. Epub 2010 Dec 4.
• [646] Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.Hum Pathol. 2009 Jun;40(6):854-60. doi: 10.1016/j.humpath.2008.11.007. Epub 2009 Mar 9.
• [647] Neuroglobin and myoglobin in non-small cell lung cancer: expression, regulation and prognosis.Lung Cancer. 2011 Dec;74(3):411-8. doi: 10.1016/j.lungcan.2011.05.001. Epub 2011 Jun 2.
• [648] Relationship of aquaporin 1, 3, and 5 expression in lung cancer cells to cellular differentiation, invasive growth, and metastasis potential.Hum Pathol. 2011 May;42(5):669-78. doi: 10.1016/j.humpath.2010.07.022. Epub 2011 Jan 15.
• [649] Characterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissues.J Cell Mol Med. 2011 Jan;15(1):86-93. doi: 10.1111/j.1582-4934.2009.00925.x.
• [650] Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas.PLoS One. 2011;6(7):e22009. doi: 10.1371/journal.pone.0022009. Epub 2011 Jul 19.
• [651] A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide.Sci Rep. 2019 Apr 5;9(1):5662. doi: 10.1038/s41598-019-42076-2.
• [652] Expression of IAP family proteins in colon cancers from patients with different age groups.Cancer Immunol Immunother. 2004 Sep;53(9):770-6. doi: 10.1007/s00262-004-0534-8. Epub 2004 May 11.
• [653] Subtypes of cervical adenosquamous carcinomas classified by EpCAM expression related to radiosensitivity.Cancer Biol Ther. 2010 Nov 15;10(10):1019-26. doi: 10.4161/cbt.10.10.13249. Epub 2010 Nov 15.
• [654] Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese.Int J Cancer. 1997 Jul 17;72(2):225-30. doi: 10.1002/(sici)1097-0215(19970717)72:2<225::aid-ijc4>3.0.co;2-t.
• [655] PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.Am J Pathol. 2013 Nov;183(5):1634-1644. doi: 10.1016/j.ajpath.2013.07.028. Epub 2013 Sep 17.
• [656] Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.J Nucl Med. 2019 Sep;60(Suppl 2):13S-19S. doi: 10.2967/jnumed.118.220566.
• [657] Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival.Gastric Cancer. 2009;12(1):43-51. doi: 10.1007/s10120-008-0497-0. Epub 2009 Apr 24.
• [658] Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation.Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):16927-31. doi: 10.1073/pnas.1112047108. Epub 2011 Sep 26.
• [659] Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients.Lung Cancer. 2012 Jan;75(1):110-8. doi: 10.1016/j.lungcan.2011.05.024.
• [660] Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer.Cancer Sci. 2011 Dec;102(12):2255-63. doi: 10.1111/j.1349-7006.2011.02102.x. Epub 2011 Oct 17.
• [661] Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation.J Cell Physiol. 2010 Jun;223(3):623-9. doi: 10.1002/jcp.22058.
• [662] Protein inhibitor of activated STAT3 expression in lung cancer.Mol Oncol. 2011 Jun;5(3):256-64. doi: 10.1016/j.molonc.2011.03.004. Epub 2011 Mar 30.
• [663] Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.BMC Cancer. 2006 Oct 9;6:241. doi: 10.1186/1471-2407-6-241.
• [664] Plexin B1 is downregulated in renal cell carcinomas and modulates cell growth.Transl Res. 2008 Mar;151(3):134-40. doi: 10.1016/j.trsl.2007.12.003. Epub 2008 Jan 7.
• [665] Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.Cancer Res. 2005 Jan 1;65(1):166-76.
• [666] Comparison of glutathione S-transferase-Pi expression at mRNA levels in oesophageal mucosa using RT-PCR-ELISA in individuals with reflux diseases, adenocarcinoma and squamous cell carcinoma.Clin Biochem. 2006 Oct;39(10):997-1001. doi: 10.1016/j.clinbiochem.2006.06.010. Epub 2006 Jul 21.
• [667] GST M1 and CYP1A1 gene polymorphism and daily fruit consumption in Turkish patients with non-small cell lung carcinomas.In Vivo. 2003 Nov-Dec;17(6):625-32.
• [668] Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L.Cancer Biol Ther. 2008 Feb;7(2):285-92. doi: 10.4161/cbt.7.2.5302. Epub 2007 Nov 14.
• [669] Potential roles for PA28beta in gastric adenocarcinoma development and diagnosis.J Cancer Res Clin Oncol. 2010 Aug;136(8):1275-82. doi: 10.1007/s00432-010-0778-y. Epub 2010 Feb 6.
• [670] Combination of L-3-phosphoserine phosphatase and CEA using real-time RT-PCR improves accuracy in detection of peritoneal micrometastasis of gastric cancer.Anticancer Res. 2004 Mar-Apr;24(2C):1113-20.
• [671] Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.J Clin Pathol. 2011 Jan;64(1):16-24. doi: 10.1136/jcp.2010.075853. Epub 2010 Nov 2.
• [672] Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas.J Clin Invest. 2010 Mar;120(3):840-9. doi: 10.1172/JCI40728. Epub 2010 Feb 8.
• [673] Mutation analysis of Rad18 in human cancer cell lines and non small cell lung cancer tissues.J Exp Clin Cancer Res. 2009 Jul 25;28(1):106. doi: 10.1186/1756-9966-28-106.
• [674] Correlation of aberrant expression of p53, Rad50, and cyclin-E proteins with microsatellite instability in gallbladder adenocarcinomas.Genet Mol Res. 2009 Oct 6;8(4):1202-10. doi: 10.4238/vol8-4gmr653.
• [675] Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.Gastroenterology. 2009 Jan;136(1):206-16. doi: 10.1053/j.gastro.2008.09.063. Epub 2008 Oct 2.
• [676] Study of FoxA pioneer factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal adenocarcinoma development.PLoS Genet. 2011 Sep;7(9):e1002277. doi: 10.1371/journal.pgen.1002277. Epub 2011 Sep 15.
• [677] Histoculture drug response assay for gefitinib in non-small-cell lung cancer.Gen Thorac Cardiovasc Surg. 2009 Mar;57(3):138-43. doi: 10.1007/s11748-008-0332-x. Epub 2009 Mar 12.
• [678] High RIN1 expression is associated with poor prognosis in patients with gastric adenocarcinoma.Tumour Biol. 2012 Oct;33(5):1557-63. doi: 10.1007/s13277-012-0409-0. Epub 2012 May 6.
• [679] Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.Prostate Cancer Prostatic Dis. 2006;9(1):77-82. doi: 10.1038/sj.pcan.4500848.
• [680] Frequent aberrant methylation of the promoter region of sterile alpha motif domain 14 in pulmonary adenocarcinoma.Cancer Sci. 2008 Nov;99(11):2177-84. doi: 10.1111/j.1349-7006.2008.00965.x. Epub 2008 Sep 22.
• [681] Secretin receptor promotes the proliferation of endocrine tumor cells via the PI3K/AKT pathway.Mol Endocrinol. 2012 Aug;26(8):1394-405. doi: 10.1210/me.2012-1055. Epub 2012 Jun 12.
• [682] Analysis of succinate dehydrogenase subunit B gene alterations in gastric cancers.Pathol Int. 2010 Aug;60(8):559-65. doi: 10.1111/j.1440-1827.2010.02558.x.
• [683] SEL1L expression in non-small cell lung cancer.Hum Pathol. 2006 May;37(5):505-12. doi: 10.1016/j.humpath.2005.12.012. Epub 2006 Mar 20.
• [684] Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions.Oncogene. 2003 Nov 27;22(54):8677-87. doi: 10.1038/sj.onc.1207127.
• [685] Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus.Oncogene. 2006 May 18;25(21):3084-92. doi: 10.1038/sj.onc.1209338.
• [686] Methylation analysis of SFRP genes family in cervical adenocarcinoma.J Cancer Res Clin Oncol. 2009 Dec;135(12):1665-74. doi: 10.1007/s00432-009-0613-5. Epub 2009 Jun 10.
• [687] Tumor progression and cellular differentiation of pulmonary adenocarcinomas in SV40 large T antigen transgenic mice.Am J Respir Cell Mol Biol. 1997 Jun;16(6):713-23. doi: 10.1165/ajrcmb.16.6.9191473.
• [688] Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?.Cancer Genet Cytogenet. 2007 Sep;177(2):153-7. doi: 10.1016/j.cancergencyto.2007.06.017.
• [689] Relatively high expression ratio of sex hormone-binding globulin exon VII splicing variant to wild-type mRNA in human uterine cervical cancers.Jpn J Cancer Res. 1998 Jan;89(1):47-52. doi: 10.1111/j.1349-7006.1998.tb00478.x.
• [690] Homo sapiens systemic RNA interference-defective-1 transmembrane family member 1 (SIDT1) protein mediates contact-dependent small RNA transfer and microRNA-21-driven chemoresistance.J Biol Chem. 2012 Feb 17;287(8):5267-77. doi: 10.1074/jbc.M111.318865. Epub 2011 Dec 15.
• [691] Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays.Oncogene. 2008 Mar 20;27(13):1951-60. doi: 10.1038/sj.onc.1210832. Epub 2007 Oct 22.
• [692] Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma.Clin Nucl Med. 2020 Jan;45(1):38-43. doi: 10.1097/RLU.0000000000002840.
• [693] Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.Mol Cancer Res. 2008 Sep;6(9):1421-30. doi: 10.1158/1541-7786.MCR-07-2175.
• [694] p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation.Oncogene. 2012 Feb 2;31(5):624-33. doi: 10.1038/onc.2011.257. Epub 2011 Jul 4.
• [695] Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas.Hum Pathol. 2007 Sep;38(9):1351-60. doi: 10.1016/j.humpath.2007.01.022. Epub 2007 May 22.
• [696] Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.Cancer Res. 2009 Mar 15;69(6):2234-43. doi: 10.1158/0008-5472.CAN-08-3338. Epub 2009 Mar 3.
• [697] TAF4b and Jun/activating protein-1 collaborate to regulate the expression of integrin alpha6 and cancer cell migration properties.Mol Cancer Res. 2010 Apr;8(4):554-68. doi: 10.1158/1541-7786.MCR-09-0159. Epub 2010 Mar 30.
• [698] Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer.Clin Cancer Res. 2012 Jul 15;18(14):3868-79. doi: 10.1158/1078-0432.CCR-11-3211. Epub 2012 May 18.
• [699] Key genes in lung cancer translational research: a meta-analysis.Pathobiology. 2010;77(2):53-63. doi: 10.1159/000278292. Epub 2010 Mar 22.
• [700] Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma.Thyroid. 2005 Mar;15(3):267-73. doi: 10.1089/thy.2005.15.267.
• [701] THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling.Mod Pathol. 2011 Oct;24(10):1390-403. doi: 10.1038/modpathol.2011.99. Epub 2011 Jun 24.
• [702] In vivo and in vitro degradation of heparan sulfate (HS) proteoglycans by HPR1 in pancreatic adenocarcinomas. Loss of cell surface HS suppresses fibroblast growth factor 2-mediated cell signaling and proliferation.J Biol Chem. 2007 Jan 26;282(4):2363-73. doi: 10.1074/jbc.M604218200. Epub 2006 Nov 22.
• [703] Hypermethylation of hMLH1, HPP1, p14(ARF), p16(INK4A) and APC in primary adenocarcinomas of the small bowel.Int J Cancer. 2006 Sep 15;119(6):1298-302. doi: 10.1002/ijc.21990.
• [704] Hypomethylation of the thymosin (10) gene is not associated with its overexpression in non-small cell lung cancer.Mol Cells. 2011 Oct;32(4):343-8. doi: 10.1007/s10059-011-0073-z. Epub 2011 Oct 17.
• [705] Overexpression of decoy receptor 3 in precancerous lesions and adenocarcinoma of the esophagus.Am J Clin Pathol. 2005 Aug;124(2):282-7. doi: 10.1309/XK59-4E4B-5WU8-2QR6.
• [706] Protein expression in human non-small cell lung cancer: a systematic database.Pathobiology. 2009;76(6):277-85. doi: 10.1159/000245893. Epub 2009 Nov 30.
• [707] miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.PLoS One. 2012;7(10):e46090. doi: 10.1371/journal.pone.0046090. Epub 2012 Oct 5.
• [708] Significance of TRIM29 and -catenin expression in non-small-cell lung cancer.J Chin Med Assoc. 2012 Jun;75(6):269-74. doi: 10.1016/j.jcma.2012.04.015. Epub 2012 May 31.
• [709] Objective response to mTOR inhibition in a metastatic collision tumor of the liver composed of melanoma and adenocarcinoma with TSC1 loss: a case report.BMC Cancer. 2017 Mar 16;17(1):197. doi: 10.1186/s12885-017-3167-y.
• [710] CFL1 and Arp3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinomas of gallbladder.Cancer Invest. 2013 Feb;31(2):132-9. doi: 10.3109/07357907.2012.756113. Epub 2013 Jan 15.
• [711] Bcl-2 associated anthanogen-1 (Bag-1) expression and prognostic value in pancreatic head and periampullary cancer.Eur J Cancer. 2013 Jan;49(2):323-8. doi: 10.1016/j.ejca.2012.07.030. Epub 2012 Aug 29.
• [712] Poorer outcome in stromal HIF-2 alpha- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis.Br J Cancer. 2008 Sep 2;99(5):727-33. doi: 10.1038/sj.bjc.6604547. Epub 2008 Aug 19.
• [713] Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung.Cancer Sci. 2009 Mar;100(3):429-33. doi: 10.1111/j.1349-7006.2008.01066.x. Epub 2008 Dec 11.
• [714] Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis.PLoS One. 2013;8(1):e53310. doi: 10.1371/journal.pone.0053310. Epub 2013 Jan 2.
• [715] Somatic mutations to CSMD1 in colorectal adenocarcinomas.Cancer Biol Ther. 2008 Apr;7(4):609-13. doi: 10.4161/cbt.7.4.5623.
• [716] Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen.Mod Pathol. 2008 Aug;21(8):925-36. doi: 10.1038/modpathol.2008.49. Epub 2008 May 23.
• [717] DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.Carcinogenesis. 2013 May;34(5):1031-8. doi: 10.1093/carcin/bgt022. Epub 2013 Jan 24.
• [718] Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma.Nat Commun. 2019 Nov 28;10(1):5438. doi: 10.1038/s41467-019-13295-y.
• [719] The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas.BMC Cancer. 2009 Mar 6;9:79. doi: 10.1186/1471-2407-9-79.
• [720] HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis.BMC Cancer. 2013 Oct 2;13:451. doi: 10.1186/1471-2407-13-451.
• [721] Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells.PLoS One. 2013 Sep 9;8(9):e73593. doi: 10.1371/journal.pone.0073593. eCollection 2013.
• [722] mRNA expression of minichromosome maintenance 2 in colonic adenoma and adenocarcinoma.Eur J Cancer Prev. 2009 Feb;18(1):40-5. doi: 10.1097/CEJ.0b013e32830c8d5a.
• [723] Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients.Exp Mol Pathol. 2013 Feb;94(1):301-8. doi: 10.1016/j.yexmp.2012.10.006. Epub 2012 Oct 9.
• [724] Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.Genes Chromosomes Cancer. 2013 May;52(5):450-66. doi: 10.1002/gcc.22043. Epub 2013 Jan 23.
• [725] Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase.Mol Cell Biol. 2008 Aug;28(15):4665-74. doi: 10.1128/MCB.00650-07. Epub 2008 Jun 9.
• [726] Down-regulation and aberrant cytoplasmic expression of GLTSCR2 in prostatic adenocarcinomas.Cancer Lett. 2013 Oct 28;340(1):134-40. doi: 10.1016/j.canlet.2013.07.035. Epub 2013 Aug 3.
• [727] RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer.PLoS One. 2013 Aug 9;8(8):e72820. doi: 10.1371/journal.pone.0072820. eCollection 2013.
• [728] Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens.Am J Clin Pathol. 2008 Jan;129(1):81-8. doi: 10.1309/5D76NDE81LE8G545.
• [729] Down-regulation of Bax-interacting factor-1 in colorectal adenocarcinoma.Cancer. 2008 Nov 15;113(10):2665-70. doi: 10.1002/cncr.23892.
• [730] Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.PLoS One. 2013 Aug 16;8(8):e71816. doi: 10.1371/journal.pone.0071816. eCollection 2013.
• [731] Cancerous, but not stromal, thrombospondin-2 contributes prognosis in pulmonary adenocarcinoma.Oncol Rep. 2009 Aug;22(2):279-83.
• [732] The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence.Int J Cancer. 2013 Jul;133(1):31-42. doi: 10.1002/ijc.27996. Epub 2013 Jan 10.
• [733] Analysis of CD137 and CD137L expression in human primary tumor tissues.Croat Med J. 2008 Apr;49(2):192-200. doi: 10.3325/cmj.2008.2.192.
• [734] TSPAN1 protein expression: a significant prognostic indicator for patients with colorectal adenocarcinoma.World J Gastroenterol. 2009 May 14;15(18):2270-6. doi: 10.3748/wjg.15.2270.
• [735] Cloning and characterization of a novel human homolog* of mouse U26, a putative PQQ-dependent AAS dehydrogenase.Mol Biol Rep. 2005 Mar;32(1):47-53. doi: 10.1007/s11033-003-2716-4.
• [736] Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6880-8. doi: 10.1158/1078-0432.CCR-05-0751.
• [737] The ACIN1 gene is hypermethylated in early stage lung adenocarcinoma.J Thorac Oncol. 2006 Feb;1(2):160-7.
• [738] Parametrial and rectovaginal adenocarcinoma arising from endometriosis.Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1206-9. doi: 10.1111/j.1525-1438.2005.00184.x.
• [739] Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.Gastroenterology. 2006 Nov;131(5):1418-30. doi: 10.1053/j.gastro.2006.08.034. Epub 2006 Aug 18.
• [740] Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.Acta Chir Belg. 2005 Aug;105(4):378-82. doi: 10.1080/00015458.2005.11679740.
• [741] Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.Lab Invest. 2019 Nov;99(11):1622-1635. doi: 10.1038/s41374-019-0277-y. Epub 2019 Jun 23.
• [742] Biomarker expression and druggable gene alterations for development of an appropriate therapeutic protocol for pulmonary adenosquamous carcinoma.Histopathology. 2015 Jun;66(7):939-48. doi: 10.1111/his.12556. Epub 2015 Feb 5.
• [743] High frequency of promoter methylation of the 14-3-3 sigma and CAGE-1 genes, but lack of hypermethylation of the caveolin-1 gene, in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.Int J Mol Med. 2007 Oct;20(4):557-63.
• [744] Immunohistochemical and mutational analysis of FLASH in gastric carcinomas.APMIS. 2007 Aug;115(8):900-5. doi: 10.1111/j.1600-0463.2007.apm_706.x.
• [745] CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.Am J Surg Pathol. 2005 Mar;29(3):390-9. doi: 10.1097/00000478-200503000-00014.
• [746] Poor outcome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression.Int J Oncol. 2006 Jun;28(6):1369-74.
• [747] Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells.J Biol Chem. 2017 Feb 10;292(6):2411-2421. doi: 10.1074/jbc.M116.762807. Epub 2017 Jan 5.
• [748] Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non small cell lung cancer cell line.Cancer Res. 2007 Aug 15;67(16):7807-14. doi: 10.1158/0008-5472.CAN-07-0681.
• [749] Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.Oncol Rep. 2007 Aug;18(2):489-95.
• [750] Desmocollin switching in colorectal cancer.Br J Cancer. 2006 Nov 20;95(10):1367-70. doi: 10.1038/sj.bjc.6603453. Epub 2006 Oct 31.
• [751] Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.Oncogene. 2006 Apr 27;25(18):2628-35. doi: 10.1038/sj.onc.1209289.
• [752] Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary).BMC Cancer. 2007 Dec 18;7:225. doi: 10.1186/1471-2407-7-225.
• [753] Detection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma.Am J Gastroenterol. 2007 Jul;102(7):1489-98. doi: 10.1111/j.1572-0241.2007.01240.x. Epub 2007 Apr 24.
• [754] High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas.Cytogenet Genome Res. 2007;118(2-4):130-7. doi: 10.1159/000108293.
• [755] Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):830-4. doi: 10.1158/1055-9965.EPI-04-0506.
• [756] Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12507-12. doi: 10.1073/pnas.0500397102. Epub 2005 Aug 18.
• [757] Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.Gastroenterology. 2006 Jun;130(7):2145-54. doi: 10.1053/j.gastro.2006.03.016.
• [758] Alternative splicing of the FGF antisense gene: differential subcellular localization in human tissues and esophageal adenocarcinoma.J Mol Med (Berl). 2007 Nov;85(11):1215-28. doi: 10.1007/s00109-007-0219-9. Epub 2007 Jun 14.
• [759] Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours.Br J Cancer. 2006 Mar 13;94(5):686-91. doi: 10.1038/sj.bjc.6602988.
• [760] Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation.Dev Biol. 2006 Feb 1;290(1):66-80. doi: 10.1016/j.ydbio.2005.11.009. Epub 2005 Dec 15.
• [761] Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer.Neoplasia. 2018 Aug;20(8):838-847. doi: 10.1016/j.neo.2018.06.007. Epub 2018 Jul 13.
• [762] Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma.Br J Cancer. 2008 Nov 4;99(9):1484-92. doi: 10.1038/sj.bjc.6604717. Epub 2008 Oct 14.
• [763] Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.Prostate. 2007 Sep 15;67(13):1465-74. doi: 10.1002/pros.20596.
• [764] In situ adenocarcinoma and squamous carcinoma of uterine cervix. Pathological and immunohistochemical analysis with cytokeratin 13.Eur J Obstet Gynecol Reprod Biol. 2007 Oct;134(2):249-53. doi: 10.1016/j.ejogrb.2006.07.047. Epub 2006 Sep 1.
• [765] DC-LAMP stains pulmonary adenocarcinoma with bronchiolar Clara cell differentiation.Hum Pathol. 2007 Feb;38(2):260-8. doi: 10.1016/j.humpath.2006.07.018. Epub 2006 Oct 23.
• [766] Mutation and expression analysis of LZTS1 in ovarian cancer.Cancer Lett. 2006 Feb 20;233(1):151-7. doi: 10.1016/j.canlet.2005.03.008.
• [767] Transforming Growth Factor TGF Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal Adenocarcinomas.PLoS One. 2015 Nov 16;10(11):e0143150. doi: 10.1371/journal.pone.0143150. eCollection 2015.
• [768] Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2474-80. doi: 10.1158/1055-9965.EPI-05-0423.
• [769] Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancer.Jpn J Clin Oncol. 2006 Aug;36(8):483-8. doi: 10.1093/jjco/hyl055. Epub 2006 Jun 27.
• [770] Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.Endocr Relat Cancer. 2006 Mar;13(1):113-34. doi: 10.1677/erc.1.01118.
• [771] Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms.Cancer Biol Ther. 2005 May;4(5):596-601. doi: 10.4161/cbt.4.5.1748. Epub 2005 May 13.
• [772] Net1 and Myeov: computationally identified mediators of gastric cancer.Br J Cancer. 2006 Apr 24;94(8):1204-12. doi: 10.1038/sj.bjc.6603054.
• [773] Cofactor of BRCA1: a novel transcription factor regulator in upper gastrointestinal adenocarcinomas.Cancer Res. 2006 Feb 1;66(3):1346-53. doi: 10.1158/0008-5472.CAN-05-3593.
• [774] Neuronatin expression and its clinicopathological significance in pulmonary non-small cell carcinoma.J Thorac Oncol. 2007 Sep;2(9):796-801. doi: 10.1097/JTO.0b013e318145af5e.
• [775] Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-based oxidase system in the human stomach.Free Radic Biol Med. 2007 Dec 15;43(12):1627-38. doi: 10.1016/j.freeradbiomed.2007.08.029. Epub 2007 Sep 14.
• [776] Reverse transcription-polymerase chain reaction and western blotting analysis for detection of p63 isoforms in uterine cervical cancers.Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1643-7. doi: 10.1111/j.1525-1438.2006.00638.x.
• [777] Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer.Int J Cancer. 2007 May 1;120(9):1909-13. doi: 10.1002/ijc.22541.
• [778] Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A.Prostate. 2007 Dec 1;67(16):1761-9. doi: 10.1002/pros.20654.
• [779] Group VIB Ca2+-independent phospholipase A2gamma promotes cellular membrane hydrolysis and prostaglandin production in a manner distinct from other intracellular phospholipases A2.J Biol Chem. 2005 Apr 8;280(14):14028-41. doi: 10.1074/jbc.M413766200. Epub 2005 Feb 4.
• [780] Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk.Int J Cancer. 2005 May 1;114(5):730-7. doi: 10.1002/ijc.20790.
• [781] Clinicopathological significance of BGP expression in non-small-cell lung carcinoma: relationship with histological type, microvessel density and patients' survival.Pathology. 2006 Dec;38(6):555-60. doi: 10.1080/00313020601024029.
• [782] Characterization of human Rab20 overexpressed in exocrine pancreatic carcinoma.Hum Pathol. 2006 Mar;37(3):256-63. doi: 10.1016/j.humpath.2005.10.017.
• [783] RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas.Int J Cancer. 2006 Aug 15;119(4):801-6. doi: 10.1002/ijc.21912.
• [784] Systemic analysis of the differential gene expression profile in a colonic adenoma-normal SSH library.Clin Chim Acta. 2007 Mar;378(1-2):42-7. doi: 10.1016/j.cca.2006.10.024. Epub 2006 Nov 14.
• [785] Stratifin Inhibits SCF(FBW7) Formation and Blocks Ubiquitination of Oncoproteins during the Course of Lung Adenocarcinogenesis.Clin Cancer Res. 2019 May 1;25(9):2809-2820. doi: 10.1158/1078-0432.CCR-18-3631. Epub 2019 Feb 6.
• [786] Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer.Clin Cancer Res. 2007 Oct 15;13(20):6087-92. doi: 10.1158/1078-0432.CCR-07-0591.
• [787] Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China.Cancer Causes Control. 2007 Mar;18(2):143-52. doi: 10.1007/s10552-006-0097-4. Epub 2007 Jan 6.
• [788] Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.Cancer Cell. 2005 Jan;7(1):39-49. doi: 10.1016/j.ccr.2004.11.024.
• [789] High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.Virchows Arch. 2007 Mar;450(3):303-10. doi: 10.1007/s00428-006-0361-8. Epub 2007 Jan 18.
• [790] Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.Cancer Res. 2005 Apr 15;65(8):3146-54. doi: 10.1158/0008-5472.CAN-04-2490.
• [791] Expression of ST13 in colorectal cancer and adjacent normal tissues.World J Gastroenterol. 2005 Jan 21;11(3):336-9. doi: 10.3748/wjg.v11.i3.336.
• [792] STRAD in Peutz-Jeghers syndrome and sporadic cancers.J Clin Pathol. 2005 Oct;58(10):1091-5. doi: 10.1136/jcp.2005.026013.
• [793] Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.Am J Pathol. 2007 Oct;171(4):1324-33. doi: 10.2353/ajpath.2007.070111. Epub 2007 Aug 23.
• [794] Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer.J Pathol. 2006 Nov;210(3):351-7. doi: 10.1002/path.2056.
• [795] OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis.Cancer Sci. 2007 Jan;98(1):50-7. doi: 10.1111/j.1349-7006.2006.00346.x.
• [796] Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.Pathol Int. 2005 Nov;55(11):707-15. doi: 10.1111/j.1440-1827.2005.01900.x.
• [797] Reduced GlcNAc glycosylation on gastric gland mucin is a biomarker of malignant potential for gastric cancer, Barrett's adenocarcinoma, and pancreatic cancer.Histochem Cell Biol. 2018 Jun;149(6):569-575. doi: 10.1007/s00418-018-1667-8. Epub 2018 Apr 16.
• [798] High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy.PLoS One. 2015 Aug 13;10(8):e0135576. doi: 10.1371/journal.pone.0135576. eCollection 2015.
• [799] Early Response Monitoring Following Radiation Therapy by Using [(18)F]FDG and [(11)C]Acetate PET in Prostate Cancer Xenograft Model with Metabolomics Corroboration.Molecules. 2017 Nov 10;22(11):1946. doi: 10.3390/molecules22111946.
• [800] Increase in receptor-like protein tyrosine phosphatase activity and expression level on density-dependent growth arrest of endothelial cells.Biochem J. 1995 Oct 1;311 ( Pt 1)(Pt 1):97-103. doi: 10.1042/bj3110097.
• [801] Low acyl-CoA synthetase 5 expression in colorectal carcinomas is prognostic for early tumour recurrence.Pathol Res Pract. 2017 Mar;213(3):261-266. doi: 10.1016/j.prp.2016.09.002. Epub 2016 Sep 26.
• [802] Airborne particulate matter induces mitotic slippage and chromosomal missegregation through disruption of the spindle assembly checkpoint (SAC).Chemosphere. 2019 Nov;235:794-804. doi: 10.1016/j.chemosphere.2019.06.232. Epub 2019 Jul 1.
• [803] The invasion and metastasis promotion role of CD97 small isoform in gastric carcinoma.PLoS One. 2012;7(6):e39989. doi: 10.1371/journal.pone.0039989. Epub 2012 Jun 29.
• [804] Expression of A-kinase anchor protein 13 and Rho-associated coiled-coil containing protein kinase in restituted and regenerated mucosal epithelial cells following mucosal injury and colorectal cancer cells in mouse models.Exp Toxicol Pathol. 2017 Sep 5;69(7):443-450. doi: 10.1016/j.etp.2017.04.002. Epub 2017 Apr 20.
• [805] 15-Lipoxygenase-2 expression in benign and neoplastic sebaceous glands and other cutaneous adnexa.J Invest Dermatol. 2001 Jul;117(1):36-43. doi: 10.1046/j.1523-1747.2001.01378.x.
• [806] (89)Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake.Clin Cancer Res. 2019 Jun 15;25(12):3517-3527. doi: 10.1158/1078-0432.CCR-18-2918. Epub 2019 Feb 11.
• [807] DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity.Oncogene. 2004 Jun 24;23(29):5056-67. doi: 10.1038/sj.onc.1207681.
• [808] Heterotopic salivary gland adenocarcinoma in the cervical region.Int J Oral Maxillofac Surg. 1997 Aug;26(4):290-2. doi: 10.1016/s0901-5027(97)80872-7.
• [809] pp32 reduction induces differentiation of TSU-Pr1 cells.Am J Pathol. 2004 Jan;164(1):273-83. doi: 10.1016/S0002-9440(10)63117-3.
• [810] Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.Mol Cell Proteomics. 2017 Mar;16(3):407-427. doi: 10.1074/mcp.M116.062273. Epub 2017 Jan 4.
• [811] ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapy.Cancer Immunol Immunother. 2019 Oct;68(10):1597-1603. doi: 10.1007/s00262-019-02392-y. Epub 2019 Sep 14.
• [812] Modulation of cell surface lectin receptors on K562 human erythroleukemia cells induced by transfection with annexin IV cDNA.FEBS Lett. 1997 Mar 17;405(1):107-10. doi: 10.1016/s0014-5793(97)00161-0.
• [813] Downregulation of annexin A7 decreases proliferation, migration, and invasion of gastric cancer cells by reducing matrix metalloproteinase 1 and 9 expression.Am J Transl Res. 2019 May 15;11(5):2754-2764. eCollection 2019.
• [814] Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas.Oncogene. 2004 Jun 3;23(26):4646-54. doi: 10.1038/sj.onc.1207588.
• [815] Increased mRNA expression of a novel prostacyclin-stimulating factor in human colon cancer.J Gastroenterol. 1998 Apr;33(2):213-7. doi: 10.1007/s005350050072.
• [816] Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer.Lung Cancer. 2001 Oct;34(1):53-7. doi: 10.1016/s0169-5002(01)00213-6.
• [817] Differences between gastric signet-ring cell carcinoma and poorly differentiated adenocarcinoma: A comparison of histopathologic features determined by mucin core protein and trefoil factor family peptide immunohistochemistry.Pathol Int. 2017 Aug;67(8):398-403. doi: 10.1111/pin.12559. Epub 2017 Jul 9.
• [818] p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cells.Cancer Res. 2004 Sep 15;64(18):6390-3. doi: 10.1158/0008-5472.CAN-04-2176.
• [819] Changes in gene expression during progression of ovarian carcinoma.Cancer Genet Cytogenet. 2001 Jul 1;128(1):1-6. doi: 10.1016/s0165-4608(01)00386-7.
• [820] Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung.Oncogene. 1988 Oct;3(4):471-5.
• [821] Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer.Cancer. 1992 Mar 1;69(5):1130-6. doi: 10.1002/cncr.2820690512.
• [822] Role of artemin in non-small cell lung cancer.Thorac Cancer. 2018 May;9(5):555-562. doi: 10.1111/1759-7714.12615. Epub 2018 Mar 25.
• [823] p38MAPK family isoform p38 and activating transcription factor 2 are associated with the malignant phenotypes and poor prognosis of patients with ovarian adenocarcinoma.Pathol Res Pract. 2017 Oct;213(10):1282-1288. doi: 10.1016/j.prp.2017.08.003. Epub 2017 Aug 25.
• [824] Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo.Pharm Res. 1995 Nov;12(11):1598-604. doi: 10.1023/A:1016276613684.
• [825] Aberrant SERCA3 expression during the colorectal adenoma-adenocarcinoma sequence.Oncol Rep. 2014 Jan;31(1):232-40. doi: 10.3892/or.2013.2837. Epub 2013 Nov 7.
• [826] ATP5b and 2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer.J Mol Histol. 2015 Feb;46(1):57-65. doi: 10.1007/s10735-014-9597-9. Epub 2014 Oct 14.
• [827] (Pro)renin Receptor Expression Increases throughout the Colorectal Adenoma-Adenocarcinoma Sequence and It Is Associated with Worse Colorectal Cancer Prognosis.Cancers (Basel). 2019 Jun 24;11(6):881. doi: 10.3390/cancers11060881.
• [828] Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.Mol Cancer Res. 2019 Dec;17(12):2480-2491. doi: 10.1158/1541-7786.MCR-19-0654. Epub 2019 Oct 14.
• [829] Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.Br J Cancer. 2004 Feb 23;90(4):892-9. doi: 10.1038/sj.bjc.6601589.
• [830] Differential expression of beta1,3galactosyltransferases in human colon cells derived from adenocarcinomas or normal mucosa.FEBS Lett. 1999 May 14;451(1):75-80. doi: 10.1016/s0014-5793(99)00547-5.
• [831] beta 1,3-Galactosyltransferase beta 3Gal-T5 acts on the GlcNAcbeta 1-->3Galbeta 1-->4GlcNAcbeta 1-->R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas.J Biol Chem. 2001 Feb 2;276(5):3564-73. doi: 10.1074/jbc.M006662200. Epub 2000 Oct 31.
• [832] Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2?CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.Trials. 2018 Aug 9;19(1):432. doi: 10.1186/s13063-018-2790-5.
• [833] The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer.Int J Oncol. 2002 Nov;21(5):929-33.
• [834] Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.Cancer Res. 1996 May 15;56(10):2422-7.
• [835] Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach.Mod Pathol. 2008 Apr;21(4):464-75. doi: 10.1038/modpathol.3801050. Epub 2008 Jan 18.
• [836] Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers.Cell Prolif. 2008 Aug;41(4):645-59. doi: 10.1111/j.1365-2184.2008.00539.x.
• [837] Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix.Pathol Int. 2015 Sep;65(9):476-85. doi: 10.1111/pin.12332. Epub 2015 Jul 27.
• [838] Loss of CADM4 expression is associated with poor prognosis in small intestinal adenocarcinomas.APMIS. 2017 May;125(5):437-443. doi: 10.1111/apm.12684.
• [839] L-CAM expression in lymph node and liver metastases of colorectal carcinomas.J Pathol. 1994 Feb;172(2):177-81. doi: 10.1002/path.1711720204.
• [840] Changes in the Distribution of Cocaine- and Amphetamine-Regulated Transcript-Containing Neural Structures in the Human Colon Affected by the Neoplastic Process.Int J Mol Sci. 2018 Jan 31;19(2):414. doi: 10.3390/ijms19020414.
• [841] Heterochromatin Protein 1 Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.Cancer Res. 2018 May 15;78(10):2691-2704. doi: 10.1158/0008-5472.CAN-17-3677. Epub 2018 Feb 27.
• [842] Dro1/Ccdc80 inactivation promotes AOM/DSS-induced colorectal carcinogenesis and aggravates colitis by DSS in mice.Carcinogenesis. 2018 Sep 21;39(9):1176-1184. doi: 10.1093/carcin/bgy077.
• [843] Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues.Mol Pathol. 2001 Aug;54(4):275-80. doi: 10.1136/mp.54.4.275.
• [844] Improved Survival Seen for Some with Pancreatic Cancer.Cancer Discov. 2018 Sep;8(9):OF1. doi: 10.1158/2159-8290.CD-NB2018-105. Epub 2018 Aug 13.
• [845] CD151 Gene and Protein Expression Provides Independent Prognostic Information for Patients with Adenocarcinoma of the Esophagus and Gastroesophageal Junction Treated by Esophagectomy.Ann Surg Oncol. 2016 Dec;23(Suppl 5):746-754. doi: 10.1245/s10434-016-5504-9. Epub 2016 Aug 30.
• [846] A novel core protein as well as polymorphic epithelial mucin carry peanut agglutinin binding sites in human gastric carcinoma cells: sequence analysis and examination of gene expression.J Biochem. 1992 Nov;112(5):609-15. doi: 10.1093/oxfordjournals.jbchem.a123948.
• [847] Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.Cancer Res. 1996 Apr 15;56(8):1751-5.
• [848] Alterations of type II classical cadherin, cadherin-10 (CDH10), is associated with pancreatic ductal adenocarcinomas.Genes Chromosomes Cancer. 2017 May;56(5):427-435. doi: 10.1002/gcc.22447. Epub 2017 Mar 7.
• [849] (111)In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis.Ann Nucl Med. 2020 Jan;34(1):13-23. doi: 10.1007/s12149-019-01408-y. Epub 2019 Oct 12.
• [850] Comparison of cofilin? and Twist? protein expression in human nonsmall cell lung cancer tissues.Oncol Rep. 2019 Aug;42(2):805-816. doi: 10.3892/or.2019.7193. Epub 2019 Jun 10.
• [851] Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.Oncotarget. 2015 Oct 13;6(31):31181-90. doi: 10.18632/oncotarget.5070.
• [852] Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.Respir Med. 2015 Jan;109(1):131-6. doi: 10.1016/j.rmed.2014.11.004. Epub 2014 Nov 21.
• [853] Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).J Cancer Res Clin Oncol. 2019 Sep;145(9):2285-2292. doi: 10.1007/s00432-019-02989-x. Epub 2019 Aug 1.
• [854] Prognostic Significance of CIP2A in Esophagogastric Junction Adenocarcinoma: A Study of 65 Patients and a Meta-Analysis.Dis Markers. 2019 Aug 22;2019:2312439. doi: 10.1155/2019/2312439. eCollection 2019.
• [855] MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions.Pathol Res Pract. 2018 Jun;214(6):835-839. doi: 10.1016/j.prp.2018.04.018. Epub 2018 May 1.
• [856] Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas.J Cancer Res Clin Oncol. 2003 Nov;129(11):621-30. doi: 10.1007/s00432-003-0484-0. Epub 2003 Aug 26.
• [857] Tetranectin expression in gastric adenocarcinomas.Histol Histopathol. 2002 Apr;17(2):471-5. doi: 10.14670/HH-17.471.
• [858] CLIC4 abrogation promotes epithelial-mesenchymal transition in gastric cancer.Carcinogenesis. 2020 Jul 10;41(6):841-849. doi: 10.1093/carcin/bgz156.
• [859] Decreased risk of developing lung cancer in subjects carrying the CLPTM1L rs401681 (G>A) polymorphism: evidence from a meta-analysis.Genet Mol Res. 2014 Feb 28;13(1):1373-82. doi: 10.4238/2014.February.28.10.
• [860] The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3 pathway in non-small cell lung cancer.Cell Biol Int. 2018 Aug;42(8):959-964. doi: 10.1002/cbin.10961. Epub 2018 Apr 17.
• [861] Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug.Cytotechnology. 1993;12(1-3):109-25. doi: 10.1007/BF00744660.
• [862] Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins.Br J Cancer. 1994 Jan;69(1):144-51. doi: 10.1038/bjc.1994.24.
• [863] Distribution of basement membrane anchoring molecules in normal and transformed endometrium: altered expression of laminin gamma2 chain and collagen type XVII in endometrial adenocarcinomas.J Mol Histol. 2004 Nov;35(8-9):715-22. doi: 10.1007/s10735-004-1051-y.
• [864] COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer.Mol Cancer Ther. 2019 Nov;18(11):2111-2123. doi: 10.1158/1535-7163.MCT-19-0150. Epub 2019 Aug 29.
• [865] Coronin 2A (CRN5) expression is associated with colorectal adenoma-adenocarcinoma sequence and oncogenic signalling.BMC Cancer. 2015 Sep 15;15:638. doi: 10.1186/s12885-015-1645-7.
• [866] Differential Expression of Cytochrome C Oxidase Subunit I Along the Colorectal Adenoma: Carcinoma Progression.Appl Immunohistochem Mol Morphol. 2018 Oct;26(9):689-696. doi: 10.1097/PAI.0000000000000509.
• [867] Downregulation of cytochrome c oxidase subunit 7A1 expression is important in enhancing cell proliferation in adenocarcinoma cells.Biochem Biophys Res Commun. 2017 Jan 22;482(4):713-719. doi: 10.1016/j.bbrc.2016.11.100. Epub 2016 Nov 17.
• [868] Crumbs3 is a critical factor that regulates invasion and metastasis of colon adenocarcinoma via the specific interaction with FGFR1.Int J Cancer. 2019 Nov 15;145(10):2740-2753. doi: 10.1002/ijc.32336. Epub 2019 Apr 29.
• [869] Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer.Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1419-26.
• [870] Cystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer.Oncotarget. 2017 Dec 20;9(18):14084-14098. doi: 10.18632/oncotarget.23505. eCollection 2018 Mar 6.
• [871] Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.Int J Cancer. 2009 Jun 15;124(12):2893-8. doi: 10.1002/ijc.24296.
• [872] FBXL5 targets cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration.Tumour Biol. 2014 Sep;35(9):8633-8. doi: 10.1007/s13277-014-2104-9. Epub 2014 May 28.
• [873] Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2). Oncotarget. 2018 Jun 8;9(44):27363-27379.
• [874] Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.Oncol Rep. 2016 Apr;35(4):2461-5. doi: 10.3892/or.2016.4605. Epub 2016 Feb 1.
• [875] The clinical significance of CXCL5 in non-small cell lung cancer.Onco Targets Ther. 2017 Nov 21;10:5561-5573. doi: 10.2147/OTT.S148772. eCollection 2017.
• [876] IL-33 drives the antitumour effects of dendritic cells via upregulating CYLD expression in pulmonary adenocarcinoma.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1335-1341. doi: 10.1080/21691401.2019.1596926.
• [877] Expression and prognostic impact of alpha thalassemia/mental retardation X-linked and death domain-associated protein in human lung cancer.Medicine (Baltimore). 2019 Aug;98(31):e16712. doi: 10.1097/MD.0000000000016712.
• [878] Functional variants in DCAF4 associated with lung cancer risk in European populations.Carcinogenesis. 2017 May 1;38(5):541-551. doi: 10.1093/carcin/bgx033.
• [879] Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.J Gastrointest Surg. 2008 Oct;12(10):1664-72; discussion 1672-3. doi: 10.1007/s11605-008-0577-9. Epub 2008 Aug 2.
• [880] First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis.Cancer Manag Res. 2018 Nov 20;10:5965-5978. doi: 10.2147/CMAR.S162980. eCollection 2018.
• [881] SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.Ann Thorac Surg. 2004 Nov;78(5):1734-41. doi: 10.1016/j.athoracsur.2004.05.056.
• [882] The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas.Dis Markers. 2015;2015:379568. doi: 10.1155/2015/379568. Epub 2015 Jul 30.
• [883] Calpain inhibitors ameliorate muscle wasting in a cachectic mouse model bearing CT26 colorectal adenocarcinoma.Oncol Rep. 2017 Mar;37(3):1601-1610. doi: 10.3892/or.2017.5396. Epub 2017 Jan 20.
• [884] Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.Clin Cancer Res. 2001 Nov;7(11):3495-503.
• [885] Genetic Variants in the Wingless Antagonist Genes (sFRP, DKK, and Axin2) Predict the Overall Survival and Prognosis of North Indian Lung Cancer Patients Treated with Platinum-Based Doublet Chemotherapy.Cancer Biother Radiopharm. 2018 Dec;33(10):466-477. doi: 10.1089/cbr.2018.2491. Epub 2018 Oct 20.
• [886] Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer.Carcinogenesis. 2005 Jun;26(6):1129-37. doi: 10.1093/carcin/bgi045. Epub 2005 Mar 10.
• [887] Dentin matrix protein 1 is expressed in human lung cancer.J Bone Miner Res. 2003 Aug;18(8):1506-12. doi: 10.1359/jbmr.2003.18.8.1506.
• [888] Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK-dependent signaling pathway.Mol Carcinog. 2015 Oct;54(10):1205-13. doi: 10.1002/mc.22194. Epub 2014 Jul 7.
• [889] TdIF1: a putative oncogene in NSCLC tumor progression.Signal Transduct Target Ther. 2018 Oct 19;3:28. doi: 10.1038/s41392-018-0030-9. eCollection 2018.
• [890] Doc-2/hDab2 expression is up-regulated in primary pancreatic cancer but reduced in metastasis.Lab Invest. 2001 Jun;81(6):863-73. doi: 10.1038/labinvest.3780295.
• [891] Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes.Lung Cancer. 2002 May;36(2):133-41. doi: 10.1016/s0169-5002(01)00486-x.
• [892] Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.Clin Cancer Res. 2002 Apr;8(4):1127-38.
• [893] High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers.J Cancer. 2017 Aug 23;8(14):2756-2764. doi: 10.7150/jca.19545. eCollection 2017.
• [894] The clinical and pathological significance of RCAS1 expression as a prognostic biomarker in non-small cell lung cancer.In Vivo. 2014 May-Jun;28(3):375-81.
• [895] del(1)(q12) in adenocarcinomas of the prostate.Cancer Genet Cytogenet. 1996 Mar;87(1):79-81. doi: 10.1016/0165-4608(95)00213-8.
• [896] Expression of an elongation factor 1 gamma-related sequence in adenocarcinomas of the colon.Gastroenterology. 1992 Jul;103(1):98-102. doi: 10.1016/0016-5085(92)91101-9.
• [897] Sumoylation of eukaryotic elongation factor 2 is vital for protein stability and anti-apoptotic activity in lung adenocarcinoma cells. Cancer Sci. 2011 Aug;102(8):1582-9. doi: 10.1111/j.1349-7006.2011.01975.x. Epub 2011 Jun 23.
• [898] EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma. Mol Cancer Res. 2009 Feb;7(2):189-98. doi: 10.1158/1541-7786.MCR-08-0132. Epub 2009 Feb 10.
• [899] Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer.J Cancer Res Clin Oncol. 2002 Jul;128(7):343-8. doi: 10.1007/s00432-002-0355-0. Epub 2002 Jun 26.
• [900] Reversion of the malignant phenotype of gastric cancer cell SGC7901 by c-erbB-2-specific hammerhead ribozyme.Cancer Gene Ther. 2001 Nov;8(11):835-42. doi: 10.1038/sj.cgt.7700372.
• [901] A pan-cancer genome-wide analysis reveals tumour dependencies by induction of nonsense-mediated decay.Nat Commun. 2017 Jun 26;8:15943. doi: 10.1038/ncomms15943.
• [902] Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.Eur J Cancer. 2018 Sep;101:165-180. doi: 10.1016/j.ejca.2018.07.001. Epub 2018 Aug 1.
• [903] The Expression of HSD17B12 Is Associated with COX-2 Expression and Is Increased in High-Grade Epithelial Ovarian Cancer.Oncology. 2018;94(4):233-242. doi: 10.1159/000485624. Epub 2018 Jan 12.
• [904] Expression of engrailed homeobox 2 regulates the proliferation, migration and invasion of non-small cell lung cancer cells.Oncol Lett. 2018 Jul;16(1):536-542. doi: 10.3892/ol.2018.8693. Epub 2018 May 10.
• [905] Wnt/-Catenin Signaling Activation beyond Robust Nuclear -Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.Neoplasia. 2015 Jul;17(7):598-611. doi: 10.1016/j.neo.2015.07.006.
• [906] Genetic polymorphisms in DNA repair genes XPC, XPD, and XRCC4, and susceptibility to Helicobacter pylori infection-related gastric antrum adenocarcinoma in Guangxi population, China.Mol Carcinog. 2010 Jun;49(6):611-8. doi: 10.1002/mc.20630.
• [907] Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis.Lung Cancer. 2017 Oct;112:47-56. doi: 10.1016/j.lungcan.2017.08.001. Epub 2017 Aug 5.
• [908] Relationship between ETS Transcription Factor ETV1 and TGF--regulated SMAD Proteins in Prostate Cancer.Sci Rep. 2019 Jun 3;9(1):8186. doi: 10.1038/s41598-019-44685-3.
• [909] PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma.Br J Cancer. 2011 Jun 28;105(1):124-30. doi: 10.1038/bjc.2011.187. Epub 2011 Jun 14.
• [910] Expression profile and potential roles of EVA1A in normal and neoplastic pancreatic tissues.Asian Pac J Cancer Prev. 2015;16(1):373-6. doi: 10.7314/apjcp.2015.16.1.373.
• [911] Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis.Mutat Res. 2000 Jun 30;460(1):41-52. doi: 10.1016/s0921-8777(00)00012-4.
• [912] High FA2H and UGT8 transcript levels predict hydroxylated hexosylceramide accumulation in lung adenocarcinoma.J Lipid Res. 2019 Oct;60(10):1776-1786. doi: 10.1194/jlr.M093955. Epub 2019 Aug 13.
• [913] A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression.Cancer Lett. 2013 Jan 28;328(2):278-84. doi: 10.1016/j.canlet.2012.09.026. Epub 2012 Oct 8.
• [914] A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas.Sci Rep. 2019 Sep 16;9(1):13396. doi: 10.1038/s41598-019-49475-5.
• [915] Cloning and functional expression of human inducible nitric oxide synthase (NOS) cDNA from a glioblastoma cell line A-172.J Biochem. 1994 Sep;116(3):575-81. doi: 10.1093/oxfordjournals.jbchem.a124563.
• [916] A new monoclonal antibody which binds to the cytoplasm of large cell lymphomas.Hematol Oncol. 1992 Mar-Apr;10(2):95-104. doi: 10.1002/hon.2900100205.
• [917] Clinicopathological and molecular characteristics of synchronous gastric adenocarcinoma and gastrointestinal stromal tumors.Sci Rep. 2017 Oct 10;7(1):12890. doi: 10.1038/s41598-017-12622-x.
• [918] Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas.Cancer Res. 2001 Jul 15;61(14):5511-6.
• [919] Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.J Pathol. 2019 Oct;249(2):193-205. doi: 10.1002/path.5290. Epub 2019 Jun 24.
• [920] Pulmonary Neoplasms in Patients with Birt-Hogg-Dub Syndrome: Histopathological Features and Genetic and Somatic Events.PLoS One. 2016 Mar 14;11(3):e0151476. doi: 10.1371/journal.pone.0151476. eCollection 2016.
• [921] FOXA1 in HPV associated carcinomas: Its expression in carcinomas of the head and neck and of the uterine cervix.Exp Mol Pathol. 2017 Apr;102(2):230-236. doi: 10.1016/j.yexmp.2017.02.010. Epub 2017 Feb 14.
• [922] Identification of Pancreatic Cancer in Biliary Obstruction Patients by FRY Site-specific Methylation.Asian Pac J Cancer Prev. 2016;17(9):4487-4490.
• [923] Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.Int J Cancer. 2004 Apr 20;109(4):568-75. doi: 10.1002/ijc.20006.
• [924] Detection of cerebroside sulfotransferase mRNA in human gastric mucosa and adenocarcinoma.Cancer Lett. 1999 Apr 26;138(1-2):45-51. doi: 10.1016/s0304-3835(98)00373-5.
• [925] Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.Pathobiology. 2004;71(1):12-8. doi: 10.1159/000072957.
• [926] De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.J Biol Chem. 2018 Jan 26;293(4):1298-1314. doi: 10.1074/jbc.M117.812826. Epub 2017 Nov 29.
• [927] Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection.Cell Oncol (Dordr). 2017 Oct;40(5):529-536. doi: 10.1007/s13402-017-0334-8. Epub 2017 Jun 20.
• [928] Psf3 as a possible biomarker of postoperative chemotherapy for patients with early pulmonary adenocarcinoma.Thorac Cancer. 2019 Dec;10(12):2300-2307. doi: 10.1111/1759-7714.13230. Epub 2019 Oct 22.
• [929] Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway.J Exp Clin Cancer Res. 2019 Feb 21;38(1):96. doi: 10.1186/s13046-019-1057-7.
• [930] Dynamic enhanced CT: is there a difference between liver metastases of gastroenteropancreatic neuroendocrine tumor and adenocarcinoma.Oncotarget. 2017 Nov 20;8(64):108146-108155. doi: 10.18632/oncotarget.22554. eCollection 2017 Dec 8.
• [931] Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.Histopathology. 2007 May;50(6):720-6. doi: 10.1111/j.1365-2559.2007.02675.x.
• [932] Tissue and cell-specific patterns of expression of rat liver and intestinal fatty acid binding protein during development and in experimental colonic and small intestinal adenocarcinomas.Lab Invest. 1993 Jun;68(6):663-75.
• [933] Glypican-1 immunohistochemistry does not separate mesothelioma from pulmonary adenocarcinoma.Mod Pathol. 2018 Sep;31(9):1400-1403. doi: 10.1038/s41379-018-0066-y. Epub 2018 May 21.
• [934] Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody.Int J Mol Sci. 2019 Oct 23;20(21):5261. doi: 10.3390/ijms20215261.
• [935] G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.J Thorac Oncol. 2012 Dec;7(12):1747-1754. doi: 10.1097/JTO.0b013e31826bb1ff.
• [936] Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.PLoS One. 2019 Dec 4;14(12):e0225931. doi: 10.1371/journal.pone.0225931. eCollection 2019.
• [937] Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death.Clin Cancer Res. 2018 Dec 1;24(23):6066-6077. doi: 10.1158/1078-0432.CCR-18-1478. Epub 2018 Jul 30.
• [938] Comparing survival predicted by the diagnosis-specific Graded Prognostic Assessment (DS-GPA) to actual survival in patients with 1-10 brain metastases treated with stereotactic radiosurgery.Radiother Oncol. 2019 Sep;138:173-179. doi: 10.1016/j.radonc.2019.06.033. Epub 2019 Jul 11.
• [939] Novel candidate tumor marker genes for lung adenocarcinoma.Oncogene. 2002 Oct 24;21(49):7598-604. doi: 10.1038/sj.onc.1205953.
• [940] Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells.J Biol Chem. 2002 Mar 22;277(12):10050-7. doi: 10.1074/jbc.M110069200. Epub 2002 Jan 14.
• [941] Leptin enhances N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced tumour growth in gastric mucosa of male Sprague-Dawley rats.Mol Biol Rep. 2019 Dec;46(6):5967-5975. doi: 10.1007/s11033-019-05030-z. Epub 2019 Aug 23.
• [942] Systematic Selective Sampling of Cholecystectomy Specimens Is Adequate to Detect Incidental Gallbladder Adenocarcinoma.Am J Surg Pathol. 2019 Dec;43(12):1668-1673. doi: 10.1097/PAS.0000000000001351.
• [943] The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53.Oncogene. 2018 Apr;37(14):1939-1948. doi: 10.1038/s41388-017-0022-1. Epub 2018 Jan 25.
• [944] Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC).BMC Cancer. 2018 Apr 16;18(1):429. doi: 10.1186/s12885-018-4215-y.
• [945] DNA methylation profile during multistage progression of pulmonary adenocarcinomas.Virchows Arch. 2011 Aug;459(2):201-11. doi: 10.1007/s00428-011-1079-9. Epub 2011 Apr 15.
• [946] Biochemical and cytogenetic studies of human lung cancers.J Thorac Cardiovasc Surg. 1988 Dec;96(6):840-8.
• [947] Heat shock protein 70-2 (HSP70-2) a novel cancer testis antigen that promotes growth of ovarian cancer.Am J Cancer Res. 2017 Jun 1;7(6):1252-1269. eCollection 2017.
• [948] Protein expression profiles in adenocarcinomas and squamous cell carcinomas of the lung generated using tissue microarrays.J Pathol. 2004 Jul;203(3):798-807. doi: 10.1002/path.1584.
• [949] Identification of Hyal2 as the cell-surface receptor for jaagsiekte sheep retrovirus and ovine nasal adenocarcinoma virus.Curr Top Microbiol Immunol. 2003;275:179-99. doi: 10.1007/978-3-642-55638-8_7.
• [950] Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.Oncogene. 2003 Oct 9;22(44):6946-53. doi: 10.1038/sj.onc.1206799.
• [951] Activation of ERK/IER3/PP2A-B56-positive feedback loop in lung adenocarcinoma by allelic deletion of B56 gene.Oncol Rep. 2016 May;35(5):2635-42. doi: 10.3892/or.2016.4677. Epub 2016 Mar 16.
• [952] Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array.Gynecol Oncol. 2004 May;93(2):446-53. doi: 10.1016/j.ygyno.2004.02.012.
• [953] Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring.J Immunother. 2007 Jan;30(1):108-15. doi: 10.1097/01.cji.0000211317.15278.27.
• [954] Lack of interferon- receptor results in a microenvironment favorable for intestinal tumorigenesis.Oncotarget. 2016 Jul 5;7(27):42099-42109. doi: 10.18632/oncotarget.9867.
• [955] miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma.Cancer Sci. 2017 Mar;108(3):536-542. doi: 10.1111/cas.13148.
• [956] VICKZ1 enhances tumor progression and metastasis in lung adenocarcinomas in mice.Oncogene. 2019 May;38(21):4169-4181. doi: 10.1038/s41388-019-0715-8. Epub 2019 Jan 30.
• [957] WIF-1 and Ihh Expression and Clinical Significance in Patients With Lung Squamous Cell Carcinoma and Adenocarcinoma.Appl Immunohistochem Mol Morphol. 2018 Aug;26(7):454-461. doi: 10.1097/PAI.0000000000000449.
• [958] Use of indocyanine green (ICG) augmented near-infrared fluorescence imaging in robotic radical resection of gallbladder adenocarcinomas.Surg Endosc. 2020 Jun;34(6):2490-2494. doi: 10.1007/s00464-019-07053-w. Epub 2019 Aug 6.
• [959] IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3.Clin Cancer Res. 2019 Jul 1;25(13):4026-4037. doi: 10.1158/1078-0432.CCR-18-3458. Epub 2019 Apr 12.
• [960] Cellular mechanism of resistance of human colorectal adenocarcinoma cells against apoptosis-induction by Russell's Viper venom l-amino acid oxidase (Rusvinoxidase).Biochimie. 2018 Jul;150:8-15. doi: 10.1016/j.biochi.2018.04.017. Epub 2018 Apr 25.
• [961] ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.Cancer Lett. 2003 Mar 20;192(1):109-16. doi: 10.1016/s0304-3835(02)00635-3.
• [962] ING4 induces cell growth inhibition in human lung adenocarcinoma A549 cells by means of Wnt-1/beta-catenin signaling pathway. Anat Rec (Hoboken). 2008 May;291(5):593-600.
• [963] The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.Oncotarget. 2016 Aug 23;7(34):54596-54615. doi: 10.18632/oncotarget.10519.
• [964] Inositol polyphosphate-4-phosphatase type II plays critical roles in the modulation of cadherin-mediated adhesion dynamics of pancreatic ductal adenocarcinomas.Cell Adh Migr. 2018;12(6):548-563. doi: 10.1080/19336918.2018.1491496. Epub 2018 Aug 19.
• [965] Mouse mammary tumor virus sequences responsible for activating cellular oncogenes.J Virol. 1998 Dec;72(12):9428-35. doi: 10.1128/JVI.72.12.9428-9435.1998.
• [966] Expression profiling of integrins in lung cancer cells.Pathol Res Pract. 2009;205(12):847-53. doi: 10.1016/j.prp.2009.07.005. Epub 2009 Aug 11.
• [967] Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.Epigenetics. 2015;10(10):903-12. doi: 10.1080/15592294.2015.1078049. Epub 2015 Aug 7.
• [968] Anti-tumour effects of beta-sitosterol are mediated by AMPK/PTEN/HSP90 axis in AGS human gastric adenocarcinoma cells and xenograft mouse models.Biochem Pharmacol. 2018 Jun;152:60-70. doi: 10.1016/j.bcp.2018.03.010. Epub 2018 Mar 17.
• [969] Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial.Br J Cancer. 2018 Apr;118(8):1042-1050. doi: 10.1038/s41416-018-0020-2. Epub 2018 Mar 19.
• [970] KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinoma.Anticancer Res. 2018 Apr;38(4):2295-2302. doi: 10.21873/anticanres.12474.
• [971] Tandem RNA isolation reveals functional rearrangement of RNA-binding proteins on CDKN1B/p27(Kip1) 3'UTRs in cisplatin treated cells.RNA Biol. 2020 Jan;17(1):33-46. doi: 10.1080/15476286.2019.1662268. Epub 2019 Sep 16.
• [972] A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.J Ovarian Res. 2016 Mar 18;9:17. doi: 10.1186/s13048-016-0224-0.
• [973] ALK-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature.Onco Targets Ther. 2018 Aug 17;11:4991-4998. doi: 10.2147/OTT.S172124. eCollection 2018.
• [974] Chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas.Pharm Res. 2004 Mar;21(3):406-12. doi: 10.1023/B:PHAM.0000019292.03875.3e.
• [975] Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas.Mod Pathol. 2018 Jun;31(6):989-996. doi: 10.1038/s41379-018-0003-0. Epub 2018 Feb 8.
• [976] Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7).PLoS One. 2015 Dec 17;10(12):e0145023. doi: 10.1371/journal.pone.0145023. eCollection 2015.
• [977] A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer.Sci Rep. 2019 Mar 26;9(1):5207. doi: 10.1038/s41598-019-41585-4.
• [978] In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma.Cancer Res. 2006 Oct 1;66(19):9583-90. doi: 10.1158/0008-5472.CAN-06-1842.
• [979] Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues.Anticancer Res. 2003 Jan-Feb;23(1A):161-5.
• [980] Genes of laminin B1 chain, alpha 1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas.Am J Pathol. 1993 May;142(5):1622-30.
• [981] LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.Oncogene. 2020 Mar;39(11):2290-2304. doi: 10.1038/s41388-019-1146-2. Epub 2019 Dec 13.
• [982] L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management.Cancer Biomark. 2015;15(4):365-74. doi: 10.3233/CBM-150486.
• [983] Variation in nucleolar organizer activity in lymphocytes of females with adenocarcinoma.Clin Genet. 1981 Mar;19(3):145-8. doi: 10.1111/j.1399-0004.1981.tb00687.x.
• [984] Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase.Pathol Res Pract. 2017 Sep;213(9):1134-1138. doi: 10.1016/j.prp.2017.07.006. Epub 2017 Jul 6.
• [985] Distinct tumor specific expression of TGFB4 (ebaf)*, a novel human gene of the TGF-beta superfamily.Front Biosci. 1997 Jul 15;2:a18-25. doi: 10.2741/a158.
• [986] G protein-coupled receptor LGR6 is an independent risk factor for colon adenocarcinoma.Front Med. 2019 Aug;13(4):482-491. doi: 10.1007/s11684-018-0633-0. Epub 2018 Jul 4.
• [987] Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.Int J Cancer. 2018 Nov 15;143(10):2537-2550. doi: 10.1002/ijc.31786. Epub 2018 Sep 19.
• [988] Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci.Carcinogenesis. 2016 Jan;37(1):96-105. doi: 10.1093/carcin/bgv165. Epub 2015 Nov 20.
• [989] Latent transforming growth factor -binding protein 4 is downregulated in esophageal cancer via promoter methylation.PLoS One. 2013 May 31;8(5):e65614. doi: 10.1371/journal.pone.0065614. Print 2013.
• [990] The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy.Sci Rep. 2019 Mar 26;9(1):5120. doi: 10.1038/s41598-019-41379-8.
• [991] Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients.Lung Cancer. 2011 Oct;74(1):124-31. doi: 10.1016/j.lungcan.2011.01.025. Epub 2011 Mar 4.
• [992] MAGI2 is an independent predictor of biochemical recurrence in prostate cancer.Prostate. 2018 Jun;78(8):616-622. doi: 10.1002/pros.23506. Epub 2018 Mar 14.
• [993] On The Role of Myelin and Lymphocyte Protein (MAL) In Cancer: A Puzzle With Two Faces.J Cancer. 2019 May 21;10(10):2312-2318. doi: 10.7150/jca.30376. eCollection 2019.
• [994] The Clinical Influence of Autophagy-Associated Proteins on Human Lung Cancer.Dis Markers. 2018 Jan 9;2018:8314963. doi: 10.1155/2018/8314963. eCollection 2018.
• [995] MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.Clin Cancer Res. 2004 Dec 15;10(24):8516-20. doi: 10.1158/1078-0432.CCR-04-0885.
• [996] Tricellulin expression in normal and neoplastic human pancreas.Histopathology. 2012 May;60(6B):E76-86. doi: 10.1111/j.1365-2559.2012.04189.x. Epub 2012 Mar 6.
• [997] Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett esophagus.Am J Clin Pathol. 2000 Dec;114(6):890-5. doi: 10.1309/L1Q3-E3AQ-APU9-NA0A.
• [998] Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.Dig Dis Sci. 2019 Oct;64(10):2815-2822. doi: 10.1007/s10620-019-05607-5. Epub 2019 Apr 13.
• [999] Microsecretory Adenocarcinoma: A Novel Salivary Gland Tumor Characterized by a Recurrent MEF2C-SS18 Fusion.Am J Surg Pathol. 2019 Aug;43(8):1023-1032. doi: 10.1097/PAS.0000000000001273.
• [1000] Loss of microfibril-associated protein 5 (MFAP5) expression in colon cancer stroma.Virchows Arch. 2020 Mar;476(3):383-390. doi: 10.1007/s00428-019-02649-y. Epub 2019 Aug 18.
• [1001] Down-regulation of matrix Gla protein messenger RNA in human colorectal adenocarcinomas.Cancer Lett. 2001 Apr 10;165(1):63-9. doi: 10.1016/s0304-3835(01)00416-5.
• [1002] Migration and Invasion Enhancer 1 Is an NF-B-Inducing Gene Enhancing the Cell Proliferation and Invasion Ability of Human Prostate Carcinoma Cells In Vitro and In Vivo.Cancers (Basel). 2019 Oct 2;11(10):1486. doi: 10.3390/cancers11101486.
• [1003] Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.J Cutan Pathol. 2004 Aug;31(7):483-91. doi: 10.1111/j.0303-6987.2004.00211.x.
• [1004] Reversible mislocalization of a disease-associated MRE11 splice variant product.Sci Rep. 2018 Jul 4;8(1):10121. doi: 10.1038/s41598-018-28370-5.
• [1005] DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.Hum Pathol. 2019 Mar;85:18-26. doi: 10.1016/j.humpath.2018.10.013. Epub 2018 Oct 28.
• [1006] Immunohistochemical profiling of mucins in sinonasal adenocarcinomas.Pathol Res Pract. 2019 Jul;215(7):152439. doi: 10.1016/j.prp.2019.152439. Epub 2019 May 4.
• [1007] Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa.Dis Markers. 2016;2016:1532791. doi: 10.1155/2016/1532791. Epub 2016 Sep 27.
• [1008] FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas.PLoS Genet. 2017 Dec 21;13(12):e1007097. doi: 10.1371/journal.pgen.1007097. eCollection 2017 Dec.
• [1009] Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies.Am J Gastroenterol. 2011 Jul;106(7):1359-63. doi: 10.1038/ajg.2011.22. Epub 2011 Jun 7.
• [1010] Concomitance of P-gp/LRP Expression with EGFR Mutations in Exons 19 and 21 in Non-Small Cell Lung Cancers.Yonsei Med J. 2016 Jan;57(1):50-7. doi: 10.3349/ymj.2016.57.1.50.
• [1011] Prognostic significance of MYH9 expression in resected non-small cell lung cancer.PLoS One. 2015 Mar 31;10(3):e0121460. doi: 10.1371/journal.pone.0121460. eCollection 2015.
• [1012] The Mechanisms Underlying the Cytotoxic Effects of Copper Via Differentiated Embryonic Chondrocyte Gene 1.Int J Mol Sci. 2019 Oct 22;20(20):5225. doi: 10.3390/ijms20205225.
• [1013] Prognostic significance of neuroepithelial transforming gene 1 in adenocarcinoma of the oesophagogastric junction.Br J Surg. 2014 Jan;101(2):55-62. doi: 10.1002/bjs.9373.
• [1014] NEU protein overexpression in benign, borderline, and malignant ovarian neoplasms.Gynecol Oncol. 1992 Mar;44(3):245-53. doi: 10.1016/0090-8258(92)90051-j.
• [1015] Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma.Cancer Med. 2018 May;7(5):1756-1765. doi: 10.1002/cam4.1434. Epub 2018 Mar 25.
• [1016] NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis.Nature. 2017 Nov 30;551(7682):639-643. doi: 10.1038/nature24637. Epub 2017 Nov 22.
• [1017] LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer.Pathol Res Pract. 1999;195(10):677-80. doi: 10.1016/S0344-0338(99)80058-2.
• [1018] The biological and therapeutic importance of gastrin gene expression in pancreatic adenocarcinomas.Cancer Res. 2004 Aug 15;64(16):5624-31. doi: 10.1158/0008-5472.CAN-04-0106.
• [1019] Quantitation of NM23 expression in human prostate tissues.J Urol. 1994 Jul;152(1):202-7. doi: 10.1016/s0022-5347(17)32862-8.
• [1020] HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells.Free Radic Biol Med. 2010 Jun 15;48(12):1626-35. doi: 10.1016/j.freeradbiomed.2010.03.008. Epub 2010 Mar 24.
• [1021] Research on circadian clock genes in non-small-cell lung carcinoma.Chronobiol Int. 2019 Jun;36(6):739-750. doi: 10.1080/07420528.2018.1509080. Epub 2019 Apr 24.
• [1022] Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res. 2007 Nov-Dec;27(6B):3813-8.
• [1023] High collagen density augments mTOR-dependent cancer stem cells in ER+ mammary carcinomas, and increases mTOR-independent lung metastases.Cancer Lett. 2018 Oct 1;433:1-9. doi: 10.1016/j.canlet.2018.06.025. Epub 2018 Jun 20.
• [1024] High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma.Pathol Int. 2018 Nov;68(11):596-604. doi: 10.1111/pin.12724. Epub 2018 Oct 15.
• [1025] Haptoglobin groups and lung cancer.Hum Hered. 1986;36(4):258-60. doi: 10.1159/000153638.
• [1026] Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.Int J Biochem Cell Biol. 2016 Jan;70:68-75. doi: 10.1016/j.biocel.2015.11.006. Epub 2015 Nov 10.
• [1027] Upregulation of OTUD7B (Cezanne) Promotes Tumor Progression via AKT/VEGF Pathway in Lung Squamous Carcinoma and Adenocarcinoma.Front Oncol. 2019 Sep 11;9:862. doi: 10.3389/fonc.2019.00862. eCollection 2019.
• [1028] Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas.J Vis Exp. 2019 Feb 28;(144). doi: 10.3791/56880.
• [1029] Peripheral airway cell differentiation in human lung cancer cell lines.Cancer Res. 1990 Sep 1;50(17):5481-7.
• [1030] Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer.J Thorac Oncol. 2019 Feb;14(2):304-310. doi: 10.1016/j.jtho.2018.10.168. Epub 2018 Nov 22.
• [1031] Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression.Cytoskeleton (Hoboken). 2015 Aug;72(8):402-11. doi: 10.1002/cm.21239. Epub 2015 Sep 3.
• [1032] Deletion of tumor suppressor genes in Chinese non-small cell lung cancer.Cancer Lett. 2002 Oct 28;184(2):189-95. doi: 10.1016/s0304-3835(02)00204-5.
• [1033] High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma.Lab Invest. 2009 Jan;89(1):80-90. doi: 10.1038/labinvest.2008.103. Epub 2008 Nov 10.
• [1034] SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.Ann Diagn Pathol. 2017 Feb;26:47-51. doi: 10.1016/j.anndiagpath.2016.10.006. Epub 2016 Oct 20.
• [1035] MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma.J Exp Clin Cancer Res. 2018 Aug 17;37(1):195. doi: 10.1186/s13046-018-0871-7.
• [1036] Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination.Cell Death Differ. 2017 Mar;24(3):469-480. doi: 10.1038/cdd.2016.143. Epub 2016 Dec 23.
• [1037] Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.Am J Pathol. 2002 May;160(5):1573-81. doi: 10.1016/S0002-9440(10)61104-2.
• [1038] A novel PHD-finger protein 14/KIF4A complex overexpressed in lung cancer is involved in cell mitosis regulation and tumorigenesis.Oncotarget. 2017 Mar 21;8(12):19684-19698. doi: 10.18632/oncotarget.14962.
• [1039] PINK1 Expression Is Associated with Poor Prognosis in Lung Adenocarcinoma.Tohoku J Exp Med. 2018 Jun;245(2):115-121. doi: 10.1620/tjem.245.115.
• [1040] GATA3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15.Diagn Pathol. 2017 Jul 10;12(1):51. doi: 10.1186/s13000-017-0638-z.
• [1041] Desmosomal plakophilin 2 as a differentiation marker in normal and malignant tissues.Differentiation. 1999 Jun;64(5):277-90. doi: 10.1046/j.1432-0436.1999.6450277.x.
• [1042] Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma.Onco Targets Ther. 2016 Dec 19;10:47-54. doi: 10.2147/OTT.S126401. eCollection 2017.
• [1043] An early evaluation of malignant tendency with plectin expression in human colorectal adenoma and adenocarcinoma.J Med. 2004;35(1-6):141-9.
• [1044] Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 Deficiency.Appl Immunohistochem Mol Morphol. 2017 Jul;25(6):399-406. doi: 10.1097/PAI.0000000000000389.
• [1045] A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.Cancer Res. 2019 Jun 1;79(11):2878-2891. doi: 10.1158/0008-5472.CAN-18-3369. Epub 2019 Apr 11.
• [1046] Genetic profile and biological implication of PIN2/TRF1-interacting telomerase inhibitor 1 (PinX1) in human cancers: an analysis using The Cancer Genome Atlas.Oncotarget. 2017 Jun 21;8(40):67241-67253. doi: 10.18632/oncotarget.18589. eCollection 2017 Sep 15.
• [1047] Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.Clin Exp Metastasis. 1995 May;13(3):196-202. doi: 10.1007/BF00132208.
• [1048] Nrf2-peroxiredoxin I axis in polymorphous adenocarcinoma is associated with low matrix metalloproteinase 2 level.Virchows Arch. 2017 Dec;471(6):793-798. doi: 10.1007/s00428-017-2218-8. Epub 2017 Aug 28.
• [1049] Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland.Histopathology. 2016 Jun;68(7):1055-62. doi: 10.1111/his.12883. Epub 2016 Jan 4.
• [1050] Identification of a novel PRR15L-RSPO2 fusion transcript in a sigmoid colon cancer derived from superficially serrated adenoma.Virchows Arch. 2019 Nov;475(5):659-663. doi: 10.1007/s00428-019-02604-x. Epub 2019 Jun 17.
• [1051] Expression of prothymosin in lung cancer is associated with squamous cell carcinoma and smoking.Oncol Lett. 2019 Jun;17(6):5740-5746. doi: 10.3892/ol.2019.10248. Epub 2019 Apr 12.
• [1052] Prothymosin- and parathymosin expression predicts poor prognosis in squamous and adenosquamous carcinomas of the gallbladder.Oncol Lett. 2018 Apr;15(4):4485-4494. doi: 10.3892/ol.2018.7824. Epub 2018 Jan 19.
• [1053] PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks.Oncogene. 2001 Mar 22;20(12):1455-64. doi: 10.1038/sj.onc.1204233.
• [1054] PTPRF as a novel tumor suppressor through deactivation of ERK1/2 signaling in gastric adenocarcinoma.Onco Targets Ther. 2018 Nov 2;11:7795-7803. doi: 10.2147/OTT.S178152. eCollection 2018.
• [1055] Analysis of poliovirus receptor, CD155 expression in different human colorectal cancer cell lines: Implications for poliovirus virotherapy.J Cancer Res Ther. 2019 Jan-Mar;15(1):61-67. doi: 10.4103/jcrt.JCRT_13_17.
• [1056] Quiescin sulfhydryl oxidase 1 (QSOX1) glycosite mutation perturbs secretion but not Golgi localization.Glycobiology. 2018 Aug 1;28(8):580-591. doi: 10.1093/glycob/cwy044.
• [1057] Prognostic significance of positive circumferential resection margin post neoadjuvant chemotherapy in patients with esophageal or gastro-esophageal junction adenocarcinoma.Eur J Surg Oncol. 2019 Mar;45(3):439-445. doi: 10.1016/j.ejso.2018.10.530. Epub 2018 Oct 24.
• [1058] Genome-wide association study of familial lung cancer.Carcinogenesis. 2018 Sep 21;39(9):1135-1140. doi: 10.1093/carcin/bgy080.
• [1059] Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer.Oncotarget. 2019 Nov 26;10(63):6805-6815. doi: 10.18632/oncotarget.27308. eCollection 2019 Nov 26.
• [1060] Decreased level of RASSF6 in sporadic colorectal cancer and its anti-tumor effects both in vitro and in vivo.Oncotarget. 2016 Apr 12;7(15):19813-23. doi: 10.18632/oncotarget.7852.
• [1061] Increased cell apoptosis in human lung adenocarcinoma and in vivo tumor growth inhibition by RBM10, a tumor suppressor gene.Oncol Lett. 2017 Oct;14(4):4663-4669. doi: 10.3892/ol.2017.6765. Epub 2017 Aug 17.
• [1062] In vivo evidence that RBM5 is a tumour suppressor in the lung.Sci Rep. 2017 Nov 24;7(1):16323. doi: 10.1038/s41598-017-15874-9.
• [1063] Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer.J Clin Pathol. 2004 Aug;57(8):872-6. doi: 10.1136/jcp.2003.014555.
• [1064] A new gene family including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2).Genomics. 2000 Mar 15;64(3):252-63. doi: 10.1006/geno.2000.6127.
• [1065] Regulation of p27 by ubiquitin ligases and its pathological significance in human lung carcinomas.Hum Pathol. 2017 Aug;66:67-78. doi: 10.1016/j.humpath.2017.05.022. Epub 2017 Jun 7.
• [1066] Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes.Cancer Biol Ther. 2006 Dec;5(12):1714-20. doi: 10.4161/cbt.5.12.3469. Epub 2006 Dec 30.
• [1067] Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.Genes Chromosomes Cancer. 2018 May;57(5):240-251. doi: 10.1002/gcc.22525. Epub 2018 Jan 30.
• [1068] RFX-B, a MHC class II transcription factor, suppressed in human colorectal adenocarcinomas.Int J Mol Med. 2002 Mar;9(3):213-6.
• [1069] Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development.Oncotarget. 2019 Mar 5;10(19):1760-1774. doi: 10.18632/oncotarget.26678. eCollection 2019 Mar 5.
• [1070] Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy.Clin Epigenetics. 2019 Nov 12;11(1):157. doi: 10.1186/s13148-019-0770-6.
• [1071] Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer.Gastroenterology. 2003 May;124(5):1337-47. doi: 10.1016/s0016-5085(03)00264-6.
• [1072] Frequent occurrence of Ha-rasl allelic deletion in human ovarian adenocarcinomas.Tumori. 1991 Feb 28;77(1):16-20. doi: 10.1177/030089169107700104.
• [1073] Increased expression of a Myc target gene Mina53 in human colon cancer.Am J Pathol. 2004 Jan;164(1):205-16. doi: 10.1016/S0002-9440(10)63111-2.
• [1074] Receptor-interacting protein kinase 3 as a predictive adjuvant chemotherapy marker after lung adenocarcinoma resection.Ann Transl Med. 2019 Feb;7(3):42. doi: 10.21037/atm.2018.12.65.
• [1075] Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.Medicine (Baltimore). 2017 Jan;96(4):e5975. doi: 10.1097/MD.0000000000005975.
• [1076] Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.Int J Cancer. 2002 Apr 10;98(5):718-23. doi: 10.1002/ijc.10253.
• [1077] A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1.Hum Genet. 2015 Nov;134(11-12):1249-1262. doi: 10.1007/s00439-015-1598-6. Epub 2015 Sep 24.
• [1078] S100A10 upregulation associates with poor prognosis in lung squamous cell carcinoma.Biochem Biophys Res Commun. 2018 Oct 28;505(2):466-470. doi: 10.1016/j.bbrc.2018.09.118. Epub 2018 Sep 27.
• [1079] Up-Regulation of S100A11 in Lung Adenocarcinoma - Its Potential Relationship with Cancer Progression.PLoS One. 2015 Nov 6;10(11):e0142642. doi: 10.1371/journal.pone.0142642. eCollection 2015.
• [1080] Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.Oncotarget. 2017 Jul 11;8(28):45710-45724. doi: 10.18632/oncotarget.17391.
• [1081] S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.Oncotarget. 2017 Apr 11;8(15):24804-24814. doi: 10.18632/oncotarget.15063.
• [1082] DNA hypomethylation is prevalent even in low-grade breast cancers.Cancer Biol Ther. 2004 Dec;3(12):1225-31. doi: 10.4161/cbt.3.12.1222. Epub 2004 Dec 9.
• [1083] Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy.Prostate. 1998 Feb 1;34(2):113-20. doi: 10.1002/(sici)1097-0045(19980201)34:2<113::aid-pros5>3.0.co;2-l.
• [1084] Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS.Clin Respir J. 2018 Jun;12(6):2036-2045. doi: 10.1111/crj.12771. Epub 2018 Feb 21.
• [1085] Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.Clin Cancer Res. 2010 Apr 1;16(7):2009-21. doi: 10.1158/1078-0432.CCR-09-2801. Epub 2010 Mar 23.
• [1086] Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.Cancer Res. 1991 Dec 1;51(23 Pt 1):6346-50.
• [1087] The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines.Cancer Res. 2003 May 1;63(9):2179-87.
• [1088] Expression pattern of human SERPINE2 in a variety of human tumors.Oncol Lett. 2018 Apr;15(4):4523-4530. doi: 10.3892/ol.2018.7819. Epub 2018 Jan 18.
• [1089] Circulating Plasma miRNAs as Potential Biomarkers of Non-Small Cell Lung Cancer Obtained by High-Throughput Real-Time PCR Profiling.Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):327-336. doi: 10.1158/1055-9965.EPI-18-0723. Epub 2018 Oct 30.
• [1090] A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients.Clin Cancer Res. 2006 Apr 15;12(8):2484-91. doi: 10.1158/1078-0432.CCR-05-2037.
• [1091] Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.Prostate. 2017 May;77(7):718-728. doi: 10.1002/pros.23302. Epub 2017 Feb 23.
• [1092] SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway.Oncogene. 2017 May 11;36(19):2724-2736. doi: 10.1038/onc.2016.425. Epub 2016 Dec 12.
• [1093] Dual and opposing roles of ERK in regulating G(1) and S-G(2)/M delays in A549 cells caused by hyperoxia.Exp Cell Res. 2004 Jul 15;297(2):472-83. doi: 10.1016/j.yexcr.2004.03.033.
• [1094] The cohesin SMC3 is a target the for beta-catenin/TCF4 transactivation pathway.J Biol Chem. 2003 May 30;278(22):20259-67. doi: 10.1074/jbc.M209511200. Epub 2003 Mar 21.
• [1095] SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression.Oncotarget. 2015 Jul 10;6(19):17121-34. doi: 10.18632/oncotarget.2736.
• [1096] SOX11: a potentially useful marker in surgical pathology: a systematic analysis of SOX11 expression in epithelial and non-epithelial tumours.Histopathology. 2019 Feb;74(3):391-405. doi: 10.1111/his.13757. Epub 2018 Dec 2.
• [1097] SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma.Histopathology. 2020 Feb;76(3):383-393. doi: 10.1111/his.13980. Epub 2019 Dec 1.
• [1098] Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma.Oncol Rep. 2018 Jan;39(1):201-208. doi: 10.3892/or.2017.6077. Epub 2017 Nov 6.
• [1099] SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.Respir Res. 2018 Dec 4;19(1):241. doi: 10.1186/s12931-018-0952-3.
• [1100] SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.Mol Cancer. 2015 Feb 3;14:24. doi: 10.1186/s12943-014-0284-y.
• [1101] RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients.Tumour Biol. 2015 Nov;36(11):8993-9003. doi: 10.1007/s13277-015-3576-y. Epub 2015 Jun 17.
• [1102] Spondin2 is a new prognostic biomarker for lung adenocarcinoma.Oncotarget. 2017 Jul 26;8(35):59324-59332. doi: 10.18632/oncotarget.19577. eCollection 2017 Aug 29.
• [1103] SPRR1B overexpression enhances entry of cells into the G0 phase of the cell cycle.Am J Physiol Lung Cell Mol Physiol. 2003 Oct;285(4):L889-98. doi: 10.1152/ajplung.00065.2003. Epub 2003 Jun 27.
• [1104] Expression of drs mRNA in human lung adenocarcinomas.Hum Pathol. 2002 Jun;33(6):615-9. doi: 10.1053/hupa.2002.125373.
• [1105] SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition.Eur Urol. 2017 Jan;71(1):68-78. doi: 10.1016/j.eururo.2016.04.028. Epub 2016 May 11.
• [1106] SRSF5: a novel marker for small-cell lung cancer and pleural metastatic cancer.Lung Cancer. 2016 Sep;99:57-65. doi: 10.1016/j.lungcan.2016.05.018. Epub 2016 May 26.
• [1107] Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.J Ovarian Res. 2019 Oct 14;12(1):93. doi: 10.1186/s13048-019-0574-5.
• [1108] Effects of intronic single nucleotide polymorphisms (iSNPs) of a polysialyltransferase, ST8SIA2 gene found in psychiatric disorders on its gene products.Biochem Biophys Res Commun. 2016 Sep 23;478(3):1123-9. doi: 10.1016/j.bbrc.2016.08.079. Epub 2016 Aug 24.
• [1109] STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.J Cell Physiol. 2012 Jun;227(6):2421-9. doi: 10.1002/jcp.22977.
• [1110] Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report.BMC Cancer. 2018 Nov 20;18(1):1142. doi: 10.1186/s12885-018-5084-0.
• [1111] Vitamin B12 and its binding proteins in patients with non-small cell lung cancer referred to fast-track diagnostic work-up for lung cancer.Scand J Clin Lab Invest. 2020 Feb;80(1):14-19. doi: 10.1080/00365513.2019.1692232. Epub 2019 Nov 18.
• [1112] Overexpression of FZD1 and CAIX are Associated with Invasion, Metastasis, and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma.Pathol Oncol Res. 2018 Oct;24(4):899-906. doi: 10.1007/s12253-017-0284-5. Epub 2017 Sep 18.
• [1113] Clinical features of pulmonary embolism in patients with lung cancer: A meta-analysis.PLoS One. 2019 Sep 30;14(9):e0223230. doi: 10.1371/journal.pone.0223230. eCollection 2019.
• [1114] p53-Suppressed Oncogene TET1 Prevents Cellular Aging in Lung Cancer.Cancer Res. 2019 Apr 15;79(8):1758-1768. doi: 10.1158/0008-5472.CAN-18-1234. Epub 2019 Jan 8.
• [1115] Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.Virchows Arch. 2019 Jan;474(1):79-86. doi: 10.1007/s00428-018-2469-z. Epub 2018 Oct 15.
• [1116] Genomic alterations of ground-glass nodular lung adenocarcinoma.Sci Rep. 2018 May 16;8(1):7691. doi: 10.1038/s41598-018-25800-2.
• [1117] Novel Hydrogel-Advanced Modified Clay Nanocomposites as Possible Vehicles for Drug Delivery and Controlled Release.Nanomaterials (Basel). 2017 Dec 13;7(12):443. doi: 10.3390/nano7120443.
• [1118] Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.Hum Pathol. 1995 Nov;26(11):1227-32. doi: 10.1016/0046-8177(95)90198-1.
• [1119] Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.Histopathology. 2019 Jul;75(1):54-62. doi: 10.1111/his.13845. Epub 2019 May 16.
• [1120] Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations.Arch Pathol Lab Med. 2018 Mar;142(3):353-357. doi: 10.5858/arpa.2017-0046-OA. Epub 2017 Dec 8.
• [1121] Tumor necrosis factor-alpha-induced lung cell expression of antiapoptotic genes TRAF1 and cIAP2.Am J Respir Cell Mol Biol. 2000 Feb;22(2):150-6. doi: 10.1165/ajrcmb.22.2.3783.
• [1122] Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.Diagn Pathol. 2017 Jan 14;12(1):6. doi: 10.1186/s13000-017-0598-3.
• [1123] TRIM44 promotes proliferation and metastasis in nonsmall cell lung cancer via mTOR signaling pathway.Oncotarget. 2016 May 24;7(21):30479-91. doi: 10.18632/oncotarget.8586.
• [1124] HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib.Mol Cancer Ther. 2017 Jan;16(1):228-238. doi: 10.1158/1535-7163.MCT-15-0887. Epub 2016 Nov 3.
• [1125] Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.Clin Cancer Res. 2014 Aug 1;20(15):4154-66. doi: 10.1158/1078-0432.CCR-13-3292. Epub 2014 Jun 6.
• [1126] The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas.Genome Biol. 2014 Jul 31;15(7):417. doi: 10.1186/s13059-014-0417-z.
• [1127] Mitochondrial variants in MT-CO2 and D-loop instability are involved in MUTYH-associated polyposis.J Mol Med (Berl). 2015 Nov;93(11):1271-81. doi: 10.1007/s00109-015-1312-0. Epub 2015 Jul 3.
• [1128] BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.J Pathol. 2010 Jun;221(2):229-37. doi: 10.1002/path.2707.
• [1129] Landscape of genomic alterations in cervical carcinomas.Nature. 2014 Feb 20;506(7488):371-5. doi: 10.1038/nature12881. Epub 2013 Dec 25.
• [1130] CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.Dis Markers. 2014;2014:619273. doi: 10.1155/2014/619273. Epub 2014 Dec 7.
• [1131] Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression.J Clin Invest. 2014 Dec;124(12):5398-410. doi: 10.1172/JCI76614. Epub 2014 Oct 27.
• [1132] RNA sequencing identifies novel markers of non-small cell lung cancer.Lung Cancer. 2014 Jun;84(3):229-35. doi: 10.1016/j.lungcan.2014.03.018. Epub 2014 Mar 26.
• [1133] MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas.IUBMB Life. 2012 Jul;64(7):628-35. doi: 10.1002/iub.1030. Epub 2012 Apr 27.
• [1134] Cancer/testis antigen expression as a predictor for epidermal growth factor receptor mutation and prognosis in lung adenocarcinoma.Eur J Cardiothorac Surg. 2013 Apr;43(4):759-64. doi: 10.1093/ejcts/ezs426. Epub 2012 Jul 22.
• [1135] Smoking-induced CXCL14 expression in the human airway epithelium links chronic obstructive pulmonary disease to lung cancer.Am J Respir Cell Mol Biol. 2013 Sep;49(3):418-25. doi: 10.1165/rcmb.2012-0396OC.
• [1136] ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma.Cancer Sci. 2014 Apr;105(4):490-7. doi: 10.1111/cas.12363. Epub 2014 Mar 19.
• [1137] FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.Mod Pathol. 2017 Sep;30(9):1262-1272. doi: 10.1038/modpathol.2017.44. Epub 2017 Jun 16.
• [1138] Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas.Exp Mol Pathol. 2013 Feb;94(1):262-9. doi: 10.1016/j.yexmp.2012.10.014. Epub 2012 Oct 24.
• [1139] Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas.PLoS One. 2012;7(7):e41420. doi: 10.1371/journal.pone.0041420. Epub 2012 Jul 24.
• [1140] Insulin-like growth factor binding protein-4 gene silencing in lung adenocarcinomas.Pathol Int. 2011 Jan;61(1):19-27. doi: 10.1111/j.1440-1827.2010.02612.x. Epub 2010 Nov 3.
• [1141] Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.Neoplasma. 2014;61(4):468-75. doi: 10.4149/neo_2014_058.
• [1142] Downregulated inhibitor of growth 3 (ING3) expression during colorectal carcinogenesis.Indian J Med Res. 2014 Apr;139(4):561-7.
• [1143] Elevated integrin 64 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.Hum Pathol. 2016 Aug;54:174-83. doi: 10.1016/j.humpath.2016.04.003. Epub 2016 Apr 20.
• [1144] JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.PLoS Biol. 2014 Mar 25;12(3):e1001819. doi: 10.1371/journal.pbio.1001819. eCollection 2014 Mar.
• [1145] NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.Cancer Res. 2014 Jul 15;74(14):3935-46. doi: 10.1158/0008-5472.CAN-13-2733. Epub 2014 May 22.
• [1146] Stimulation of -catenin and colon cancer cell growth by the KDM4B histone demethylase.Int J Oncol. 2014 Apr;44(4):1341-8. doi: 10.3892/ijo.2014.2279. Epub 2014 Jan 27.
• [1147] The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma.PLoS One. 2013 Apr 23;8(4):e61664. doi: 10.1371/journal.pone.0061664. Print 2013.
• [1148] Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.Biochem Biophys Res Commun. 2014 Jan 24;443(4):1141-7. doi: 10.1016/j.bbrc.2013.12.106. Epub 2013 Dec 28.
• [1149] Lumican is overexpressed in lung adenocarcinoma pleural effusions.PLoS One. 2015 May 11;10(5):e0126458. doi: 10.1371/journal.pone.0126458. eCollection 2015.
• [1150] Analysis of MAT3 gene expression in NSCLC.Diagn Pathol. 2013 Oct 9;8:166. doi: 10.1186/1746-1596-8-166.
• [1151] Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.Mol Cancer Ther. 2014 Jul;13(7):1813-25. doi: 10.1158/1535-7163.MCT-13-1004. Epub 2014 Apr 30.
• [1152] NADPH oxidases and cancer.Clin Sci (Lond). 2015 Jun;128(12):863-75. doi: 10.1042/CS20140542.
• [1153] RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis.J Clin Invest. 2014 May;124(5):1899-913. doi: 10.1172/JCI65178. Epub 2014 Mar 25.
• [1154] High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma.Int J Gynecol Cancer. 2014 Feb;24(2):201-9. doi: 10.1097/IGC.0000000000000054.
• [1155] Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.Hum Pathol. 2013 Jan;44(1):1-19. doi: 10.1016/j.humpath.2012.05.014. Epub 2012 Sep 7.
• [1156] Increased expression of proline-, glutamic acid- and leucine-rich protein PELP1 in non-small cell lung cancer.Biomed Pharmacother. 2015 Jul;73:97-101. doi: 10.1016/j.biopha.2015.05.015. Epub 2015 Jun 1.
• [1157] PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.Gastroenterology. 2014 May;146(5):1301-12.e1-10. doi: 10.1053/j.gastro.2014.02.003. Epub 2014 Feb 11.
• [1158] Both gene deletion and promoter hyper-methylation contribute to the down-regulation of ZAC/PLAGL1 gene in gastric adenocarcinomas: a case control study.Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):744-50. doi: 10.1016/j.clinre.2013.06.007. Epub 2014 Aug 1.
• [1159] Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers.Clin Lung Cancer. 2013 Jan;14(1):45-9. doi: 10.1016/j.cllc.2012.04.004. Epub 2012 Jun 1.
• [1160] DARPP-32: from neurotransmission to cancer.Oncotarget. 2016 Apr 5;7(14):17631-40. doi: 10.18632/oncotarget.7268.
• [1161] Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers.J Ovarian Res. 2015 May 14;8:29. doi: 10.1186/s13048-015-0156-0.
• [1162] Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.Hum Pathol. 2001 Apr;32(4):360-7. doi: 10.1053/hupa.2001.23514.
• [1163] Pair-wise comparison analysis of differential expression of mRNAs in early and advanced stage primary colorectal adenocarcinomas.BMJ Open. 2014 Aug 8;4(8):e004930. doi: 10.1136/bmjopen-2014-004930.
• [1164] Cytoplasmic overexpression of CD95L in esophageal adenocarcinoma cells overcomes resistance to CD95-mediated apoptosis.Neoplasia. 2011 Mar;13(3):198-205. doi: 10.1593/neo.101304.
• [1165] Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.PLoS One. 2015 May 11;10(5):e0123369. doi: 10.1371/journal.pone.0123369. eCollection 2015.
• [1166] Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas.Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):133-40. doi: 10.1097/PAI.0b013e3181f09179.
• [1167] Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.Int J Cancer. 2015 Nov 1;137(9):2104-13. doi: 10.1002/ijc.29596. Epub 2015 May 21.
• [1168] Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency.Hum Pathol. 2016 Sep;55:83-90. doi: 10.1016/j.humpath.2016.04.018. Epub 2016 May 14.
• [1169] Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer.Cancer Res. 2014 Oct 1;74(19):5631-43. doi: 10.1158/0008-5472.CAN-14-0476.
• [1170] STAG2 expression in oral cancer and potentially malignant lesions.Tumour Biol. 2014 Apr;35(4):3641-5. doi: 10.1007/s13277-013-1482-8. Epub 2013 Dec 8.
• [1171] Ets1 and heat shock factor 1 regulate transcription of the Transformer 2 gene in human colon cancer cells.J Gastroenterol. 2013 Nov;48(11):1222-33. doi: 10.1007/s00535-012-0745-2. Epub 2013 Jan 30.